<SEC-DOCUMENT>0001121404-25-000002.txt : 20250130
<SEC-HEADER>0001121404-25-000002.hdr.sgml : 20250130
<ACCEPTANCE-DATETIME>20250130095049
ACCESSION NUMBER:		0001121404-25-000002
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20241231
FILED AS OF DATE:		20250130
DATE AS OF CHANGE:		20250130

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Sanofi
		CENTRAL INDEX KEY:			0001121404
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				133529324
		STATE OF INCORPORATION:			I0
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-31368
		FILM NUMBER:		25571455

	BUSINESS ADDRESS:	
		STREET 1:		46 AVENUE DE LA GRANDE ARMEE
		CITY:			PARIS
		STATE:			I0
		ZIP:			75017
		BUSINESS PHONE:		33153774400

	MAIL ADDRESS:	
		STREET 1:		46 AVENUE DE LA GRANDE ARMEE
		CITY:			PARIS
		STATE:			I0
		ZIP:			75017

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SANOFI-AVENTIS
		DATE OF NAME CHANGE:	20040826

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SANOFI SYNTHELABO SA
		DATE OF NAME CHANGE:	20010104
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>a6kcoverpagepressreleaseq4.htm
<DESCRIPTION>6-K
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i38cca4bef9f44a109a3c14e10c6cdbdd_1"></div><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UNITED STATES</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Washington, D.C. 20549</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FORM&#160;6-K</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">REPORT OF FOREIGN PRIVATE ISSUER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO RULE&#160;13a-16&#160;OR&#160;15d-16</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UNDER THE SECURITIES EXCHANGE ACT OF 1934</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the month of January 2025</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission File Number&#58;&#160;001-31368</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SANOFI</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Translation of registrant&#8217;s name into English)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">46, avenue de la Grande Arm&#233;e, 75017 Paris, FRANCE</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Address of principal executive offices)</font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:3pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant files or will file annual reports under cover Form&#160;20-F&#160;or Form&#160;40-F.</font></div><div style="margin-top:3pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Form 20-F&#160;&#160;&#9746;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Form&#160;40-F&#160;&#160;&#9744;</font></div><div style="margin-top:3pt;text-align:center"><font><br></font></div><div style="margin-top:3pt"><font><br></font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="margin-top:3pt"><font><br></font></div><div style="margin-top:3pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2025, Sanofi issued the press release attached hereto as Exhibit 99.1 which is incorporated herein by reference.</font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit Index</font></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"><tr><td style="width:1.0%"></td><td style="width:18.426%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.374%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit No.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Description</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exhibit 99.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Press release dated January 30, 2025&#58; Sanofi&#58; Q4 sales growth of 10.3%, 2024 business EPS guidance exceeded, and strong business EPS rebound expected in 2025</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SIGNATURES</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.163%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.747%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.303%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.635%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated&#58; January 30, 2025</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SANOFI</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#47;s&#47; Alexandra Roger</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alexandra Roger</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Head of Legal Corporate &#38; Finance</font></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>pressreleaseq42024english.htm
<DESCRIPTION>EX-99.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i51fa31ed94a244b2b3f81c6cd6a64363_1"></div><div style="min-height:53.86pt;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.052%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.056%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:63.592%"></td><td style="width:0.1%"></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#23004c;font-family:'Verdana',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Press Release</font></div></td><td colspan="3" style="padding:0 1pt"><div style="padding-right:53.86pt;text-align:right"><img alt="fsridynmyoja6mde4ndmxymzjn.gif" src="fsridynmyoja6mde4ndmxymzjn.gif" style="height:45px;margin-bottom:5pt;vertical-align:text-bottom;width:165px"></div></td></tr></table></div></div><div style="margin-bottom:8pt;text-align:justify"><font><br></font></div><div style="margin-bottom:8pt;text-align:justify"><font><br></font></div><div style="margin-bottom:8pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;margin-top:9pt"><font style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:16pt;font-style:italic;font-weight:400;line-height:120%">Sanofi&#58; Q4 sales growth of 10.3%, 2024 business EPS guidance exceeded, and strong business EPS rebound expected in 2025</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Paris, January 30, 2025</font></div><div style="margin-bottom:3pt;margin-top:12pt"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Q4&#58; sales growth of 10.3% at CER</font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.8pt;font-weight:700;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> and business EPS</font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.8pt;font-weight:700;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> of &#8364;1.31</font></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Pharma launches up 56.5%, reaching sales of &#8364;0.8 billion, 8% of total sales, led by ALTUVIIIO</font></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Dupixent sales up 16.0% to &#8364;3.5 billion</font></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Vaccines sales up 10.8% to &#8364;2.2 billion, driven by Beyfortus sales in Europe</font></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Business EPS of &#8364;1.31, -11.0% at CER and -14.9% reported&#59; IFRS EPS of &#8364;0.54</font></div><div style="margin-bottom:1pt;margin-top:8pt"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">FY&#58; double-digit sales growth and business EPS guidance exceeded</font></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Sales totaled &#8364;41.1 billion, an increase of 11.3% at CER</font></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Sales targets exceeded&#58; Dupixent &#62;&#8364;13 billion and Beyfortus blockbuster status (&#8364;1.7 billion) in its first full year</font></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Research and Development expenses reached &#8364;7.4 billion, up 14.6%, in line with commitments</font></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Business EPS of &#8364;7.12, +4.1% at CER, above guidance, and -1.8% reported&#59; IFRS EPS of &#8364;4.59</font></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">The Board of Directors met on January 29, 2025&#59; proposes a dividend of &#8364;3.92 for 2024, 30th year of consecutive increases</font></div><div style="margin-bottom:1pt;margin-top:8pt"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Pipeline&#58; increased investment and progress</font></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Q4&#58; four regulatory approvals&#58; Dupixent EoE (children) (EU), Kevzara PMR (EU), Cerdelga GD1 (children) (EU), Efluelda flu (JP)</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">3</font></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">FY&#58; 14 regulatory approvals of medicines and vaccines, 21 regulatory submission acceptances, and eight positive phase 3 readouts emphasize a positive and improving pipeline momentum</font></div><div style="margin-bottom:1pt;margin-top:8pt"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Further progress towards a focused biopharma business</font></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Intention to sell a controlling stake in Opella consumer health at an attractive valuation&#59; closing in Q2 2025 at the earliest</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">4</font></div><div style="margin-bottom:1pt;margin-top:8pt"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Guidance</font></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">In 2025, sales are anticipated to grow by a mid-to-high single-digit percentage at CER</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">5</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">. Sanofi confirms the expectation of a strong rebound in business EPS with growth at a low double-digit percentage at CER (before share buyback).</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">6</font></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Sanofi intends to execute a share buyback program in 2025 of &#8364;5 billion. Shares will be purchased preferably through block trades and in the open market with the purpose of cancellation.</font></div><div style="margin-bottom:5pt;margin-top:6pt;text-align:justify"><font style="color:#7802e6;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">Paul Hudson, Chief Executive Officer&#58;</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7.8pt;font-style:italic;font-weight:400;line-height:120%">&#8220;We achieved double-digit sales growth in 2024 while pursuing the transformation of the company. Innovation was a key driver of our growth as launches already contributed 11 percent of sales, with Beyfortus becoming a blockbuster in its first full year of sales. We exceeded our business EPS guidance. In 2024, we announced an intention to sell a controlling stake in Opella consumer health, which will make Sanofi a focused, science-driven biopharma company. We increased R&#38;D investments and achieved significant progress with our pipeline in 2024, including positive phase 3 study results for new medicines such as rilzabrutinib in rare diseases and tolebrutinib in multiple sclerosis. As we enter 2025, we expect continued, solid growth in sales and a strong rebound in earnings. We are also confident in the mid to long-term growth prospects of Sanofi, supported by ongoing launches, Dupixent (currently expected to reach sales of around &#8364;22 billion in 2030</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.07pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.73pt;vertical-align:baseline">7</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7.8pt;font-style:italic;font-weight:400;line-height:120%">, in line with the current ambition), and expected future launches from our pipeline.&#8221;</font></div><div style="margin-bottom:3pt;text-align:justify"><font><br></font></div><div id="i51fa31ed94a244b2b3f81c6cd6a64363_4"></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.948%"><tr><td style="width:1.0%"></td><td style="width:24.940%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.226%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.226%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.226%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.226%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.226%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.230%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Q4 2024</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Change</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Change <br>at CER</font></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">FY 2024</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Change</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Change <br>at CER</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">IFRS net sales reported</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8364;10,564&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">m</font></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+9.1&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+10.3&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8364;41,081&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">m</font></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+8.6&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+11.3&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">IFRS net income reported</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8364;683&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">m</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8364;5,744&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">m</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+6.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">IFRS EPS reported</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8364;0.54&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8364;4.59&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+6.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Free cash flow<font style="font-size:4.55pt;position:relative;top:-2.44pt;vertical-align:baseline">8</font></font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8364;2,340&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">m</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-25.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8364;5,955&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">m</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-19.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Business operating income</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8364;2,078&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">m</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-11.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-7.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8364;11,343&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">m</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+1.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+7.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Business net income</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8364;1,642&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">m</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-15.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-11.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8364;8,912&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">m</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-1.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+4.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Business EPS</font></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8364;1.31&#160;</font></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"></td><td colspan="2" style="border-bottom:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-14.9&#160;</font></td><td style="border-bottom:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="border-bottom:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-11.0&#160;</font></td><td style="border-bottom:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8364;7.12&#160;</font></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"></td><td colspan="2" style="border-bottom:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-1.8&#160;</font></td><td style="border-bottom:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="border-bottom:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+4.1&#160;</font></td><td style="border-bottom:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr></table></div><div style="border-bottom:1pt solid #000000;margin-bottom:5pt;margin-top:10pt;opacity:1;width:150pt"></div><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"> Changes in net sales are at constant exchange rates (CER) unless stated otherwise (definition in Appendix 9).</font></div><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"> To facilitate an understanding of operational performance, Sanofi comments on the business net income statement which is a non-IFRS financial </font></div><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">measure (definition in Appendix 9). The income statement is in Appendix 3 and a reconciliation of reported IFRS to business net income is in Appendix 4.</font></div><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">3</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"> For the definition of medical and scientific terms, please see the first use of the word in the Pipeline update section.</font></div><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">4</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"> Subject to finalization of definitive agreements and subject to obtaining regulatory approvals from the competent authorities.</font></div><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">5</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"> In 2025, sales growth will exclude any impact from hyperinflation. In 2024, it is estimated that sales growth benefited by 1.8 percentage points.</font></div><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">6</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"> Applying average January 2025 exchange rates, the currency impacts are estimated between +2% and +3% on sales and +2% and +3% on business EPS.</font></div><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">7</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"> At CER.</font></div><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">8</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"> Free cash flow is a non-IFRS financial measure (definition in Appendix 9).</font></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:5pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:94.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.882%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI&#160;&#160; &#160;&#160;</font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">PRESS RELEASE</font><font style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%"> Q4 2024</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">1</font></div></td></tr></table></div></div></div><div id="i51fa31ed94a244b2b3f81c6cd6a64363_7"></div><hr style="page-break-after:always"><div style="min-height:53.86pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:9pt"><font style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:16pt;font-style:italic;font-weight:400;line-height:120%">Q4 and FY 2024 summary</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">A conference call and webcast for investors and analysts will begin at 15&#58;00 CET. Details can be accessed via sanofi.com, including presentation slides.</font></div><div style="margin-bottom:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.332%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #7802e6;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-style:italic;font-weight:400;line-height:120%">The performance shown in this press release covers the three-month period to December 31, 2024 (the quarter or Q4 2024) and the 12-month period to December 31, 2024 (the year or FY 2024) compared to the three-month period to December 31, 2023 (Q4 2023) and the 12-month period to December 31, 2023 (FY 2023) respectively. All percentage changes in sales in this press release are at CER and the commentary below emphasizes the recent quarterly performance, unless stated otherwise.</font></div><div style="margin-bottom:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.332%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #7802e6;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In Q4 2024, sales were &#8364;10,564 million and increased by 10.3%. Exchange rate movements had a negative effect of 1.2&#160;percentage points (pp)&#59; therefore, as reported, sales increased by 9.1%. The divestments of medicines&#47;portfolio streamlining had a negative impact of 0.6pp.</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In FY 2024, sales were &#8364;41,081 million and increased by 11.3%. Exchange rate movements had a negative effect of 2.7pp&#59; therefore, as reported, sales increased by 8.6%. The divestments of medicines&#47;portfolio streamlining had a negative impact of 0.7pp.</font></div><div style="margin-bottom:3pt;margin-top:12pt"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Sales by geography</font></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.948%"><tr><td style="width:1.0%"></td><td style="width:49.593%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.226%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.226%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.226%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.229%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net sales</font></div><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</font></div></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Q4 2024</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Change <br>at CER</font></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">FY 2024</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Change <br>at CER</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5,151&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+13.3&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">19,986&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+16.2&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Europe</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,433&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+6.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9,027&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+2.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Rest of World</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,980&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+8.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12,068&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+10.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #23004c;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">of which China</font></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">549&#160;</font></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-bottom:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">-10.4&#160;</font></td><td style="border-bottom:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">2,666&#160;</font></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-bottom:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">-0.5&#160;</font></td><td style="border-bottom:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:115%">US</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:115%"> </font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:115%">sales were &#8364;5,151 million and increased by 13.3%. The strong performance was driven by launches, including Beyfortus, and by Dupixent and Lantus. Other main medicines, and vaccines excluding Beyfortus had slightly lower sales during the quarter.</font></div><div style="margin-bottom:3pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Europe</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> sales were &#8364;2,433 million and increased by 6.0%. Growth was driven by Beyfortus, Dupixent and pharma launches. Other medicines, including Aubagio which faced generic competition, and flu vaccines all had lower sales during Q4.</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Rest of World</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">sales were &#8364;2,980 million and increased by 8.8%. The performance was led by Dupixent, Beyfortus, PPH and booster vaccines, and pharma launches offset by flu vaccines and legacy medicines, including Plavix. </font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">China</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> sales were &#8364;549 million and decreased by 10.4%, generally impacted by one-off inventory effects ahead of upcoming changes to the national reimbursement drug list and volume-based procurement. In the year, China sales were broadly stable. Hyperinflation in </font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Argentina</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> contributed 1.8pp to the total Sanofi growth rate in the quarter and 1.4pp in the year.</font></div><div style="margin-bottom:3pt;margin-top:12pt"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Business operating income</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In Q4 2024, business operating income (BOI) was &#8364;2,078 million and decreased by 7.7% (-11.8% reported). The ratio of BOI to net sales was 20.4% and decreased by 3.9pp (19.7% reported, down by 4.6pp). This decrease was mainly driven by a lower gross margin and higher R&#38;D expenses. In FY 2024, BOI was &#8364;11,343 million and increased by 7.6% (+1.5% reported). The ratio of BOI to net sales was 28.6% and decreased by 1.0pp (27.6% reported, down by 2.0pp).</font></div><div style="margin-bottom:3pt;margin-top:12pt"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Business development</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Business development, including strategic investments in external innovation is an integrated part of Sanofi&#8217;s efforts to continuously access optionality from new and promising scientific developments and platforms and replenish the pipeline.</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In October, Sanofi made a strategic equity investment in Resalis Therapeutics, an Italian company dedicated to developing RNA-based therapies that tackle the root causes of complex metabolic disorders. Sanofi also participated in a &#8364;82 million series D financing of Agomab, a Belgian company focused on achieving disease modification by modulating fibrosis and regeneration in chronic indications such as fibrostenosing Crohn&#8217;s disease and idiopathic pulmonary fibrosis.</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In November, Sanofi made a strategic investment in Zucara, a Canadian company, as part of a $20 million series B financing. As part of the agreement, Sanofi will receive an exclusive right of first negotiation.</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In November, Recordati announced the closing of the acquisition of global rights to Enjaymo. Enjaymo is a targeted, biologic medicine approved in the US, the EU and Japan for the treatment of cold agglutinin disease, a rare lymphoproliferative disease.</font></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:5pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:94.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.882%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI&#160;&#160; &#160;&#160;</font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">PRESS RELEASE</font><font style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%"> Q4 2024</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">2</font></div></td></tr></table></div></div></div><div id="i51fa31ed94a244b2b3f81c6cd6a64363_10"></div><hr style="page-break-after:always"><div style="min-height:53.86pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:9pt"><font style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:16pt;font-style:italic;font-weight:400;line-height:120%">Biopharma segment</font></div><div id="i51fa31ed94a244b2b3f81c6cd6a64363_13"></div><div style="margin-bottom:3pt;margin-top:12pt"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Pharma</font></div><div id="i51fa31ed94a244b2b3f81c6cd6a64363_16"></div><div style="margin-bottom:3pt;margin-top:12pt"><font style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Pharma launches</font></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.948%"><tr><td style="width:1.0%"></td><td style="width:49.593%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.226%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.226%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.226%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.229%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net sales </font></div><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</font></div></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Q4 2024</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Change <br>at CER</font></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">FY 2024</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Change <br>at CER</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">ALTUVIIIO</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">230&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+143.6&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">682&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+330.2&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Nexviazyme&#47;Nexviadyme</font></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">184&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+42.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">667&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+61.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:133%">Rezurock</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">132&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+53.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">470&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+51.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Sarclisa</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">130&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+30.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">471&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+29.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:133%">Cablivi</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">73&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+24.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">249&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+9.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Xenpozyme</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">38&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+50.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">151&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+68.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Enjaymo</font></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">22&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-8.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">105&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+48.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:133%">Tzield</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">18&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+80.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">54&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+116.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</font></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">827</font><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+56.5</font><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,849</font><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+71.4</font><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">ALTUVIIIO</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (hemophilia A) sales were &#8364;230 million of which more than 85% were in the US. Growth continued to be driven by patient switches from older factor medicines and an increasing percentage from non-factor treatments. Rest of World sales of &#8364;32 million benefited from supply sales for the ongoing launch of Altuvoct in countries served by Sobi. The hemophilia A franchise (ALTUVIIIO and Eloctate) sales were &#8364;311 million and increased by 57.4% as fewer patients switch away from Eloctate.</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Nexviazyme&#47;Nexviadyme</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (Pompe disease) sales were &#8364;184 million and increased by 42.0%, driven by Europe (+68.6%) and Rest of World (+55.0%). In the US (+26.3%), most patients have already converted from Myozyme&#47;Lumizyme. The Pompe disease franchise (Nexviazyme&#47;Nexviadyme and Myozyme&#47;Lumizyme) sales were &#8364;316 million and increased by 9.7%.</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Rezurock</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (chronic graft-versus-host disease) sales were &#8364;132 million and increased by 53.5%, driven by the US (+43.4%) and by launches in Europe (sales of &#8364;8 million) and in Rest of World (sales of &#8364;5 million).</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Sarclisa</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (multiple myeloma) sales were &#8364;130 million and increased by 30.1%, driven by increased use in earlier lines of treatment, mainly in second-line combination treatment, and market share gains in general, in Europe and in Rest of World, including Japan.</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Cablivi </font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(acquired thrombotic thrombocytopenic purpura) sales were &#8364;73 million and increased by 24.1%, driven by an increased number of patients being identified for appropriate treatment, in the US and from launches in Europe and in Rest of World.</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Xenpozyme </font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(acid sphingomyelinase deficiency) sales were &#8364;38 million and increased by 50.0%, driven by an increased number of patients being identified for appropriate treatment across all geographies.</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Enjaymo</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (cold agglutinin disease) sales were &#8364;22 million and decreased by 8.7%. On November 29, 2024, Recordati announced the closing of the acquisition of global rights to Enjaymo at which point Sanofi stopped booking in-market sales of the medicine.</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Tzield </font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(delay onset of type 1 diabetes) sales were &#8364;18 million, a sequential increase from Q3 2024 of &#8364;3 million, reflecting continued growth in patients and infusions supported by ongoing efforts to increase awareness and screening.</font></div><div id="i51fa31ed94a244b2b3f81c6cd6a64363_19"></div><div style="margin-bottom:3pt;margin-top:12pt"><font style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Immunology</font></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.948%"><tr><td style="width:1.0%"></td><td style="width:49.593%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.226%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.226%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.226%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.229%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net sales </font></div><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</font></div></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Q4 2024</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Change <br>at CER</font></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">FY 2024</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Change <br>at CER</font></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Dupixent</font></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,458&#160;</font></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+16.0&#160;</font></td><td style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13,072&#160;</font></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+23.1&#160;</font></td><td style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Dupixent</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> sales were &#8364;3,458 million and increased by 16.0%. In the US, sales were &#8364;2,551 million and increased by 10.4%. Growth was driven by continued strong prescription trends in atopic dermatitis, asthma, chronic rhinosinusitis with nasal polyposis, eosinophilic esophagitis, and prurigo nodularis. The launch in COPD has initiated and is expected to gain momentum in 2025. Sales growth was impacted by fewer business days in Q4 2024 compared to prior periods and a year-end gross-to-net adjustment. In Europe, Dupixent sales were &#8364;431 million and increased by 30.4% reflecting continued growth in all approved indications. Following the July 2024 EU approval in COPD, Europe benefited from initial sales in Germany while reimbursement decisions are anticipated throughout Europe in 2025. In Rest of World, sales were &#8364;476&#160;million and increased by 38.1%, driven mainly by sales in Japan. In FY 2024, Dupixent</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"> </font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">sales were &#8364;13,072&#160;million and increased by 23.1%, exceeding the target of around &#8364;13 billion in sales in 2024 at constant exchange rates.</font></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:5pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:94.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.882%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI&#160;&#160; &#160;&#160;</font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">PRESS RELEASE</font><font style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%"> Q4 2024</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">3</font></div></td></tr></table></div></div></div><div id="i51fa31ed94a244b2b3f81c6cd6a64363_22"></div><hr style="page-break-after:always"><div style="min-height:53.86pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:3pt;margin-top:12pt"><font style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Other main medicines</font></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.948%"><tr><td style="width:1.0%"></td><td style="width:49.593%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.226%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.226%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.226%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.229%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net sales </font></div><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</font></div></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Q4 2024</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Change <br>at CER</font></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">FY 2024</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Change <br>at CER</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Lantus</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">439&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+63.4&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,628&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+20.8&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Toujeo</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">290&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+6.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,227&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+13.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:133%">Fabrazyme</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">269&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+12.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,047&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+9.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Lovenox</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">231&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-7.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">982&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-7.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Plavix</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">211&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-16.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">914&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-0.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:133%">Cerezyme</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">171&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+33.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">742&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+20.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:133%">Alprolix</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">169&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+19.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">588&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+9.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:133%">Myozyme&#47;Lumizyme</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">132&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-17.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">671&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-12.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Thymoglobulin</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">125&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+15.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">492&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+7.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Praluent</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">110&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-6.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">483&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+15.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cerdelga</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">87&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+16.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">333&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+12.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Eloctate</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">81&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-21.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">368&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-20.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Aubagio</font></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">78&#160;</font></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-bottom:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-35.5&#160;</font></td><td style="border-bottom:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">379&#160;</font></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-bottom:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-59.4&#160;</font></td><td style="border-bottom:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Lantus</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> sales were &#8364;439 million and increased by 63.4%. US sales were &#8364;193 million and benefited from a lower base of comparison from a net-price adjustment in the prior period and another quarter of windfall sales due to the continued unavailability of a competing medicine. In 2025, customer demand is expected to normalize and windfall sales to reduce as well.</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Toujeo</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> sales were &#8364;290 million and increased by 6.5%, mainly driven by Europe (+10.1%) and Rest of World (+7.4%) where Toujeo continued to increase its basal insulin market share. US sales declined slightly (-4.3%) as windfall sales started to subside.</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Fabrazyme</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> sales were &#8364;269 million and increased by 12.4%, mainly driven by growth in the number of patients and improved treatment compliance.</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Lovenox</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"> </font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">sales were &#8364;231 million and decreased by 7.6%, reflecting the continued impact from volume-based procurement in China and biosimilar competition in Europe.</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Plavix</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> sales were &#8364;211 million and decreased by 16.9%, reflecting renewal of volume-based procurement in China and market volatility in Japan.</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Cerezyme</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">sales were &#8364;171 million and increased by 33.8%, driven by growth in the number of patients in Rest of World as well as an element of high-inflation boost from Argentina. The Gaucher disease franchise (Cerezyme and Cerdelga) sales were &#8364;258 million and increased by 27.4%.</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Alprolix</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> sales were &#8364;169 million and increased by 19.0%, benefiting from an increase in US market share and supply sales to Sobi.</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Myozyme&#47;Lumizyme</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> sales were &#8364;132 million and decreased by 17.0% due to the aforesaid shift to Nexviazyme&#47;Nexviadyme.</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Thymoglobulin</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> sales were &#8364;125 million and increased by 15.2%, reflecting increased sales in the US and in Rest of World.</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Praluent</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> sales were &#8364;110 million and decreased by 6.8%, reflecting lower sales in Rest of World, specifically in China.</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Cerdelga</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> sales were &#8364;87 million and increased by 16.0%, primarily driven by a higher number of patients and volume in the US.</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Eloctate</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> sales were &#8364;81 million and decreased by 21.4%, mainly due to patients converting to ALTUVIIIO in the US and in Japan.</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Aubagio</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline"> </font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">sales were &#8364;78 million and decreased by 35.5%, reflecting the loss of exclusivity starting in the US in March 2023 followed by the EU in September 2023. Aubagio sales are expected to continue to decrease albeit at a slower rate.</font></div><div id="i51fa31ed94a244b2b3f81c6cd6a64363_25"></div><div style="margin-bottom:3pt;margin-top:12pt"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Vaccines</font></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.948%"><tr><td style="width:1.0%"></td><td style="width:49.593%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.226%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.226%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.226%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.229%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net sales </font></div><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</font></div></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Q4 2024</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Change <br>at CER</font></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">FY 2024</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Change <br>at CER</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">RSV (Beyfortus)</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">841&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+106.6&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,686&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+214.4&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Polio&#47;Pertussis&#47;Hib vaccines and boosters</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">632&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+10.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,741&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+1.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Influenza vaccines</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">454&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-36.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,555&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-1.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Meningitis, Travel and endemic vaccines </font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">249&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-4.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,316&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+5.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</font></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,177</font><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+10.8</font><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8,299</font><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+13.5</font><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Vaccines</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> sales were &#8364;2,177 million and increased by 10.8%, driven by continued Beyfortus roll-out, mostly in Europe. In FY 2024, sales were &#8364;8,299 million and increased by 13.5%. This performance was driven by a successful roll-out of Beyfortus, reaching &#8364;1.7 billion in sales, partly offset by the absence of COVID-19 sales compared to &#8364;226 million in FY 2023.</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Beyfortus</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> sales were &#8364;841 million, driven by additional sales in Europe, in particular Germany, and in the US. Beyfortus is now protecting babies in more than 20 countries. The continued successful roll-out was enabled by additional manufacturing capacity approved during the second half-year of 2024.</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Polio&#47;Pertussis&#47;Hib (PPH) and booster vaccines</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> sales were &#8364;632 million and increased by 10.8%, driven by increased booster demand in several countries to re-vaccinate adolescents and adults.</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Influenza vaccines</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> sales were &#8364;454 million and decreased by 36.8%, due to earlier deliveries in Q3 2024 compared to last year.</font></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:5pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:94.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.882%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI&#160;&#160; &#160;&#160;</font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">PRESS RELEASE</font><font style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%"> Q4 2024</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">4</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:53.86pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Meningitis, Travel and endemic vaccines</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> sales were &#8364;249 million and decreased by 4.2%, reflecting unfavorable US Centers for Disease Control and Prevention buying patterns partly offset by continued MenQuadfi roll-out in Europe and Rest of World.</font></div><div id="i51fa31ed94a244b2b3f81c6cd6a64363_28"></div><div style="margin-bottom:3pt;margin-top:12pt"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Biopharma business operating income</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In Q4 2024, Biopharma BOI was &#8364;2,038 million and decreased by 8.9% (-13.0% reported). The ratio of BOI to net sales was 20.0% and decreased by 4.2pp (19.3% reported, down by 4.9pp). This decrease was mainly driven by a lower gross margin and higher R&#38;D expenses. In FY 2024, BOI was &#8364;11,285 million and increased by 7.3% (+1.2% reported). The ratio of BOI to net sales was 28.4% and decreased by 1.1pp (27.5% reported, down by 2.0pp).</font></div><div id="i51fa31ed94a244b2b3f81c6cd6a64363_31"></div><div style="margin-bottom:3pt;margin-top:12pt"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Pipeline update</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi has 83 projects in a pipeline across four main disease areas (Immunology, Rare diseases, Neurology, and Oncology) and Vaccines, including 38 potential new medicines (NMEs) and vaccines (NVEs). The following section highlights significant developments in the late- and mid-stage pipeline in the quarter&#58;</font></div><div style="margin-bottom:3pt;margin-top:12pt"><font style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Highlights</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.948%"><tr><td style="width:1.0%"></td><td style="width:31.411%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:66.389%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Regulatory approvals</font></td><td colspan="3" style="border-left:0.25pt solid #000;border-right:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Dupixent &#8211; EoE (children) (EU)<br>Kevzara &#8211; Polymyalgia rheumatica (PMR) (EU)<br>Cerdelga &#8211; GD1 (children) (EU)<br>Efluelda &#8211; Influenza (JP)</font></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Regulatory submissions&#47;acceptances<font style="font-size:4.55pt;position:relative;top:-2.44pt;vertical-align:baseline">1</font></font></td><td colspan="3" style="border-left:0.25pt solid #000;border-right:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Dupixent &#8211; CSU (US)</font></div><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Dupixent &#8211; BP (US</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">)</font></div><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">rilzabrutinib &#8211; ITP (US, EU, CN)</font></div><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Tzield &#8211; DO (EU)</font></div><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Tzield &#8211; EI (EU)</font></div><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">tolebrutinib &#8211; SPMS (US</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">)</font></div><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sarclisa &#8211; NDMM, TE (HD7 study) (EU)</font></div></td></tr><tr><td colspan="3" style="border-bottom:0.25pt solid #000;border-left:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Phase 3 study starts</font></td><td colspan="3" style="border-bottom:0.25pt solid #000;border-left:0.25pt solid #000;border-right:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Fluzone HD &#8211; Flu (50 years+)<br>SP0202 &#8211; Pneumococcal disease<br>Dupixent &#8211; Lichen simplex chronicus</font></td></tr></table></div><div style="margin-bottom:3pt;margin-top:12pt"><font style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Immunology</font></div><div style="margin-bottom:3pt;margin-top:9pt"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Dupixent</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (dupilumab)</font></div><div style="margin-bottom:5pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Following the adoption of a positive opinion by the European Medicines Agency (EMA)&#8217;s Committee for Medicinal Products for Human Use, the EU approved Dupixent to treat </font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">eosinophilic esophagitis</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (EoE) in children as young as one year of age. The approval covers children aged one to 11 years who weigh at least 15 kg and who are inadequately controlled by, intolerant to, or who are not candidates for conventional medicinal therapy. The approval is based on the two-part (Part A and B) EoE KIDS phase 3 study (clinical study identifier&#58; NCT04394351). This expands the initial approval in the EU for EoE in adults and adolescents and makes Dupixent the first and only medicine indicated to treat these young patients.</font></div><div style="margin-bottom:5pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">The US Food and Drug Administration (FDA) accepted for review the resubmission of the supplemental biologics license application (sBLA) for Dupixent to treat adults and pediatric patients aged 12 years and older with </font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">chronic spontaneous urticaria</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (CSU) whose disease is not adequately controlled with H1 antihistamine treatment. The target action date for the FDA decision is April 18, 2025.</font></div><div style="margin-bottom:5pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Regeneron announced that the sBLA for Dupixent to treat adults with moderate-to-severe </font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">bullous pemphigoid</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (BP) had been submitted to the FDA. BP is a chronic and relapsing disease characterized by intense itch and blisters, reddening of the skin, and painful chronic lesions. The blisters and rash can form over much of the body and cause the skin to bleed and crust, resulting in patients being more prone to infection and affecting their daily functioning. Regeneron and Sanofi are awaiting regulatory submission acceptance in the US. </font></div><div style="margin-bottom:5pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">The STYLE 1 (clinical study identifier&#58; NCT06687967) and STYLE 2 (clinical study identifier&#58; NCT06687980) phase 3 studies of Dupixent compared with placebo in patients with </font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">lichen simplex chronicus</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> commenced dosing the first patient.</font></div><div style="margin-bottom:3pt;margin-top:9pt"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">duvakitug</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (TL1A mAb)</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The RELIEVE UCCD phase 2b study (clinical study identifier&#58; NCT05499130) met its primary endpoints in patients with </font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">ulcerative colitis</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (UC) and </font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Crohn&#8217;s disease</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (CD). RELIEVE UCCD assessed duvakitug, a human IgG1-&#955;2 monoclonal antibody targeting TL1A, for the treatment of moderate-to-severe inflammatory bowel disease. In the study, 36.2% (low dose) and 47.8% (high dose) of patients with UC treated with duvakitug achieved clinical remission compared to 20.4% on placebo, placebo-adjusted rates were 15.7% (low dose) and 27.4% (high dose), at week 14 (p&#61;0.050 and 0.003, respectively). In patients with CD, 26.1% (low dose) and 47.8% (high dose) treated with duvakitug achieved endoscopic response compared to 13.0% on placebo, placebo-adjusted rates were 13.0% (low dose) and 34.8% (high dose), at week 14 (p&#61;0.058 and &#60;0.001, respectively). Overall, the treatment effect was consistent across subgroups. This is the first and only randomized, placebo-controlled study to evaluate the impact of an anti-TL1A monoclonal antibody in CD. Detailed results are expected to be presented at the 20th Congress of the European Crohn's and Colitis Organisation in February 2025.</font></div><div style="border-bottom:1pt solid #000000;margin-bottom:5pt;margin-top:10pt;opacity:1;width:150pt"></div><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"> Disclosed by Regeneron&#47;awaiting regulatory submission acceptance.</font></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:5pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:94.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.882%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI&#160;&#160; &#160;&#160;</font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">PRESS RELEASE</font><font style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%"> Q4 2024</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">5</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:53.86pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:3pt;margin-top:9pt"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Tzield</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (teplizumab)</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The EMA accepted for review the regulatory submission for Tzield in children and adolescents to delay the onset (DO) of stage 3 </font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">type 1 diabetes</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (T1D) as well as for the early intervention (EI) of stage 3 T1D. Tzield is approved in the US to delay the onset of stage 3 T1D.</font></div><div style="margin-bottom:3pt;margin-top:9pt"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">balinatunfib </font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(oral TNFR1si)</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The SPECIFY-CD phase 2 study (clinical study identifier&#58; NCT06637631) of balinatunfib compared with placebo in adults with moderate-to-severe </font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">CD</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> commenced dosing the first patient.</font></div><div style="margin-bottom:3pt;margin-top:9pt"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">lunsekimig </font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(IL13xTSLP Nanobody VHH</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">)</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The AIRLYMPUS phase 2 study (clinical study identifier&#58; NCT06676319) of subcutaneous lunsekimig compared with placebo as an add-on therapy in </font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">high-risk asthma</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> adults not currently eligible for biologic treatments commenced dosing the first patient.</font></div><div style="margin-bottom:3pt;margin-top:12pt"><font style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Rare diseases</font></div><div style="margin-bottom:3pt;margin-top:9pt"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">rilzabrutinib</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (BTK inhibitor)</font></div><div style="margin-bottom:5pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Positive results from the LUNA 3 phase 3 study (clinical study identifier&#58; NCT04562766) of rilzabrutinib in adults with persistent or chronic </font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">immune thrombocytopenia</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (ITP), a rare immune-mediated disease, were presented at the 66th American Society of Hematology Annual Meeting and Exposition in San Diego, US. The primary endpoint was met, with rilzabrutinib demonstrating durable platelet response in 23% of ITP adult patients compared to 0% on the placebo arm (p&#60;0.0001). Platelet response was achieved in 65% (n&#61;86) of patients receiving rilzabrutinib compared to 33% (n&#61;23) of patients on placebo. Other key secondary endpoints were met including reduced bleeding, number of weeks with platelet response, the need for rescue therapy use, and improved physical fatigue and quality of life measures. Rilzabrutinib is under regulatory review in the EU, China, and the US with a target date for the FDA decision of August 29, 2025.</font></div><div style="margin-bottom:5pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">During the quarter, the 52-week open-label two-cohort phase 2 study (clinical study identifier&#58; NCT04520451) of rilzabrutinib in </font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">IgG4-related disease</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> showed considerable outcomes on disease flare and glucocorticoid sparing. Data are planned to be shared at a medical meeting later this year.</font></div><div style="margin-bottom:3pt;margin-top:9pt"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cerdelga </font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(eliglustat)</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Cerdelga was approved in the EU for the treatment of children with </font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Gaucher disease type 1</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (GD1), expanding the current use in adults.</font></div><div style="margin-bottom:3pt;margin-top:12pt"><font style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Neurology</font></div><div style="margin-bottom:3pt;margin-top:9pt"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">tolebrutinib</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (BTK inhibitor)</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The FDA granted breakthrough-therapy designation to tolebrutinib for the treatment of adults with non-relapsing secondary progressive </font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">multiple sclerosis</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (nrSPMS). This is based on positive results from the HERCULES phase 3 study (clinical study identifier&#58; NCT04411641), demonstrating that tolebrutinib delayed the time to onset of 6-month confirmed disability progression by 31% compared to placebo (HR 0.69&#59; 95% CI 0.55-0.88&#59; p&#61;0.0026), with further analysis of secondary endpoints demonstrating that the number of participants who experienced confirmed disability improvement was nearly double with tolebrutinib (10%) compared to those on placebo (5%) (HR 1.88&#59; 95% CI 1.10-3.21&#59; nominal p&#61;0.021). Sanofi is awaiting regulatory submission acceptance in the US with an EU submission anticipated during H1 2025.</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The PERSEUS phase 3 study in primary progressive MS (PPMS) is ongoing with study results anticipated in H2 2025 (clinical study identifier&#58; NCT04458051).</font></div><div style="margin-bottom:3pt;margin-top:12pt"><font style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Oncology</font></div><div style="margin-bottom:3pt;margin-top:9pt"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Sarclisa</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (isatuximab)</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The EMA accepted for review the regulatory submission for Sarclisa in combination with lenalidomide, bortezomib, and dexamethasone (RVd) induction therapy in transplant-eligible, newly diagnosed </font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">multiple myeloma</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (NDMM, TE) based on the GMMG-HD7 phase 3 study (clinical study identifier&#58; NCT03617731). In the study, Sarclisa significantly prolonged progression-free survival from first randomization, resulting in a statistically significant and clinically meaningful 30% reduction in disease progression or death, compared to RVd induction regardless of the maintenance regimen (HR 0.70&#59; 95% CI 0.52-0.95&#59; stratified log-rank p&#61;0.0184).</font></div><div style="margin-bottom:3pt;margin-top:12pt"><font style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Vaccines</font></div><div style="margin-bottom:3pt;margin-top:9pt"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SP0202</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (PCV21)</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">A phase 3 program (clinical study identifier&#58; NCT06736041) was initiated for SP0202, a 21-valent pneumococcal conjugate vaccine (PCV21). SP0202 is the first pneumococcal conjugate vaccine candidate with more than 20 serotypes to enter phase 3 in infants and toddlers. The phase 3 program will include more than 7,700 infants, toddlers, young children, and adolescents across multiple geographies, including in the US, Europe, Australia, Asia, and Latin America. In addition, Sanofi and SK bioscience expanded the agreement to develop, license and commercialize next-generation PCVs for both pediatric and adult populations. Despite decades of public health vaccination programs, invasive </font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">pneumococcal disease</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> continues to inflict a substantial burden of disease, primarily due to Streptococcus pneumoniae serotypes that are not included in currently available conjugate vaccines. Next-generation PCVs have the potential to extend vaccine coverage of disease-causing serotypes.</font></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:5pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:94.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.882%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI&#160;&#160; &#160;&#160;</font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">PRESS RELEASE</font><font style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%"> Q4 2024</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">6</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:53.86pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:3pt;margin-top:9pt"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SP0178 </font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(Fluzone HD)</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The vaccine candidate is in development to prevent </font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">influenza</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> infections in people aged 50 to 64 years. A phase 3 study (clinical study identifier&#58; NCT06641180) commenced dosing the first patient.</font></div><div style="margin-bottom:3pt;margin-top:9pt"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SP0287 </font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(Fluzone HD&#47;Flublok and Nuvaxovid)</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The FDA granted fast-track designation to two combination vaccine candidates to prevent </font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">influenza</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">COVID-19</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> infections in people 50 years of age and older. Both candidates combine two already licensed and authorized vaccines with proven efficacy through randomized controlled studies, and with favorable tolerability.</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The first combination vaccine candidate (clinical study identifier&#58; NCT06695117) consists of the inactivated flu vaccine Fluzone High-Dose combined with the adjuvanted recombinant Nuvaxovid COVID-19 vaccine. The second candidate (clinical study identifier&#58; NCT06695130) combines the recombinant protein-based flu vaccine Flublok with Nuvaxovid. Two separate phase 1&#47;2 studies have initiated.</font></div><div style="margin-bottom:3pt;margin-top:9pt"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SP0289</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (flu H5 mRNA)</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The FDA granted fast-track designation to the vaccine candidate to prevent </font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">pandemic influenza</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> and a phase 1&#47;2 study (clinical study identifier&#58; NCT06727058) commenced dosing the first patient.</font></div><div style="margin-bottom:3pt;margin-top:9pt"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SP0256 </font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(RSV+hMPV mRNA)</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The FDA granted fast-track designation to the vaccine candidate to prevent </font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">respiratory syncytial virus</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (RSV) and </font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">human metapneumovirus</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (hMPV) infections in people aged 60 to 75 years. A phase 1&#47;2 study (clinical study identifier&#58; NCT06583031) is ongoing.</font></div><div style="margin-bottom:3pt;margin-top:12pt"><font style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Anticipated major upcoming pipeline milestones</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.948%"><tr><td style="width:1.0%"></td><td style="width:9.223%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.852%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.810%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.715%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000;border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Medicine&#47;vaccine</font></td><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Indication</font></td><td colspan="3" style="border-right:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Description</font></td></tr><tr style="height:12pt"><td colspan="3" rowspan="15" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">H1 2025</font></td><td colspan="3" rowspan="2" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">Dupixent</font></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">COPD</font></td><td colspan="3" style="border-right:0.25pt solid #000;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">Regulatory decision (JP)</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">CSU</font></td><td colspan="3" style="border-right:0.25pt solid #000;border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">Regulatory decision (US, EU)</font></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">amlitelimab</font></td><td colspan="3" style="border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">Asthma</font></td><td colspan="3" style="border-right:0.25pt solid #000;border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">Phase 2 data</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">Hidradenitis suppurativa (HS)</font></td><td colspan="3" style="border-right:0.25pt solid #000;border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">Phase 2 data</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">balinatunfib (oral TNFR1si)</font></td><td colspan="3" style="border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">Psoriasis</font></td><td colspan="3" style="border-right:0.25pt solid #000;border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">Phase 2 data</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">brivekimig (TNFaxOX40L)</font></td><td colspan="3" style="border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">HS</font></td><td colspan="3" style="border-right:0.25pt solid #000;border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">Phase 2 data</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">Cerezyme</font></td><td colspan="3" style="border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">Gaucher disease type 3 (GD3)</font></td><td colspan="3" style="border-right:0.25pt solid #000;border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">Regulatory submission (US)</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">rilzabrutinib</font></td><td colspan="3" style="border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">ITP</font></td><td colspan="3" style="border-right:0.25pt solid #000;border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">Regulatory submission (JP)</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">fitusiran</font></td><td colspan="3" style="border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">Hemophilia A&#47;B</font></td><td colspan="3" style="border-right:0.25pt solid #000;border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">Regulatory decision (US)</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">tolebrutinib</font></td><td colspan="3" style="border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">SPMS</font></td><td colspan="3" style="border-right:0.25pt solid #000;border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">Regulatory submission (EU)</font></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">Sarclisa</font></td><td colspan="3" style="border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">NDMM, transplant ineligible (IMROZ study)</font></div></td><td colspan="3" style="border-right:0.25pt solid #000;border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">Regulatory decision (JP, CN)</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">Subcutaneous formulation</font></td><td colspan="3" style="border-right:0.25pt solid #000;border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">Regulatory submission (US, EU)</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">SAR447873</font></td><td colspan="3" style="border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">Gastroenteropancreatic neuroendocrine tumors</font></td><td colspan="3" style="border-right:0.25pt solid #000;border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">Phase 2 data (final)</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">MenQuadfi</font></td><td colspan="3" style="border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">Meningitis (six weeks+)</font></td><td colspan="3" style="border-right:0.25pt solid #000;border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">Regulatory decision (US)</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-bottom:0.25pt solid #000000;border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">SP0087</font></td><td colspan="3" style="border-bottom:0.25pt solid #000000;border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">Rabies</font></td><td colspan="3" style="border-bottom:0.25pt solid #000000;border-right:0.25pt solid #000;border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">Phase 3 data</font></td></tr></table></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:5pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:94.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.882%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI&#160;&#160; &#160;&#160;</font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">PRESS RELEASE</font><font style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%"> Q4 2024</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">7</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:53.86pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.948%"><tr><td style="width:1.0%"></td><td style="width:9.223%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.852%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.810%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.715%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" rowspan="20" style="border-left:0.25pt solid #000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">H2 2025</font></td><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">Dupixent</font></td><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">BP</font></td><td colspan="3" style="border-right:0.25pt solid #000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">Regulatory decision (US)</font></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">itepekimab</font></td><td colspan="3" rowspan="2" style="border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">COPD</font></td><td colspan="3" style="border-right:0.25pt solid #000;border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">Phase 3 data</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-right:0.25pt solid #000;border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">Regulatory submission (US, EU)</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">balinatunfib</font></td><td colspan="3" style="border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">Rheumatoid arthritis</font></td><td colspan="3" style="border-right:0.25pt solid #000;border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">Phase 2 data</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">Rezurock</font></td><td colspan="3" style="border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Chronic graft-versus-host disease, third line</font></div></td><td colspan="3" style="border-right:0.25pt solid #000;border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">Regulatory decision (EU)</font></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">Tzield</font></td><td colspan="3" style="border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">Delay onset of type 1 diabetes</font></td><td colspan="3" style="border-right:0.25pt solid #000;border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">Regulatory decision (EU, CN)</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">Early intervention in type 1 diabetes</font></td><td colspan="3" style="border-right:0.25pt solid #000;border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">Regulatory decision (EU)</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">rilzabrutinib</font></td><td colspan="3" style="border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">ITP</font></td><td colspan="3" style="border-right:0.25pt solid #000;border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">Regulatory decision (US, EU, CN)</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">fitusiran</font></td><td colspan="3" style="border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">Hemophilia A&#47;B</font></td><td colspan="3" style="border-right:0.25pt solid #000;border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">Regulatory decision (CN)</font></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">venglustat</font></td><td colspan="3" style="border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">Fabry disease (FD)</font></td><td colspan="3" style="border-right:0.25pt solid #000;border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">Phase 3 data</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">GD3</font></td><td colspan="3" style="border-right:0.25pt solid #000;border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">Phase 3 data</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">SAR447537</font></td><td colspan="3" style="border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">Alpha-1 antitrypsin deficiency</font></td><td colspan="3" style="border-right:0.25pt solid #000;border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">Phase 2 data</font></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">tolebrutinib</font></td><td colspan="3" style="border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">SPMS</font></td><td colspan="3" style="border-right:0.25pt solid #000;border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">Regulatory decision (US)</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">PPMS</font></td><td colspan="3" style="border-right:0.25pt solid #000;border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">Phase 3 data</font></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">Sarclisa</font></td><td colspan="3" style="border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">NDMM, TE (HD7)</font></td><td colspan="3" style="border-right:0.25pt solid #000;border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">Regulatory decision (EU)</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Subcutaneous formulation</font></td><td colspan="3" style="border-right:0.25pt solid #000;border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">Regulatory submission (JP, CN)</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">SP0087</font></td><td colspan="3" style="border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Rabies</font></td><td colspan="3" style="border-right:0.25pt solid #000;border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">Regulatory submission (US, EU)</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">SP0230</font></td><td colspan="3" style="border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">Meningitis</font></td><td colspan="3" style="border-right:0.25pt solid #000;border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">Phase 2 data</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">SP0256</font></td><td colspan="3" style="border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">RSV (older adults)</font></td><td colspan="3" style="border-right:0.25pt solid #000;border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">Phase 2 data</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">Fluzone HD</font></td><td colspan="3" style="border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Influenza (50 years+)</font></td><td colspan="3" style="border-right:0.25pt solid #000;border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">Phase 3 data</font></td></tr><tr style="height:12pt"><td colspan="3" rowspan="22" style="border-bottom:0.25pt solid #000;border-left:0.25pt solid #000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2026</font></td><td colspan="3" rowspan="2" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">itepekimab</font></td><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">COPD</font></td><td colspan="3" style="border-right:0.25pt solid #000;border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">Regulatory submission (JP, CN)</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">Bronchiectasis</font></td><td colspan="3" style="border-right:0.25pt solid #000;border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">Phase 2 data</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">amlitelimab</font></td><td colspan="3" style="border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Atopic dermatitis (AD)</font></div></td><td colspan="3" style="border-right:0.25pt solid #000;border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">Phase 3 data</font></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">lunsekimig</font></td><td colspan="3" style="border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">Asthma</font></td><td colspan="3" style="border-right:0.25pt solid #000;border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">Phase 2 data</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">Chronic rhinosinusitis with nasal polyps</font></td><td colspan="3" style="border-right:0.25pt solid #000;border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">Phase 2 data</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">frexalimab</font></td><td colspan="3" style="border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Systemic lupus erythematosus</font></div></td><td colspan="3" style="border-right:0.25pt solid #000;border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">Phase 2 data</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">eclitasertib</font></td><td colspan="3" style="border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">UC</font></div></td><td colspan="3" style="border-right:0.25pt solid #000;border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">Phase 2 data</font></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">SAR444656</font></td><td colspan="3" style="border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">HS</font></div></td><td colspan="3" style="border-right:0.25pt solid #000;border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">Phase 2 data</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">AD</font></td><td colspan="3" style="border-right:0.25pt solid #000;border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">Phase 2 data</font></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">Nexviazyme</font></td><td colspan="3" rowspan="2" style="border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Infantile-onset Pompe disease</font></td><td colspan="3" style="border-right:0.25pt solid #000;border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">Phase 3 data</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-right:0.25pt solid #000;border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">Regulatory submission</font></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">venglustat</font></td><td colspan="3" style="border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">FD</font></td><td colspan="3" style="border-right:0.25pt solid #000;border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">Regulatory submission</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">GD3</font></td><td colspan="3" style="border-right:0.25pt solid #000;border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">Regulatory submission</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">SAR447537</font></td><td colspan="3" style="border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">Alpha-1 antitrypsin deficiency</font></td><td colspan="3" style="border-right:0.25pt solid #000;border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">Regulatory submission</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">tolebrutinib</font></td><td colspan="3" style="border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">PPMS</font></td><td colspan="3" style="border-right:0.25pt solid #000;border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">Regulatory submission (US, EU)</font></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">riliprubart</font></td><td colspan="3" rowspan="2" style="border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Chronic inflammatory demyelinating polyradiculoneuropathy</font></td><td colspan="3" style="border-right:0.25pt solid #000;border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">Phase 3 data</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-right:0.25pt solid #000;border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">Regulatory submission</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">Fluzone HD</font></td><td colspan="3" style="border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Influenza (50 years+)</font></td><td colspan="3" style="border-right:0.25pt solid #000;border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">Regulatory submission</font></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">SP0218</font></td><td colspan="3" rowspan="2" style="border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Yellow fever</font></div></td><td colspan="3" style="border-right:0.25pt solid #000;border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">Phase 3 data</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-right:0.25pt solid #000;border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">Regulatory submission</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">SP0282</font></td><td colspan="3" style="border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">E. coli sepsis</font></td><td colspan="3" style="border-right:0.25pt solid #000;border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">Phase 3 data</font></td></tr><tr style="height:12pt"><td colspan="3" style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">SP0125</font></td><td colspan="3" style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">RSV (toddlers)</font></td><td colspan="3" style="border-bottom:0.25pt solid #000;border-right:0.25pt solid #000;border-top:0.25pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:150%">Phase 3 data</font></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">An update of the Sanofi pipeline as of December 31, 2024, is available at&#58; https&#58;&#47;&#47;www.sanofi.com&#47;en&#47;our-science&#47;our-pipeline.</font></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:5pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:94.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.882%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI&#160;&#160; &#160;&#160;</font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">PRESS RELEASE</font><font style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%"> Q4 2024</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">8</font></div></td></tr></table></div></div></div><div id="i51fa31ed94a244b2b3f81c6cd6a64363_40"></div><hr style="page-break-after:always"><div style="min-height:53.86pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:9pt"><font style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:16pt;font-style:italic;font-weight:400;line-height:120%">Corporate Social Responsibility update at the end of Q4 2024</font></div><div style="margin-bottom:3pt;margin-top:12pt"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Access</font></div><div style="margin-bottom:3pt;margin-top:12pt"><font style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Sanofi is ranked 3rd in the 2024 Access to Medicine (ATM) Index </font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The ATM Index evaluates the efforts of 20 leading pharmaceutical companies in expanding access to essential medicines across low- and middle-income countries (LMICs). It measures progress across three critical areas&#58; governance of access, research and development, and equitable product delivery.</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In the 2024 ATM Index, Sanofi ranked third, significantly improving its performance from the previous edition of the index, where Sanofi was ranked eighth.</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi&#8217;s performance reflects leadership in &#8220;governance of access&#8221;, where Sanofi ranked first, with the integrated access-to-medicine strategy that is linked to leadership incentives and a clear methodology for tracking patient reach. Furthermore, Sanofi has consistently implemented structured access planning for projects in the pipeline. In addition, the vaccines portfolio, as well as the Global Health Unit (GHU) support equitable product delivery and capacity building initiatives that strengthen local healthcare systems. The GHU was also recognized as a best practice example for inclusive business models by the ATM Index report.</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">As an example, Sanofi concluded a manufacturing partnership with Biovac in South Africa in 2024, designed to enable regional manufacturing of polio vaccines to serve the potential needs of over 40 African countries. Sanofi will continue to produce the bulk of the Inactivated Polio Vaccine (IPV) and Biovac, who will hold the marketing authorization, will be responsible for final formulation, filling, packaging, and delivery of millions of IPV doses to UNICEF for countries supported by the Global Alliance for Vaccines and Immunization (GAVI) in Africa.</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">As showcased in its first Impact Report, the GHU significantly scaled its operations in 2024, delivering medicines from its Impact portfolio, a dedicated line of high-quality, affordable treatments for noncommunicable diseases (NCDs) to 30 LMICs. This includes life-saving treatments for diabetes, cardiovascular diseases, and cancer, with a clear goal to reach two million patients by 2030.</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The GHU invests heavily in strengthening of health systems, from training healthcare workers to supporting infrastructure improvements. In Zanzibar, Sanofi worked with local organizations to deliver integrated care for cardio-metabolic diseases, using digital self-management tools and community health ambassadors to reach patients in remote areas. In Djibouti, Sanofi collaborated with the Ministry of Health to improve care for diabetes and hypertension through health worker training programs and supply chain optimization. </font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Since its launch, the GHU has&#58;</font></div><div style="margin-bottom:5pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Reached over 790,000 patients with NCD treatments&#59;</font></div><div style="margin-bottom:5pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Trained over 13,000 healthcare providers and community health workers in NCD management&#59; and</font></div><div style="margin-bottom:5pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Supported 128 health facilities in optimizing access and availability of NCD treatments.</font></div><div style="margin-bottom:3pt;margin-top:12pt"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ESG ratings</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">See Sanofi&#8217;s latest ESG rankings below&#58;</font></div><div style="margin-bottom:5pt;text-align:justify"><img alt="image.jpg" src="image.jpg" style="height:287px;margin-bottom:5pt;vertical-align:text-bottom;width:658px"></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:5pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:94.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.882%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI&#160;&#160; &#160;&#160;</font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">PRESS RELEASE</font><font style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%"> Q4 2024</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">9</font></div></td></tr></table></div></div></div><div id="i51fa31ed94a244b2b3f81c6cd6a64363_43"></div><hr style="page-break-after:always"><div style="min-height:53.86pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:9pt"><font style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:16pt;font-style:italic;font-weight:400;line-height:120%">Q4 and FY 2024 financial results</font></div><div style="margin-bottom:3pt;margin-top:12pt"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Business net income</font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7.8pt;font-weight:700;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">1</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Net sales</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> were &#8364;10,564 million in Q4 2024 and increased by 9.1% (10.3% at CER). In FY 2024, net sales were &#8364;41,081 million and increased by 8.6% (11.3% at CER).</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other revenues</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> were &#8364;856 million in Q4 2024 and decreased by 38.0% (37.9% at CER) due to COVID-19 revenue of &#8364;411 in Q4 2023. VaxServe sales of non-Sanofi products were &#8364;560 million and decreased by 21.2% (21.5% at CER). In FY 2024, other revenues were &#8364;3,205 million and decreased by 15.7% (13.3% at CER) due to COVID-19 revenue of &#8364;509 million in 2023. VaxServe sales of non-Sanofi products were &#8364;1,959 million and decreased by 9.6% (9.5% at CER). In addition, other revenues included sales of Opella products in certain markets (&#8364;339 million), supply sales to Opella (&#8364;163 million), royalties (&#8364;121 million) and others&#47;manufacturing services (&#8364;623 million).</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Gross profit</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> was &#8364;7,844 million in Q4 2024 and increased by 5.4% (6.9% at CER). The gross margin was 74.3% and decreased by 2.5pp (74.5% at CER, down by 2.3pp). The lower gross margin was caused by the lack of COVID-19 other revenue in 2024. In FY 2024, the gross profit was &#8364;31,091&#160;million and increased by 7.2% (10.3% at CER). The gross margin was 75.7% and decreased by 1.0pp (76.1% at CER, down by 0.6 pp). The lower gross margin was primarily due to the lack of COVID-19 other revenue in 2024.</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Research and Development expenses</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> were &#8364;2,257 million in Q4 2024 and increased by 24.4% (24.4% at CER). This reflected increased activity in mid- and late-stage development as several new medicines advanced to phase 3 studies or additional phase 2 studies were initiated in new indications. C.&#8364;60 million of the increase was from one-off costs associated with portfolio prioritization, including in oncology. The ratio of R&#38;D to net sales was 21.4% and increased by 2.7pp. In FY 2024, R&#38;D expenses were &#8364;7,394 million and increased by 13.6% (14.6% at CER). This increase reflected similar factors as mentioned above. The ratio of R&#38;D to net sales was 18.0% and increased by 0.8pp.</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Selling, general and administrative expenses</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> were &#8364;2,648 million in Q4 2024 and increased by 7.4% (7.9% at CER), a moderate increase that still generated growth leverage. The ratio of SG&#38;A to net sales was 25.1% and decreased by 0.4pp. In FY 2024, SG&#38;A expenses were </font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;text-decoration:line-through">&#8364;</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">9,183&#160;million and increased by 2.8% (4.5% at CER). The ratio of SG&#38;A to net sales was 22.4% and decreased by 1.2pp.</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Total operating expenses</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> were &#8364;4,905 million in Q4 2024 and increased by 14.6% (14.9% at CER). In FY 2024, total operating expenses were &#8364;16,577 million and increased by 7.4% (8.8% at CER).</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Other operating income net of expenses</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> was -&#8364;886 million in Q4 2024 compared to -&#8364;844 million in Q4 2023. Income included &#8364;179 million from divestments of medicines&#47;portfolio streamlining, compared to &#8364;62 million in Q4 2023. The income was more than offset by an expense of &#8364;1,044 million from the share of profit in the Regeneron monoclonal antibody alliance compared to &#8364;889 million in Q4 2023. More details are in appendix 7. In FY 2024, other operating income net of expenses was -&#8364;3,293 million compared to -&#8364;2,464 million in 2023. Income from divestments was &#8364;394 million compared to &#8364;452 million in 2023. Expenses from the Regeneron monoclonal antibody alliance were &#8364;3,947 million compared to &#8364;3,196 million in FY 2023.</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Share of profit from associates</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">was &#8364;32 million in Q4 2024 compared to &#8364;41 million in Q4 2023 and included the share of US profit related to Vaxelis. In FY 2024, share of profit from associates was &#8364;136 million compared to &#8364;101 million in FY 2023.</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Business operating income</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> was &#8364;2,078 million in Q4 2024 and decreased by 11.8% (-7.7% at CER). The ratio of BOI to net sales was 19.7% and decreased by 4.6pp (20.4% at CER, down by 3.9pp). In FY 2024, BOI was &#8364;11,343 million and increased by 1.5% (+7.6% at CER). The ratio of BOI to net sales was 27.6% and decreased by 2.0pp (28.6% at CER, down by 1.0pp).</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Net financial expenses</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> were &#8364;62 million in Q4 2024 compared to &#8364;45 million in Q4 2023. In FY 2024, net financial expenses were &#8364;263&#160;million compared to &#8364;168 million in FY 2023, reflecting increased net debt and higher average interest rates.</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">The effective tax rate</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> increased to 18.8% in Q4 2024 from 16.5% in Q4 2023 and increased to 19.8% in FY 2024 from 17.7% in FY 2023. The effective tax rate has increased mainly due to the implementation of the Organisation for Economic Co-operation and Development Pillar Two rules.</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Business net income</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> was &#8364;1,642 million in Q4 2024 and decreased by 15.1% (-11.2% at CER). The ratio of business net income to net sales was 15.5% and decreased by 4.5pp (16.1% at CER, down by 3.9pp). In FY 2024, business net income was &#8364;8,912 million and decreased by 1.8% (+4.1% at CER). The ratio of business net income to net sales was 21.7% and decreased by 2.3pp (22.5% at CER, down by 1.5pp).</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-style:italic;font-weight:700;line-height:120%">Business earnings per share</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(EPS) was &#8364;1.31 in Q4 2024 and decreased by 14.9% (-11.0% at CER). The average number of shares outstanding was 1,253.6 million compared to 1,253.6 million in Q4 2023. In FY 2024, business earnings per share was 7.12 and decreased by 1.8% (+4.1% at CER). The average number of shares outstanding was 1,251.4 million compared to 1,251.7 million in FY 2023.</font></div><div style="margin-bottom:3pt;margin-top:12pt"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Opella</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi intends to sell a controlling stake in Opella consumer health to CD&#38;R with a closing in Q2 2025 at the earliest. Sanofi will retain c.48% ownership.</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In Q4 2024, and under the new scope of reporting, sales were &#8364;1,202 million and increased by 8% from &#8364;1,108 million in Q4 2023, primarily driven by the Wellness category (Qunol and Digestive). The Seasonal category remained stable in a lower Cough &#38; Cold market. In FY 2024, also under the new scope of reporting, sales were &#8364;4,948 million and increased by 4% from &#8364;4,765 million in 2023. On January 21, 2025, Opella announced that the FDA had lifted a clinical hold on its planned actual use trial (AUT) to support the switch of Cialis (tadalafil) from a prescription to an over-the-counter medicine. This decision allows for the initiation of the AUT.</font></div><div style="border-bottom:1pt solid #000000;margin-bottom:5pt;margin-top:10pt;opacity:1;width:150pt"></div><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"> See Appendix 3 for the Q4 and FY 2024 consolidated income statement&#59; see Appendix 9 for definitions of financial indicators, and Appendix 4 for </font></div><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">reconciliation of IFRS net income reported to business net income.</font></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:5pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:94.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.882%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI&#160;&#160; &#160;&#160;</font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">PRESS RELEASE</font><font style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%"> Q4 2024</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">10</font></div></td></tr></table></div></div></div><div id="i51fa31ed94a244b2b3f81c6cd6a64363_46"></div><hr style="page-break-after:always"><div style="min-height:53.86pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:3pt;margin-top:12pt"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Reconciliation of IFRS net income reported to business net income (see Appendix 4)</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In FY 2024, the IFRS net income was &#8364;5,744 million. The main items excluded from the business net income were&#58;</font></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Net income from Opella discontinued operation amounted to &#8364;64 million.</font></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">An amortization charge of &#8364;1,749 million related to intangible assets measured at their acquisition-date fair values of -&#8364;1,653&#160;million (mainly Bioverativ -&#8364;629 million, Provention Bio -&#8364;215 million, Ablynx -&#8364;168 million, Kadmon -&#8364;164 million, Genzyme -&#8364;152 million and Beyfortus -&#8364;115 million) and to intangible assets from separate acquisitions, measured initially at acquisition cost (licenses&#47;products) of -&#8364;96 million. These items had no cash impact.</font></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">A net impairment expense of &#8364;9 million comprising &#8364;200 millions expenses recorded in Q4 2024 mainly related to discontinued research and development projects partially offset in the YTD by impairment reversals related to increase in the expected recoverable amounts of certain marketed products and other rights in the Biopharma segment.</font></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Restructuring costs and similar items of &#8364;1,396 million mainly related to redundancy plans announced during FY 2024.</font></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">Other gains and losses, and a litigation charge of &#8364;470 million mainly comprising a provision recognized in respect of the litigation related to Plavix (clopidogrel) in the US State of Hawaii.</font></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">A financial charge of &#8364;291 million related to the remeasurement of expected future royalty on Beyfortus US sales.</font></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">A &#8364;828 million tax effect arising from the items listed above, mainly comprising &#8364;310 million of deferred taxes generated by amortization of intangible assets and &#8364;320 million associated with restructuring costs and similar items (see Appendix 4).</font></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">A loss of &#8364;77 million corresponding to the equity investment in EUROAPI.</font></div><div style="margin-bottom:3pt;margin-top:12pt"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Cash flow</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">In FY 2024, free cash flow before restructuring, acquisitions and disposals amounted to &#8364;7,517 million after a change in net working capital (-&#8364;507 million), notably including a decrease of US rebate provisions (&#8364;1,330 million) following the decision to reduce the Lantus list price effective January 1, 2024, and capital expenditures (-&#8364;1,808 million). After acquisitions</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (-&#8364;1,434 million), proceeds from disposals (&#8364;805 million) and payments related to restructuring and similar items (-&#8364;933&#160;million), </font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">free cash flow</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:700;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> was &#8364;5,955 million.</font></div><div style="margin-bottom:3pt;margin-top:12pt"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Net debt</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">After the acquisition of Inhibrx Inc. (-&#8364;1,900 million), the dividend paid by Sanofi (-&#8364;4,704 million) and the impact of the cash provided by the discontinued Opella business (&#8364;322 million), the change in net debt before Opella reclassification to &#8220;Assets held-for-sale&#8221; was -&#8364;881 million. After the reclassification of Opella to &#8220;Assets held-for-sale&#8221; (-&#8364;98 million), net debt increased from &#8364;7,793 million on December 31, 2023, to &#8364;8,772 million on December 31, 2024 (amount net of &#8364;7,441 million cash and cash equivalents).</font></div><div style="margin-bottom:3pt;margin-top:12pt"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Shareholder return</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The Board of Directors met on January 29, 2025, and proposes a dividend of &#8364;3.92 for 2024, marking 30 years of consecutive increases. The proposal is subject to approval at the 2025 annual general meeting on April 30, 2025. Sanofi intends to execute a share buyback program in 2025 of &#8364;5 billion. Shares will be purchased preferably through block trades and in the open market with the purpose of cancellation.</font></div><div style="margin-bottom:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.332%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #7802e6;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The Board of Directors of Sanofi, chaired by Chairman Fr&#233;d&#233;ric Oud&#233;a, met on January 29, 2025, to approve the Q4 and FY 2024 financial statements. This press release presents the results for Q4 and FY 2024 from the consolidated financial statements of Sanofi as of December 31, 2024 (unaudited). The audit procedures by the Statutory Auditors are underway.</font></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.948%"><tr><td style="width:1.0%"></td><td style="width:18.776%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.776%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.776%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.776%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.396%"></td><td style="width:0.1%"></td></tr><tr style="height:11pt"><td colspan="3" style="border-bottom:0.5pt solid #23004c;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #23004c;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #23004c;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #23004c;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #23004c;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:68.993%"><tr><td style="width:0.1%"></td><td style="width:0.692%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.701%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.248%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="9" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Media Relations</font></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Sandrine Guendoul </font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;+ 33 6 25 09 14 25</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">sandrine.guendoul&#64;sanofi.com</font></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;text-align:justify"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Evan Berland</font></div></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;+ 1 215 432 0234</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">evan.berland&#64;sanofi.com</font></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;text-align:justify"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Nicolas Obrist</font></div></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;+ 33 6 77 21 27 55</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">nicolas.obrist&#64;sanofi.com</font></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;text-align:justify"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">L&#233;o Le Bourhis</font></div></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;+ 33 6 75 06 43 81</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">leo.lebourhis&#64;sanofi.com</font></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;text-align:justify"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Victor Rouault</font></div></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;+ 33 6 70 93 71 40</font></div></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">victor.rouault&#64;sanofi.com</font></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;text-align:justify"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Timothy Gilbert</font></div></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;+ 1 516 521 2929</font></div></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">timothy.gilbert&#64;sanofi.com</font></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#7802e6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td></tr></table></div><div style="border-bottom:1pt solid #000000;margin-bottom:5pt;margin-top:10pt;opacity:1;width:150pt"></div><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"> Not exceeding &#8364;500 million per transaction (inclusive of all payments related to the transaction).</font></div><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"> Non-IFRS financial measure (definition in Appendix 9).</font></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:5pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:94.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.882%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI&#160;&#160; &#160;&#160;</font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">PRESS RELEASE</font><font style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%"> Q4 2024</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">11</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:53.86pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:3pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:68.993%"><tr><td style="width:0.1%"></td><td style="width:0.692%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.701%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.248%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.876%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="9" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Investor Relations</font></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;text-align:justify"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Thomas Kudsk Larsen</font><font style="color:#23004c;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> </font></div></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;+ 44 7545 513 693</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">thomas.larsen&#64;sanofi.com</font></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;text-align:justify"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Aliz&#233; Kaisserian</font></div></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;+ 33 6 47 04 12 11</font></div></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">alize.kaisserian&#64;sanofi.com</font></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;text-align:justify"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Felix</font><font style="color:#23004c;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> </font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Lauscher</font></div></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;+ 1 908 612 7239</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">felix.lauscher&#64;sanofi.com</font></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;text-align:justify"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Keita</font><font style="color:#23004c;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"> </font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Browne</font></div></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;+ 1 781 249 1766</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">keita.browne&#64;sanofi.com</font></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;text-align:justify"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Nathalie</font><font style="color:#23004c;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"> </font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Pham</font></div></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;+ 33 7 85 93 30 17</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">nathalie.pham&#64;sanofi.com</font></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;text-align:justify"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Tarik</font><font style="color:#23004c;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"> </font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Elgoutni</font><font style="color:#23004c;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"> </font></div></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;+ 1 617 710 3587</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">tarik.elgoutni&#64;sanofi.com</font></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;text-align:justify"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Thibaud</font><font style="color:#23004c;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"> </font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Ch&#226;telet</font></div></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;+ 33 6 80 80 89 90</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:3pt;margin-top:6pt"><font style="color:#23004c;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:115%">thibaud.chatelet&#64;sanofi.com</font></div></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#7802e6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td></tr></table></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:5pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:94.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.882%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI&#160;&#160; &#160;&#160;</font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">PRESS RELEASE</font><font style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%"> Q4 2024</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">12</font></div></td></tr></table></div></div></div><div id="i51fa31ed94a244b2b3f81c6cd6a64363_49"></div><hr style="page-break-after:always"><div style="min-height:53.86pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:9pt"><font style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:16pt;font-style:italic;font-weight:400;line-height:120%">Appendices</font></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.948%"><tr><td style="width:1.0%"></td><td style="width:10.148%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:82.104%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.448%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><a href="#i51fa31ed94a244b2b3f81c6cd6a64363_52" style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%;text-decoration:none">Appendix&#160;1</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net s<a href="#i51fa31ed94a244b2b3f81c6cd6a64363_52" style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;text-decoration:none">ales by medicine&#47;vaccine</a><a href="#i51fa31ed94a244b2b3f81c6cd6a64363_52" style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;text-decoration:none"> and geograph</a><a href="#i51fa31ed94a244b2b3f81c6cd6a64363_52" style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;text-decoration:none">y</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><a href="#i51fa31ed94a244b2b3f81c6cd6a64363_52" style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%;text-decoration:none">14</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><a href="#i51fa31ed94a244b2b3f81c6cd6a64363_58" style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%;text-decoration:none">Appendix 2</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">B<a href="#i51fa31ed94a244b2b3f81c6cd6a64363_58" style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;text-decoration:none">usiness net income statement</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><a href="#i51fa31ed94a244b2b3f81c6cd6a64363_58" style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%;text-decoration:none">16</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><a href="#i51fa31ed94a244b2b3f81c6cd6a64363_64" style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%;text-decoration:none">Appendix 3</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">C<a href="#i51fa31ed94a244b2b3f81c6cd6a64363_64" style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;text-decoration:none">onsolidated income statement</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><a href="#i51fa31ed94a244b2b3f81c6cd6a64363_64" style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%;text-decoration:none">18</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><a href="#i51fa31ed94a244b2b3f81c6cd6a64363_67" style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%;text-decoration:none">Appendix 4</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Reconciliation of net income attributable to equity holders of Sanofi to&#160;business net income</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><a href="#i51fa31ed94a244b2b3f81c6cd6a64363_67" style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%;text-decoration:none">19</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><a href="#i51fa31ed94a244b2b3f81c6cd6a64363_70" style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%;text-decoration:none">Appendix 5</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><a href="#i51fa31ed94a244b2b3f81c6cd6a64363_70" style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;text-decoration:none">Change in net debt</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><a href="#i51fa31ed94a244b2b3f81c6cd6a64363_70" style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%;text-decoration:none">20</a></font></div></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><a href="#i51fa31ed94a244b2b3f81c6cd6a64363_73" style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%;text-decoration:none">Appendix 6</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Simplified consolidated balance sheet</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><a href="#i51fa31ed94a244b2b3f81c6cd6a64363_73" style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%;text-decoration:none">21</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><a href="#i51fa31ed94a244b2b3f81c6cd6a64363_76" style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%;text-decoration:none">Appendix 7</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><a href="#i51fa31ed94a244b2b3f81c6cd6a64363_76" style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;text-decoration:none">Other </a><a href="#i51fa31ed94a244b2b3f81c6cd6a64363_76" style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;text-decoration:none">operating income net of expenses related to Regeneron</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><a href="#i51fa31ed94a244b2b3f81c6cd6a64363_76" style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%;text-decoration:none">22</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><a href="#i51fa31ed94a244b2b3f81c6cd6a64363_79" style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%;text-decoration:none">Appendix </a>8</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><a href="#i51fa31ed94a244b2b3f81c6cd6a64363_79" style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;text-decoration:none">Currency sensitivity</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><a href="#i51fa31ed94a244b2b3f81c6cd6a64363_79" style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%;text-decoration:none">23</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><a href="#i51fa31ed94a244b2b3f81c6cd6a64363_82" style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%;text-decoration:none">Appendix </a>9</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><a href="#i51fa31ed94a244b2b3f81c6cd6a64363_82" style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;text-decoration:none">Definitions of non-IFRS financial indicators</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><a href="#i51fa31ed94a244b2b3f81c6cd6a64363_82" style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%;text-decoration:none">24</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><a href="#i51fa31ed94a244b2b3f81c6cd6a64363_88" style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%;text-decoration:none">Appendix 10</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><a href="#i51fa31ed94a244b2b3f81c6cd6a64363_88" style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%;text-decoration:none">CSR dashboards</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><a href="#i51fa31ed94a244b2b3f81c6cd6a64363_88" style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%;text-decoration:none">25</a></font></div></td></tr></table></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:5pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:94.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.882%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI&#160;&#160; &#160;&#160;</font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">PRESS RELEASE</font><font style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%"> Q4 2024</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">13</font></div></td></tr></table></div></div></div><div id="i51fa31ed94a244b2b3f81c6cd6a64363_52"></div><hr style="page-break-after:always"><div style="min-height:53.86pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:3pt;margin-top:12pt"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Appendix 1&#58; Q4 2024 net sales by medicine&#47;vaccine and geography</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.948%"><tr><td style="width:1.0%"></td><td style="width:23.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.066%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.066%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.066%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.416%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.066%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.066%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.416%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.066%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.066%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.416%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.066%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.071%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Q4 2024 </font></div><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</font></div></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total sales</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">% CER</font></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">% reported</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">United States</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">% CER</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Europe</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">% CER</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Rest of World</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">% CER</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Immunology</font></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Dupixent</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,458&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+16.0&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+15.7&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,551&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+10.4&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">431&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+30.4&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">476&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+38.1&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Kevzara</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">126&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+21.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+20.0&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">76&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+24.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">32&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+3.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">18&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+46.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Rare diseases</font></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Fabrazyme</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">269&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+12.4&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+11.2&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">139&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+7.0&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">63&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+5.0&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">67&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+34.0&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">ALTUVIIIO (*)</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">230&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+143.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+144.7&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">198&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+114.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">32&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+1500.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Nexviazyme&#47;Nexviadyme (*)</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">184&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+42.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+40.5&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">97&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+26.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">59&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+68.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">28&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+55.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cerezyme</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">171&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+33.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+28.6&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">48&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">63&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+16.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">60&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+116.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Alprolix</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">169&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+19.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+19.0&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">129&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+15.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">40&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+32.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Myozyme</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">132&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-17.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-17.0&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">49&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-15.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">55&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-28.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">28&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+16.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cerdelga</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">87&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+16.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+16.0&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">50&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+19.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">32&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+6.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+66.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Eloctate</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">81&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-21.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-21.4&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">53&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-23.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">28&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-17.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cablivi (*)</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">73&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+24.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+25.9&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">42&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+46.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">26&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+20.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Aldurazyme</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">69&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+16.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+11.3&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">18&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+5.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">21&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+4.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">30&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+33.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Xenpozyme (*)</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">38&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+50.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+46.2&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">24&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+41.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+33.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+133.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Enjaymo (*)</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">22&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-8.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-4.3&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-7.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+200.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-33.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Neurology</font></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Aubagio</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">78&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-35.5&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-35.5&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">42&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-2.3&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">27&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-61.4&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+12.5&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Oncology</font></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sarclisa (*)</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">130&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+30.1&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+26.2&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">54&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+20.0&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">36&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+32.1&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">40&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+43.3&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Jevtana</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">77&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+1.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+1.3&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">58&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+3.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">17&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-5.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Fasturtec</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">51&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+27.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+27.5&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">34&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+30.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+20.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+25.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other main medicines</font></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Lantus</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">439&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+63.4&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+59.1&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">193&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+464.7&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">80&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-3.6&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">166&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+12.6&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Toujeo</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">290&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+6.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+4.3&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">46&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-4.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">120&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+10.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">124&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+7.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Lovenox</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">231&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-7.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-12.2&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+100.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">131&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-12.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">98&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-1.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Plavix</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">211&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-16.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-16.9&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-50.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">22&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-8.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">188&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-17.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Rezurock (*)</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">132&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+53.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+53.5&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">119&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+43.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+300.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+400.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Thymoglobulin</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">125&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+15.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+11.6&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">82&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+14.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">33&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+21.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Praluent</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">110&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-6.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-6.8&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">85&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+6.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">25&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-34.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Aprovel</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">105&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-0.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-0.9&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">18&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-10.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">86&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+1.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Multaq</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">77&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-12.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-11.5&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">68&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-12.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-16.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Soliqua&#47;iGlarLixi</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">58&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-1.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-4.9&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">20&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-28.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+44.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">25&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+12.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Tzield (*)</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">18&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+80.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+80.0&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">17&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+70.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Mozobil</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-60.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-63.6&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-62.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-76.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-25.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Others </font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,010&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-11.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-13.5&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">85&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-24.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">309&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-9.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">616&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-9.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Industrial Sales</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">124&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-25.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-25.3&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-100.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">123&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-23.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-80.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Vaccines</font></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">RSV (Beyfortus) (**)</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">841&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+106.6&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+105.1&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">420&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+34.6&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">335&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+252.6&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">86&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Polio&#47;Pertussis&#47;Hib vaccines and boosters</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">632&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+10.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+10.1&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">143&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-12.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">116&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+5.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">373&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+25.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Influenza vaccines</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">454&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-36.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-38.7&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">178&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-18.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">130&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-49.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">146&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-40.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Meningitis, Travel and endemic vaccines</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">249&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-4.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-5.3&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">101&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-22.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">56&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+22.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">92&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+10.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Biopharma</font></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">10,564</font><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+10.3</font><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+9.1</font><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,151</font><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+13.3</font><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,433</font><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+6.0</font><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,980</font><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+8.8</font><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Pharma launches (*)</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">827</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+56.5</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+55.7</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">562</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+53.8</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">140</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+44.3</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">125</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+87.1</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Launches (*), (**)</font></td><td colspan="3" style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,668</font></td><td colspan="3" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+78.3%</font></td><td colspan="3" style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+77.3%</font></td><td colspan="3" style="border-bottom:0.5pt solid #23004c;padding:0 1pt"></td><td colspan="2" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">982</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+44.9%</font></td><td colspan="3" style="border-bottom:0.5pt solid #23004c;padding:0 1pt"></td><td colspan="2" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">475</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+147.4%</font></td><td colspan="3" style="border-bottom:0.5pt solid #23004c;padding:0 1pt"></td><td colspan="2" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">211</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+212.9%</font></td></tr></table></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:5pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:94.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.882%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI&#160;&#160; &#160;&#160;</font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">PRESS RELEASE</font><font style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%"> Q4 2024</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">14</font></div></td></tr></table></div></div></div><div id="i51fa31ed94a244b2b3f81c6cd6a64363_55"></div><hr style="page-break-after:always"><div style="min-height:53.86pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:3pt;margin-top:12pt"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Appendix 1&#58; FY 2024 net sales by medicine&#47;vaccine and geography </font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.948%"><tr><td style="width:1.0%"></td><td style="width:23.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.066%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.066%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.066%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.416%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.066%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.066%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.416%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.066%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.066%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.416%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.066%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.071%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">FY 2024 </font></div><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</font></div></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total sales</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">% CER</font></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">% reported</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">United States</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">% CER</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Europe</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">% CER</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Rest of World</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">% CER</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Immunology</font></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Dupixent</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13,072&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+23.1&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+22.0&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9,544&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+17.2&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,618&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+31.9&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,910&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+50.8&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Kevzara</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">424&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+21.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+18.8&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">246&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+26.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">121&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+5.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">57&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+38.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Rare diseases</font></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Fabrazyme</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,047&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+9.1&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+5.8&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">531&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+5.6&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">254&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+5.4&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">262&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+19.9&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">ALTUVIIIO (*)</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">682&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+330.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+328.9&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">617&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+298.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">65&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+1575.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Nexviazyme&#47;Nexviadyme (*)</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">667&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+61.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+56.9&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">361&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+32.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">201&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+101.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">105&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+132.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cerezyme</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">742&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+20.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+8.2&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">191&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+1.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">244&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+6.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">307&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+45.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Alprolix</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">588&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+9.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+8.9&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">464&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+5.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">124&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+28.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Myozyme</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">671&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-12.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-14.2&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">234&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-7.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">260&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-23.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">177&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+2.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cerdelga</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">333&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+12.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+11.7&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">186&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+13.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">128&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+8.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">19&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+37.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Eloctate</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">368&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-20.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-21.9&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">236&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-30.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">132&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+5.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cablivi (*)</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">249&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+9.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+9.7&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">136&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+21.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">93&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-6.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">20&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+23.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Aldurazyme</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">297&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+12.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+6.5&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">72&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+7.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">84&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+2.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">141&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+20.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Xenpozyme (*)</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">151&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+68.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+65.9&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">81&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+55.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">46&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+48.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">24&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+225.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Enjaymo (*)</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">105&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+48.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+45.8&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">58&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+40.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">17&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+183.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">30&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+29.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Neurology</font></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Aubagio</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">379&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-59.4&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-60.3&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">187&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-59.1&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">152&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-65.2&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">40&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-17.2&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Oncology</font></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sarclisa (*)</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">471&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+29.7&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+23.6&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">200&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+21.2&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">134&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+20.7&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">137&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+52.4&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Jevtana</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">290&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-7.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-9.4&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">214&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-7.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-41.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">69&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-5.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Fasturtec</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">183&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+8.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+7.6&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">119&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+8.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">48&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+9.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">16&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+5.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other main medicines</font></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Lantus</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,628&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+20.8&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+14.6&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">638&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+127.0&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">340&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-4.8&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">650&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-5.8&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Toujeo</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,227&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+13.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+9.3&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">217&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+1.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">479&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+8.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">531&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+23.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Lovenox</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">982&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-7.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-12.5&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+28.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">567&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-9.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">406&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-4.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Plavix</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">914&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-0.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-3.6&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-25.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">91&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-5.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">817&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+0.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Rezurock (*)</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">470&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+51.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+51.6&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">425&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+40.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">28&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+460.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">17&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+700.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Thymoglobulin</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">492&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+7.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+2.9&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">312&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+6.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">39&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+2.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">141&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+10.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Praluent</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">483&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+15.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+14.5&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-100.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">340&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+14.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">143&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+15.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Aprovel</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">416&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+1.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-0.2&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-55.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">73&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-6.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">339&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+4.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Multaq</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">311&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-9.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-9.6&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">278&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-10.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-8.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">22&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Soliqua&#47;iGlarLixi</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">227&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+7.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+4.6&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">75&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-20.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">48&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+40.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">104&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+25.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Tzield (*)</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">54&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+116.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+116.0&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">52&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+108.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Mozobil</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">74&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-65.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-66.4&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-89.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">39&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-44.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">23&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-22.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Others </font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4,262&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-7.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-11.7&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">364&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-16.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,263&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-6.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,635&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-6.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Industrial Sales</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">523&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-5.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-5.1&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-75.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">520&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-1.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-89.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Vaccines</font></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e7e7e8;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">RSV (Beyfortus) (**)</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,686&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+214.4&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+208.2&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,068&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+167.3&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">440&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+214.3&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">178&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Polio&#47;Pertussis&#47;Hib vaccines and boosters</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,741&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+1.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-0.9&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">679&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-5.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">497&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+4.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,565&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+3.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Influenza vaccines</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,555&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-1.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-4.3&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,433&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+4.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">640&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-7.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">482&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-7.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Meningitis, Travel and endemic vaccines</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,316&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+5.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+3.9&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">736&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+1.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">204&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+28.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">376&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+3.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#7802e6;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Biopharma</font></td><td colspan="2" style="background-color:#7802e6;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">41,081</font><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#7802e6;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#7802e6;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+11.3</font><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#7802e6;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#7802e6;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+8.6</font><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#7802e6;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#7802e6;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">19,986</font><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#7802e6;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#7802e6;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+16.2</font><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#7802e6;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#7802e6;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,027</font><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#7802e6;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#7802e6;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+2.3</font><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#7802e6;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#7802e6;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">12,068</font><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#7802e6;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#7802e6;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+10.7</font><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#7802e6;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Pharma launches (*)</font></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,849</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">71.4</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">68.6</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,930</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">71.6</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">520</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">47.9</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">399</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+108.9</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Launches (*), (**)</font></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,535</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+106.3</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+102.7</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="border-bottom:0.5pt solid #23004c;padding:0 1pt"></td><td colspan="2" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,998</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+97.0</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="border-bottom:0.5pt solid #23004c;padding:0 1pt"></td><td colspan="2" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">960</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+95.3</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="border-bottom:0.5pt solid #23004c;padding:0 1pt"></td><td colspan="2" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">577</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+199.1</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td></tr></table></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:5pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:94.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.882%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI&#160;&#160; &#160;&#160;</font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">PRESS RELEASE</font><font style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%"> Q4 2024</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">15</font></div></td></tr></table></div></div></div><div id="i51fa31ed94a244b2b3f81c6cd6a64363_58"></div><hr style="page-break-after:always"><div style="min-height:53.86pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:3pt;margin-top:12pt"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Appendix 2&#58; Business net income statement</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.948%"><tr><td style="width:1.0%"></td><td style="width:15.695%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.144%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.144%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.144%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.144%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.144%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.144%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.144%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.144%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.153%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Q4 2024</font></td><td colspan="9" style="border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Biopharma</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other</font></td><td colspan="9" style="border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total group</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(&#8364; million)</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Q4 2024</font></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Q4 2023</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"> (1)</font></div></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Change</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Q4 2024</font></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Q4 2023</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"> (1)</font></div></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Change</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Q4 2024</font></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Q4 2023</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"> (1)</font></div></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Change</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net sales</font></td><td colspan="2" style="border-left:1pt solid #ffffff;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">10,564</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,687</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9.1</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="border-left:1pt solid #ffffff;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="border-left:1pt solid #ffffff;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">10,564</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,687</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9.1</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other revenues</font></td><td colspan="2" style="border-left:1pt solid #ffffff;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">774&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,309&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-40.9&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="border-left:1pt solid #ffffff;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">82&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">72&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13.9&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="border-left:1pt solid #ffffff;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">856&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,381&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-38.0&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cost of sales</font></div></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3,524)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3,571)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-1.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(52)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(54)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-3.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3,576)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3,625)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-1.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">As % of net sales</font></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(33.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">%)</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(36.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">%)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(33.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">%)</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(37.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">%)</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gross profit</font></td><td colspan="2" style="border-left:1pt solid #ffffff;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,814</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,425</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5.2</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="border-left:1pt solid #ffffff;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">30</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">18</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">66.7</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="border-left:1pt solid #ffffff;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,844</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,443</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5.4</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%">As % of net sales</font></td><td colspan="2" style="border-left:1pt solid #ffffff;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%">74.0</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%">76.6</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:0.5pt solid #23004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"></td><td colspan="2" style="border-left:1pt solid #ffffff;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%">74.3</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%">76.8</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Research and development expenses</font></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2,257)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,814)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">24.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-100.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2,257)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,815)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">24.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">As % of net sales</font></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(21.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">%)</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(18.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">%)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(21.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">%)</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(18.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">%)</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Selling and general expenses</font></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2,647)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2,465)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2,648)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2,466)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">As % of net sales</font></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(25.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">%)</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(25.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">%)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(25.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">%)</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(25.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">%)</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other operating income&#47;expenses</font></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(897)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(842)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(886)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(844)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Share of profit&#47;loss of associates* and joint ventures</font></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">32&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">41&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">32&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">41&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net income attributable to non-controlling interests</font></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(7)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(7)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Business operating income</font></td><td colspan="2" style="border-left:1pt solid #ffffff;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,038</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,342</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">-13.0</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="border-left:1pt solid #ffffff;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">40</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">14</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">185.7</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="border-left:1pt solid #ffffff;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,078</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,356</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">-11.8</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%">As % of net sales</font></td><td colspan="2" style="border-left:1pt solid #ffffff;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%">19.3</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%">24.2</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:0.5pt solid #23004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"></td><td colspan="2" style="border-left:1pt solid #ffffff;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%">19.7</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%">24.3</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Financial income and expenses</font></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(62)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(45)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="border-left:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Income tax expenses</font></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(374)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(376)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="border-left:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="border-bottom:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">Tax rate**</font></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(18.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">%)</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(16.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">%)</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="border-bottom:0.5pt solid #330e74;border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Business net income</font></td><td colspan="2" style="border-left:1pt solid #ffffff;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,642</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,935</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">-15.1</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%">As % of net sales</font></td><td colspan="2" style="border-left:1pt solid #ffffff;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%">15.5</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%">20.0</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="border-top:0.5pt solid #330e74;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="border-bottom:0.5pt solid #23004c;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Business earnings&#47;share (in euros)***</font></td><td colspan="3" style="border-bottom:0.5pt solid #23004c;border-left:1pt solid #ffffff;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1.31</font></td><td colspan="3" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1.54</font></td><td colspan="2" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">-14.9</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">* Net of tax.</font></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">** Determined based on business income before tax, associates, and non-controlling interests.</font></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">*** Based on an average number of shares outstanding of 1,253.6 million in Q4 2024 and 1,253.6 million in Q4 2023.</font></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(1) &#160;&#160;&#160;&#160;Figures for comparative periods (2023) have been re-presented on a consistent basis to reflect the classification of Opella as a discontinued operation.</font></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font><br></font></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:5pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:94.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.882%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI&#160;&#160; &#160;&#160;</font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">PRESS RELEASE</font><font style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%"> Q4 2024</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">16</font></div></td></tr></table></div></div></div><div id="i51fa31ed94a244b2b3f81c6cd6a64363_61"></div><hr style="page-break-after:always"><div style="min-height:53.86pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:5pt;text-align:justify;text-indent:4.49pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.662%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.815%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.815%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.815%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.815%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.815%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.815%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.815%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.815%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">FY 2024</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Biopharma</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total group</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(&#8364; million)</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">FY 2024</font></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">FY 2023 </font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(1)</font></div></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Change</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">FY 2024</font></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">FY 2023 </font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(1)</font></div></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Change</font></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">FY 2024</font></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">FY 2023 </font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(1)</font></div></td><td colspan="3" style="border-right:1pt solid #ffffff;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Change</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net sales</font></td><td colspan="2" style="border-left:1pt solid #ffffff;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">41,081</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">37,817</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8.6</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="border-left:1pt solid #ffffff;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="border-left:1pt solid #ffffff;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">41,081</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">37,817</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8.6</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other revenues</font></td><td colspan="2" style="border-left:1pt solid #ffffff;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,866&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,505&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-18.2&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="border-left:1pt solid #ffffff;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">339&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">296&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">14.5&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="border-left:1pt solid #ffffff;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,205&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,801&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-15.7&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cost of sales</font></div></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(12,973)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(12,415)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(222)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(204)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(13,195)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(12,619)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">As % of net sales</font></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(31.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">%)</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(32.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">%)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(32.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">%)</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(33.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">%)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gross profit</font></td><td colspan="2" style="border-left:1pt solid #ffffff;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">30,974</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">28,907</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7.2</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="border-left:1pt solid #ffffff;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">117</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">92</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">27.2</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="border-left:1pt solid #ffffff;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">31,091</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">28,999</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7.2</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">As % of net sales</font></td><td colspan="2" style="border-left:1pt solid #ffffff;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">75.4&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">76.4&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="border-top:0.5pt solid #330e74;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:0.5pt solid #330e74;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #330e74;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #330e74;padding:0 1pt"></td><td colspan="2" style="border-left:1pt solid #ffffff;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">75.7&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">76.7&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="border-top:0.5pt solid #330e74;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Research and development expenses</font></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(7,393)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6,505)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-50.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(7,394)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6,507)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">As % of net sales</font></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(18.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">%)</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(17.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">%)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(18.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">%)</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(17.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">%)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Selling and general expenses</font></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(9,113)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(8,854)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(70)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(79)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">-11.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(9,183)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(8,933)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">As % of net sales</font></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(22.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">%)</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(23.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">%)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(22.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">%)</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(23.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">%)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other operating income&#47;expenses</font></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3,305)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2,476)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3,293)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2,464)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Share of profit&#47;loss of associates* and joint ventures </font></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">136&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">101&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">136&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">101&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net income attributable to non-controlling interests</font></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(14)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(18)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(14)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(18)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Business operating income </font></td><td colspan="2" style="border-left:1pt solid #ffffff;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">11,285</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">11,155</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1.2</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="border-left:1pt solid #ffffff;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">58</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">23</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">152.2</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="border-left:1pt solid #ffffff;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">11,343</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">11,178</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1.5</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">As % of net sales</font></td><td colspan="2" style="border-left:1pt solid #ffffff;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">27.5&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">29.5&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="border-top:0.5pt solid #330e74;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;border-top:0.5pt solid #330e74;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #330e74;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #330e74;padding:0 1pt"></td><td colspan="2" style="border-left:1pt solid #ffffff;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">27.6&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">29.6&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="border-top:0.5pt solid #330e74;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Financial income and expenses</font></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(263)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(168)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Income tax expenses</font></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2,168)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,934)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="border-bottom:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">Tax rate**</font></td><td colspan="2" style="border-left:1pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(19.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">%)</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(17.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">%)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Business net income</font></td><td colspan="2" style="border-left:1pt solid #ffffff;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8,912</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,076</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">-1.8</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">As % of net sales</font></td><td colspan="2" style="border-left:1pt solid #ffffff;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">21.7&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">24.0&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="border-bottom:0.5pt solid #23004c;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Business earnings&#47;share (in euros)***</font></td><td colspan="3" style="border-bottom:0.5pt solid #23004c;border-left:1pt solid #ffffff;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7.12</font></td><td colspan="3" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7.25</font></td><td colspan="2" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">-1.8</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">* Net of tax.&#160;&#160;&#160;&#160;</font></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">** Determined based on Business income before tax, associates, and non-controlling interests.</font></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">*** Based on an average number of shares outstanding of 1,251.4 million in FY 2024 and 1,251.7 million in FY 2023.</font></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(1) &#160;&#160;&#160;&#160;Figures for comparative periods (2023) have been re-presented on a consistent basis to reflect the classification of Opella as a discontinued operation.</font></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:5pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:94.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.882%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI&#160;&#160; &#160;&#160;</font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">PRESS RELEASE</font><font style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%"> Q4 2024</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">17</font></div></td></tr></table></div></div></div><div id="i51fa31ed94a244b2b3f81c6cd6a64363_64"></div><hr style="page-break-after:always"><div style="min-height:53.86pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:3pt;margin-top:12pt"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Appendix 3&#58; Consolidated income statement</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.948%"><tr><td style="width:1.0%"></td><td style="width:49.593%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.226%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.226%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.226%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.229%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</font></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Q4 2024</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Q4 2023 </font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(1)</font></div></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">FY 2024</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">FY 2023 </font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(1)</font></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net sales</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">10,564</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,687</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">41,081</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">37,817</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other revenues</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">856&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,381&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,205&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,801&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cost of sales</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3,576)</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3,629)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(13,205)</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(12,628)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gross profit</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,844</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,439</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">31,081</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">28,990</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Research and development expenses</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2,257)</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,815)</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(7,394)</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6,507)</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Selling and general expenses</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2,648)</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2,466)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(9,183)</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(8,933)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other operating income</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">363&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">204&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,089&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">979&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other operating expenses</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,249)</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,048)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(4,382)</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3,443)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Amortization of intangible assets</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(450)</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(496)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,749)</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,911)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Impairment of intangible assets</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(200)</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(877)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(9)</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(896)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Fair value remeasurement of contingent consideration</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(22)</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(64)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(96)</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(93)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Restructuring costs and similar items</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(191)</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(506)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,396)</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,030)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Other gains and losses, and litigation</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5)</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(470)</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(196)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Operating income</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,185</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">384</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,491</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,960</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Financial expenses</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(235)</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(616)</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,073)</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,293)</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Financial income</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">111&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">157&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">519&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">584&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Income before tax and associates and joint ventures</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,061</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(75)</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,937</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,251</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Income tax expense</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(190)</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">90&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,259)</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,017)</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Share of profit&#47;(loss) of associates and joint ventures</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(134)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">60&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(136)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net income from continuing operations</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">880</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(119)</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,738</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,098</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net income from discontinued operations</font></div></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(185)</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(439)</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">64&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">338&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net income</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">695</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(558)</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,802</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,436</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net income attributable to non-controlling interests</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3)</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">58&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">36&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net income attributable to equity holders of Sanofi</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">683</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(555)</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,744</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,400</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Average number of shares outstanding (million)</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,253.6&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,253.6&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,251.4&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,251.7&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Basic earnings per share from continuing operations (in euros)</font></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">0.69</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(0.09)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4.54</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4.04</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Basic earnings per share from discontinued operations (in euros)</font></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(0.15)</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(0.35)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">0.05</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:700;line-height:100%">0.27</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Basic earnings per share (in euros)</font></div></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">0.54</font><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(0.44)</font></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4.59</font><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4.31</font><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(1) &#160;&#160;&#160;&#160;Figures for comparative periods (2023) have been re-presented on a consistent basis to reflect the classification of Opella as a discontinued operation.</font></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:5pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:94.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.882%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI&#160;&#160; &#160;&#160;</font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">PRESS RELEASE</font><font style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%"> Q4 2024</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">18</font></div></td></tr></table></div></div></div><div id="i51fa31ed94a244b2b3f81c6cd6a64363_67"></div><hr style="page-break-after:always"><div style="min-height:53.86pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:3pt;margin-top:12pt"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Appendix 4&#58; Reconciliation of net income attributable to equity holders of Sanofi to&#160;business net income</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.948%"><tr><td style="width:1.0%"></td><td style="width:49.593%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.226%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.226%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.226%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.229%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</font></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Q4 2024</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Q4 2023 </font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(1)</font></div></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">FY 2024</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">FY 2023 </font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(1)</font></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net income attributable to equity holders of Sanofi</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">683</font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(555)</font></td><td style="background-color:#ffffff;border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,744</font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,400</font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net income from discontinued operations</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">185&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">439&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(64)</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(338)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Amortization of intangible assets</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(2)</font></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">450&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">496&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,749&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,911&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Impairment of intangible assets</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">200&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">877&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">896&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Fair value remeasurement of contingent consideration</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">24&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">54&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">127&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">93&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Expenses arising from the impact of acquisitions on inventories</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Restructuring costs and similar items</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">191&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">506&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,396&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,030&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other gains and losses, and litigation </font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(13)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">470&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">196&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Financial (income) &#47; expense related to liabilities carried at amortized cost other than net indebtedness</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">62&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">414&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">291&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">541&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Tax effect of the items listed above&#58;</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(82)</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(470)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(828)</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(940)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">Amortization and impairment of intangible assets</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(149)</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(225)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(304)</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(473)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">Fair value remeasurement of contingent consideration</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(6)</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(5)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(25)</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(13)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">Restructuring costs and similar items</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">56&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(148)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(320)</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(299)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">Other items</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">17&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(92)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(179)</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(155)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other tax effects</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(102)</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(81)</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">23&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other items</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">26&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">178&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">89&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">255&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Business net income</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,642</font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,935</font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8,912</font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,076</font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#7802e6;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">IFRS earnings per share</font><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(3) </font><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(&#8364;)</font></div></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">0.54</font><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(0.44)</font></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4.59</font><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#7802e6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4.31</font><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#7802e6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(1) &#160;&#160;&#160;&#160;Figures for comparative periods (2023) have been re-presented on a consistent basis to reflect the classification of Opella as a discontinued operation.</font></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;Of which related to amortization expense generated by the intangible assets measured at their acquisition-date fair values&#58; -&#8364;407 million in Q4 2024 and -&#8364;480 million in Q4 2023.</font></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;Q4&#58; based on an average number of shares outstanding of 1,253.6 million in Q4 2024 and 1,253.6 million in Q4 2023. </font></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">       FY&#58; based on an average number of shares outstanding of 1,251.4 million in FY 2024 and 1,251.7 million in FY 2023.</font></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font><br></font></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:5pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:94.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.882%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI&#160;&#160; &#160;&#160;</font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">PRESS RELEASE</font><font style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%"> Q4 2024</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">19</font></div></td></tr></table></div></div></div><div id="i51fa31ed94a244b2b3f81c6cd6a64363_70"></div><hr style="page-break-after:always"><div style="min-height:53.86pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:3pt;margin-top:12pt"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Appendix 5&#58; Change in net debt</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.948%"><tr><td style="width:1.0%"></td><td style="width:70.240%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.229%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.231%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</font></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">FY 2024</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">FY 2023 </font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(3)</font></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Business net income</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8,912</font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,076</font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Depreciation, amortization and impairment of property, plant and equipment and software</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,546&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,509&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other items</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(626)</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(555)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Operating cash flow</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,832</font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">10,030</font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Changes in working capital</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(507)</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">207&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Acquisitions of property, plant and equipment and software</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,808)</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,677)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Free cash flow before restructuring, acquisitions, and disposals</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,517</font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8,560</font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Acquisitions of intangibles assets, investments, and other long-term financial assets</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">(1)</font></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,434)</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,091)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Restructuring costs and similar items paid</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(933)</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(849)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Proceeds from disposals of property, plant, and equipment, intangible assets, and other non-current assets net of&#160;taxes</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">(1)</font></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">805&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">789&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Free cash flow</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,955</font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,409</font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Acquisitions</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">(2)</font></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2,509)</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3,149)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Proceeds net of taxes </font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">(2)</font></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">609&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Issuance of Sanofi shares</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">187&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">195&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Acquisition of treasury shares</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(302)</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(593)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Dividends paid to shareholders of Sanofi</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(4,704)</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(4,454)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other items</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(439)</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(464)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net cash provided by&#47;(used in) the discontinued Opella business</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">322</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(300)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Change in net debt before Opella reclassification to &#8220;Assets held-for-sale&#8221;</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(881)</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(1,356)</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Impact on net debt of the reclassification of Opella to &#8220;Assets held-for-sale&#8221;</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(98)</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Change in net debt</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(979)</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(1,356)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Beginning of period</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,793</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,437</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Closing of net debt</font></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8,772</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,793</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Free cash flow includes investments and divestments not exceeding a cap of &#8364;500 million per transaction (inclusive of all payments related to the transaction).</font></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;Includes transactions that are above a cap of &#8364;500 million per transaction (inclusive of all payments related to the transaction).</font></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(3) &#160;&#160;&#160;&#160;Figures for comparative period (2023) have been re-presented on a consistent basis to reflect the classification of Opella as a discontinued operation.</font></div><div style="margin-top:1pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font><br></font></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:5pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:94.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.882%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI&#160;&#160; &#160;&#160;</font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">PRESS RELEASE</font><font style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%"> Q4 2024</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">20</font></div></td></tr></table></div></div></div><div id="i51fa31ed94a244b2b3f81c6cd6a64363_73"></div><hr style="page-break-after:always"><div style="min-height:53.86pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:3pt;margin-top:12pt"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Appendix 6&#58; Simplified consolidated balance sheet</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.948%"><tr><td style="width:1.0%"></td><td style="width:19.393%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.075%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.878%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.701%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.079%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Assets</font></div><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2024</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2023</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">liabilities and equity</font></div><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2024</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2023</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #330e74;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #330e74;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #330e74;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">Equity attributable to equity holders of Sanofi</font></td><td colspan="3" style="border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">77,692</font></td><td colspan="3" style="border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">74,040</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">Equity attributable to non-controlling interests</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">350</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">313</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total equity</font></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">78,042</font></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">74,353</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">Long-term debt</font></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">11,791</font></td><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">14,347</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">Property, plant, and equipment &#8211; owned assets</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">10,091</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">10,160</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">Non-current lease liabilities</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">1,645</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">1,755</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">Right-of-use assets</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">1,510</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">1,654</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">Non-current liabilities related to business combinations and to non-controlling interests</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">569</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">501</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">Intangible assets (including goodwill)</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">66,255</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">73,723</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">Non-current provisions and other non-current liabilities</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">8,096</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">7,602</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">Non-current income tax assets</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">560</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">188</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">Non-current income tax liabilities</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">1,512</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">1,842</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">Other non-current assets, investments in associates and joint-ventures and deferred tax assets</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">11,979</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">10,069</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">Deferred tax liabilities</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">2,166</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">1,857</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Non-current assets</font></td><td colspan="3" style="border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">90,395</font></td><td colspan="3" style="border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">95,794</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Non-current liabilities</font></td><td colspan="3" style="border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">25,779</font></td><td colspan="3" style="border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">27,904</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #330e74;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #330e74;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #330e74;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">Accounts payable and other current liabilities</font></td><td colspan="3" style="border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">21,791</font></td><td colspan="3" style="border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">21,069</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">Current liabilities related to business combinations and to non-controlling interests</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">72</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">208</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">Inventories, accounts receivable and other current assets</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">20,933</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">21,554</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">Current income tax liabilities</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">697</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">597</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">Current income tax assets</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">724</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">391</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">Current lease liabilities</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">261</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">275</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">Cash and cash equivalents</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">7,441</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">8,710</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">Short-term debt and current portion of long-term debt</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">4,209</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">2,045</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">Assets held for sale</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">13,489</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">15</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">Liabilities related to assets held for sale</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">2,131</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">13</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Current assets</font></td><td colspan="3" style="border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">42,587</font></td><td colspan="3" style="border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">30,670</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Current liabilities</font></td><td colspan="3" style="border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">29,161</font></td><td colspan="3" style="border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">24,207</font></td></tr><tr><td colspan="3" style="background-color:#7802e6;border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total assets</font></td><td colspan="3" style="background-color:#7802e6;border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">132,982</font></td><td colspan="3" style="background-color:#7802e6;border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">126,464</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#7802e6;border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total equity and liabilities</font></td><td colspan="3" style="background-color:#7802e6;border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">132,982</font></td><td colspan="3" style="background-color:#7802e6;border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">126,464</font></td></tr></table></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:5pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:94.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.882%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI&#160;&#160; &#160;&#160;</font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">PRESS RELEASE</font><font style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%"> Q4 2024</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">21</font></div></td></tr></table></div></div></div><div id="i51fa31ed94a244b2b3f81c6cd6a64363_76"></div><hr style="page-break-after:always"><div style="min-height:53.86pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:3pt;margin-top:12pt"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Appendix 7&#58; Other operating income net of expenses related to Regeneron </font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.948%"><tr><td style="width:1.0%"></td><td style="width:70.240%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.229%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.231%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</font></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">FY 2024</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">FY 2023</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Monoclonal antibodies alliance</font></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #330e74;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Income and expense related to profit&#47;loss sharing</font></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">(4,143)</font></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">(3,321)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Additional share of profit paid by Regeneron related to development costs</font></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">833</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;text-indent:10pt;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">668</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Regeneron commercial operating expenses reimbursement</font></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:83%">(637)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;text-indent:10pt;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:115%">(543)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total&#58; monoclonal antibody alliance</font></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(3,947)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(3,196)</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other Regeneron</font></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #23004c;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total others related to Regeneron (mainly Libtayo</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"> </font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">and Zaltrap)</font></div></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">158</font></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">217</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#7802e6;border-bottom:0.5pt solid #330e74;border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total related to Regeneron</font></td><td colspan="3" style="background-color:#7802e6;border-bottom:0.5pt solid #330e74;border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(3,789)</font></td><td colspan="3" style="background-color:#7802e6;border-bottom:0.5pt solid #330e74;border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(2,979)</font></td></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><font><br></font></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:5pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:94.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.882%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI&#160;&#160; &#160;&#160;</font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">PRESS RELEASE</font><font style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%"> Q4 2024</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">22</font></div></td></tr></table></div></div></div><div id="i51fa31ed94a244b2b3f81c6cd6a64363_79"></div><hr style="page-break-after:always"><div style="min-height:53.86pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:3pt;margin-top:12pt"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Appendix 8&#58; Currency sensitivity</font></div><div style="margin-bottom:3pt;margin-top:12pt"><font style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">2025 business EPS currency sensitivity</font></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.948%"><tr><td style="width:1.0%"></td><td style="width:70.240%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.229%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.231%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Currency</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Variation</font></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Business EPS sensitivity</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">US Dollar</font></td><td colspan="3" style="border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+0.05 USD&#47;EUR</font></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;-EUR 0.18</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Japanese Yen</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+5 JPY&#47;EUR</font></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;-EUR 0.02</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Chinese Yuan</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+0.2 CNY&#47;EUR</font></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;-EUR 0.02</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Brazilian Real</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">+0.4 BRL&#47;EUR</font></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;-EUR 0.01</font></td></tr></table></div><div style="margin-bottom:3pt;margin-top:12pt"><font style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Currency exposure on Q4 2024 sales </font></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.794%"><tr><td style="width:1.0%"></td><td style="width:84.548%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.252%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Currency</font></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Q4 2024</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">US Dollar</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">50.0&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Euro</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">20.2&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Chinese Yuan</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5.1&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Japanese Yen</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.4&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Canadian Dollar</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.3&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Mexican Pesos</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.4&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Turkish Lira</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.4&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Brazilian Real</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.3&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Australian Dollar</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.2&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">British Pound</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.1&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Others</font></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12.6&#160;</font></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</font></td></tr></table></div><div style="margin-bottom:3pt;margin-top:12pt"><font style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Currency average rates </font></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.948%"><tr><td style="width:1.0%"></td><td style="width:55.910%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.229%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.229%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.232%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Q4 2023</font></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Q4 2024</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Change</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8364;&#47;$</font></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.076&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.067&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">-0.8&#160;</font></td><td style="border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8364;&#47;Yen</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">159.030&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">162.434&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">+2.1%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8364;&#47;Yuan</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7.778&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7.685&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">-1.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8364;&#47;Real</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5.329&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6.229&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">+16.9%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8364;&#47;Ruble</font></td><td colspan="2" style="border-bottom:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">99.644&#160;</font></td><td style="border-bottom:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">106.724&#160;</font></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="border-bottom:0.5pt solid #23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">+7.1%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:5pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:94.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.882%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI&#160;&#160; &#160;&#160;</font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">PRESS RELEASE</font><font style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%"> Q4 2024</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">23</font></div></td></tr></table></div></div></div><div id="i51fa31ed94a244b2b3f81c6cd6a64363_82"></div><hr style="page-break-after:always"><div style="min-height:53.86pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:3pt;margin-top:12pt"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Appendix 9&#58; Definitions of non-IFRS financial indicators</font></div><div style="margin-bottom:3pt;margin-top:12pt"><font style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Company sales at constant exchange rates (CER)</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">References to changes in net sales &#8220;at constant exchange rates&#8221; (CER) means that it excludes the effect of changes in exchange rates.</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">The effect of exchange rates is eliminated by recalculating net sales for the relevant period at the exchange rates used for the previous period.</font></div><div style="margin-bottom:3pt;margin-top:12pt"><font style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Reconciliation of net sales to company sales at constant exchange rates for Q4 and FY 2024</font></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.948%"><tr><td style="width:1.0%"></td><td style="width:70.240%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.229%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.231%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</font></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Q4 2024</font></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">FY 2024</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net sales</font></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">10,564</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">41,081</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #330e74;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Effect of exchange rates</font></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(116)</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(992)</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Company sales at constant exchange rates</font></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">10,680</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">42,073</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:12pt"><font style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Business net income</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Sanofi publishes a key non-IFRS indicator. Business net income is defined as net income attributable to equity holders of Sanofi excluding&#58;</font></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">net income from discontinued operations,</font></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">amortization of intangible assets,</font></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">impairment of intangible assets, </font></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">fair value remeasurement of contingent consideration related to business combinations or to disposals,</font></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">expenses arising from the impact of acquisitions on inventories,</font></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">restructuring costs and similar items</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">,</font></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">other gains and losses (including gains and losses on disposals of non-current assets</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">),</font></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">costs or provisions associated with litigation</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">,</font></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">financial (income)&#47;expense related to liabilities carried at amortized cost other than net indebtedness, </font></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">tax effects related to the items listed above as well as effects of major tax disputes,</font></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">the share of profits&#47;losses from investments accounted for using the equity method, except for joint ventures and associates with which Sanofi has a strategic alliance,</font></div><div style="margin-bottom:2pt;padding-left:11.34pt;text-align:justify;text-indent:-11.34pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%;padding-left:8.44pt">net income attributable to non-controlling interests related to the items listed above.</font></div><div style="margin-bottom:3pt;margin-top:12pt"><font style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Free cash flow </font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Free cash flow is a non-IFRS financial indicator which is reviewed by management, and which management believes provides useful information to measure the net cash generated from Sanofi&#8217;s operations that is available for strategic investments</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> (net of divestments</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">3</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">), for debt repayment, and for capital return to shareholders. Free cash flow is determined from the Business net income adjusted for depreciation, amortization, and impairment, share of profit&#47;loss in associates and joint ventures net of dividends received, gains and losses on disposals, net change in provisions including pensions and other post-employment benefits, deferred taxes, share-based expense, and other non-cash items. It comprises net changes in working capital, capital expenditures and other asset acquisitions</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"> net of disposal proceeds</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:5.52pt;font-weight:400;line-height:120%;position:relative;top:-2.97pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">, and payments related to restructuring and similar items. Free cash flow is not defined by IFRS, and it is not a substitute measure for the IFRS aggregate net cash flows in operating activities.</font></div><div id="i51fa31ed94a244b2b3f81c6cd6a64363_85"></div><div style="margin-bottom:3pt;margin-top:12pt"><font style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Reconciliation from net cash provided by&#47;(used in) operating activities to free cash flow</font></div><div style="margin-bottom:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.948%"><tr><td style="width:1.0%"></td><td style="width:70.240%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.229%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.231%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(&#8364; million)</font></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;FY 2024</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">FY 2023 </font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(7)</font></div></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;letter-spacing:-0.005em;line-height:100%">Net cash provided by&#47;(used in) operating activities excluding the discontinued Opella business</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;letter-spacing:-0.005em;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(4)</font></div></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8,588</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,271</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Acquisition of property, plant, and equipment and software</font></div></td><td colspan="2" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,808)</font></td><td style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,677)</font></td><td style="border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Acquisitions of intangibles assets, investments, and other long-term financial assets</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(5)</font></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,434)</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,091)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Proceeds from disposals of property, plant and equipment, intangible assets, and other non-current assets net of&#160;taxes</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(5)</font></div></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">805&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">789&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Repayment of lease liabilities</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(282)</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(253)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Others</font></td><td colspan="2" style="background-color:#e7e7e8;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">86&#160;</font></td><td style="background-color:#e7e7e8;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">370&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Free cash flow</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(6)</font></div></td><td colspan="2" style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,955</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,409</font><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:0.5pt solid #23004c;border-top:0.5pt solid #23004c;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="border-bottom:1pt solid #000000;margin-bottom:5pt;margin-top:10pt;opacity:1;width:150pt"></div><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"> Reported in the line items Restructuring costs and similar items and Gains and losses on disposals, and litigation.</font></div><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"> Amount of the transaction above a cap of &#8364;500 million per transaction (inclusive of all payments related to the transaction).</font></div><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">3</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"> Not exceeding a cap of &#8364;500 million per transaction (inclusive of all payments related to the transaction).</font></div><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">4 </font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">Most directly comparable IFRS measure to free cash flow.</font></div><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">5</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"> Transactions up to &#8364;500 million per transaction.</font></div><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">6 </font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">Non IFRS indicator (see definition in Appendix 9).</font></div><div style="padding-left:8.5pt;text-align:justify;text-indent:-8.5pt"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">7 </font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">Figures for comparative period (2023) have been re-presented on a consistent basis to reflect the classification of Opella as a discontinued operation.</font></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:5pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:94.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.882%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI&#160;&#160; &#160;&#160;</font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">PRESS RELEASE</font><font style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%"> Q4 2024</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">24</font></div></td></tr></table></div></div></div><div id="i51fa31ed94a244b2b3f81c6cd6a64363_88"></div><hr style="page-break-after:always"><div style="min-height:53.86pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:3pt;margin-top:12pt"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Appendix 10&#58; CSR dashboards</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">Data are presented for the full year unless stated otherwise.</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.948%"><tr><td style="width:1.0%"></td><td style="width:16.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.326%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.326%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.329%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Topic</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Ambition</font></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Progress</font></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Affordable access </font></td><td colspan="3" style="border-top:0.5pt solid #330e74;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">FY 2024</font></td><td colspan="3" style="border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">FY 2023</font></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sanofi global health</font></td><td colspan="3" style="border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Reach 1.5 million NCD patients by 2026 (cumulative since 2022) and 2 million by 2030<br></font><font style="font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><br></font></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">349,164 patients treated in 30 countries<br></font><font style="font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><br></font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">82 active healthcare partnerships in 40 countries<br></font><font style="font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><br></font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7 investments signed through the Impact Fund</font></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">261,977 patients treated in 31 countries<br></font><font style="font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><br></font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">33 active healthcare partnerships in 15 countries<br></font><font style="font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><br></font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3 investments signed through the Impact Fund</font></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Vials donations</font></td><td colspan="3" style="border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Donate 100,000 vials a year to treat people with rare diseases, via the Humanitarian Program launched by Sanofi Specialty Care</font></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,254 patients treated<br>&#160;<br>121,130 vials donated</font></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,163 patients treated<br></font><font style="font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><br></font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">124,136 vials donated</font></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Global access plans</font></td><td colspan="3" style="border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Develop a global access plan for all new medicines&#47;vaccines to make them available within two years after first launch</font></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12 global access plans initiated or developed covering more than 15 indications</font></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8 global access plans initiated or developed covering more than 12&#160;indications</font></td><td colspan="3" style="display:none"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #330e74;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">R&#38;D for unmet needs</font></td><td colspan="3" style="border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">FY 2024</font></td><td colspan="3" style="border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">FY 2023</font></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sleeping sickness</font></td><td colspan="3" style="border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Develop and supply innovative treatments to support the elimination of sleeping sickness by 2030 (annual update)</font></div><div><font><br></font></div></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Data updated annually, next update in Q2 2025</font></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.4 million patients tested<br>699 patients treated</font></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Polio</font></td><td colspan="3" style="border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Provide inactivated polio vaccines (IPV) to UNICEF for GAVI countries to support polio eradication efforts</font></div></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">33 million IPV doses supplied to UNICEF for GAVI countries</font></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">35 million IPV doses supplied to UNICEF for GAVI countries</font></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Pediatric cancer treatment development<br></font></td><td colspan="3" style="border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Develop innovative treatments to eliminate cancer death in children</font></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3 projects undergoing preclinical assessment</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1 project in clinical study</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10 partnerships on scientific projects and engagement </font></div></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3 projects undergoing pre-clinical assessment</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">First pediatric patient dosed in a clinical study (less than 2 years after the 1st adult patient was dosed with this compound)</font></div><div><font><br></font></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Planet care</font></td><td colspan="3" style="border-top:0.5pt solid #330e74;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">FY 2024</font></td><td colspan="3" style="border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">FY 2023</font></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Climate change &#8211; carbon footprint </font></div><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(CO</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:0.98pt;vertical-align:baseline">2 </font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">emissions)</font></div></td><td colspan="3" style="border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">55% reduction in scope 1&#38;2 greenhouse gas emissions (CO</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:0.98pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"> equivalent) by 2030 (cumulative vs 2019 baseline) to contribute to carbon neutrality by 2030 and net-zero emissions by 2045 (all scopes)</font></div></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">47% GHG reduction vs 2019</font></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">38% GHG reduction vs 2019</font></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Renewable electricity</font></td><td colspan="3" style="border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100% of renewable electricity at all sites by 2030</font></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">85%</font></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">79%</font></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Eco-car fleet</font></td><td colspan="3" style="border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100% eco-car fleet in 2030</font></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">50% eco-car fleet </font></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">43% eco-car fleet</font></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Blister-free syringe vaccines</font></td><td colspan="3" style="border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100% blister-free syringe vaccines by 2027</font></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">55% blister-free syringe vaccines </font></div></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">39% blister-free syringe vaccines </font></div></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Eco-design</font></td><td colspan="3" style="border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">All new medicines&#47;vaccines to be eco-designed by 2025</font></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">27 LCAs completed (new and marketed products)</font></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13 LCAs completed (new and marketed products)</font></td><td colspan="3" style="display:none"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #330e74;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">In and beyond the workplace</font></td><td colspan="3" style="border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">FY 2024</font></td><td colspan="3" style="border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#23004c;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:100%">FY 2023</font></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Global gender balance</font></td><td colspan="3" style="border-top:0.5pt solid #330e74;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Gender parity in senior leadership roles</font></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">46%</font></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.5pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">44%</font></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">40% of women in executive roles</font></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">43%</font></td><td colspan="3" style="background-color:#e7e7e8;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">40%</font></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Engagement with communities</font></td><td colspan="3" style="border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Engage socially and economically with all communities with operations</font></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">15,684 volunteers<br></font><font style="font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><br></font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">105,926 hours</font></td><td colspan="3" style="background-color:#e7e7e8;border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12,240 volunteers<br></font><font style="font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><br></font><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">75,376 hours</font></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #23004c;border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">From leaders to citizens</font></td><td colspan="3" style="border-bottom:0.5pt solid #23004c;border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100% of leaders have CSR in their development path</font></td><td colspan="3" style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">78% of leaders have completed the e-learning phase<br><br>35% of leaders have completed the full program</font></td><td colspan="3" style="background-color:#e7e7e8;border-bottom:0.5pt solid #23004c;border-top:0.25pt solid #23004c;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:7pt;font-weight:400;line-height:100%">71% of leaders have completed the e-learning phase<br><br>30% of leaders have completed the full program</font></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:10pt"><font style="color:#7802e6;font-family:'Sanofi Sans',sans-serif;font-size:11pt;font-weight:400;line-height:120%">End.</font></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:5pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:94.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.882%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI&#160;&#160; &#160;&#160;</font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">PRESS RELEASE</font><font style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%"> Q4 2024</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">25</font></div></td></tr></table></div></div></div><div id="i51fa31ed94a244b2b3f81c6cd6a64363_91"></div><hr style="page-break-after:always"><div style="min-height:53.86pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:3pt;margin-top:12pt"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Forward-looking statements</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">This press release contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements are statements that are not historical facts. These statements include projections and estimates and their underlying assumptions, statements regarding plans, business transformations, objectives, intentions, and expectations with respect to future financial results, events, operations, services, product development and potential, and statements regarding future performance. Forward-looking statements are generally identified by the words &#8220;expects&#8221;, &#8220;anticipates&#8221;, &#8220;believes&#8221;, &#8220;intends&#8221;, &#8220;estimates&#8221;, &#8220;plans&#8221;, &#8220;potential&#8221;, &#8220;outlook&#8221;, &#8220;guidance&#8221; and similar expressions. Although Sanofi&#8217;s management believes that the expectations reflected in such forward-looking statements are reasonable, investors are cautioned that forward-looking information and statements are subject to various risks and uncertainties, many of which are difficult to predict and generally beyond the control of Sanofi, that could cause actual results and developments to differ materially from those expressed in, or implied or projected by, the forward-looking information and statements. These risks and uncertainties include among other things, the uncertainties inherent in research and development, future clinical data and analysis, including post marketing, decisions by regulatory authorities, such as the FDA or the EMA, regarding whether and when to approve any drug, device or biological application that may be filed for any such product candidates as well as their decisions regarding labelling and other matters that could affect the availability or commercial potential of such product candidates, the fact that product candidates if approved may not be commercially successful, the future approval and commercial success of therapeutic alternatives, Sanofi&#8217;s ability to benefit from external growth opportunities, to complete capital markets or other transactions and&#47;or obtain regulatory clearances, risks associated with developing standalone businesses, risks associated with intellectual property and any related pending or future litigation and the ultimate outcome of such litigation, trends in exchange rates and prevailing interest rates, volatile economic and capital market conditions, cost containment initiatives and subsequent changes thereto, and the impact that pandemics, political disruption or armed conflicts or other global crises may have on us, our customers, suppliers, vendors, and other business partners, and the financial condition of any one of them, as well as on our employees and on the global economy as a whole. The risks and uncertainties also include the uncertainties discussed or identified in the public filings with the SEC and the AMF made by Sanofi, including those listed under &#8220;Risk Factors&#8221; and &#8220;Cautionary Statement Regarding Forward-Looking Statements&#8221; in Sanofi&#8217;s annual report on Form 20-F for the year ended December 31, 2023. Other than as required by applicable law, Sanofi does not undertake any obligation to update or revise any forward-looking information or statements. </font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Sanofi Sans Light',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">All Sanofi trademarks mentioned in this document are protected.</font></div><div style="height:48.19pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:5pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:94.918%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.882%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">SANOFI&#160;&#160; &#160;&#160;</font><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:400;line-height:120%">PRESS RELEASE</font><font style="color:#7802e6;font-family:'Sanofi Serif',serif;font-size:7pt;font-weight:400;line-height:120%"> Q4 2024</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Sanofi Sans',sans-serif;font-size:7pt;font-weight:700;line-height:120%">26</font></div></td></tr></table></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>fsridynmyoja6mde4ndmxymzjn.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 fsridynmyoja6mde4ndmxymzjn.gif
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M9FD1DEANF5"4;J5DY(==WJ6@E[V)>6.:A:D$9G)N/F?GG7CFJ>>>?/;IYY^
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C(,B(%EF.&$E5:Z,Y5$A<'$E@-%F3-GF3. >9DSKI6 $! #L!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image.jpg
MB5!.1PT*&@H    -24A$4@  "2    /Z" 8   "*>F&E   ,/VE#0U!)0T,@
M4')O9FEL90  2(F55P=84\D6GEN2D$!HH4L)O0DB4@)(":$%D-YMA"1 *"$&
M@HJ]+"JX%E1$P8:NBBA8 ;&@B)U%L6%?+*@HZV+!KKQ) 5WWE>^=[YM[__O/
MF?^<.7=N&0#43G!$HAQ4'8!<88$X)MB?GI2<0B?U @00 1EH EL.-U_$C(H*
M!]"&SG^W=S>@-[2K#E*M?_;_5]/@\?.Y "!1$*?Q\KFY$!\$ *_BBL0% !"E
MO/G4 I$4PP:TQ#!!B!=+<88<5TEQFASOE?G$Q; @;@- 287#$6< H'H9\O1"
M;@;44.V'V$G($P@!4*-#[).;F\>#.!5B&^@C@EBJSTC[02?C;YIIPYH<3L8P
MEL]%9DH!@GQ1#F?Z_UF._VVY.9*A&%:PJ62*0V*D<X9UNYF=%R;%*A#W"=,B
M(B'6A/B#@"?SAQBE9$I"XN7^J"$WGP5K!G0@=N)Q L(@-H0X2)@3$:[@T](%
M06R(X0I!IPD*V'$0ZT&\F)\?&*OPV2S.BU'$0AO2Q2RF@C_'$<OB2F/=EV3'
M,Q7ZKS/Y;(4^IEJ4&9<(,05BBT)!0@3$JA [YF?'ABE\QA9ELB*&?,22&&G^
M%A#'\(7!_G)]K#!='!2C\"_)S1^:+[8Y4\".4.#]!9EQ(?+Z8&U<CBQ_.!?L
M,E_(C!_2X><GA0_-A<</")3/'7O&%\;'*G0^B K\8^1C<8HH)TKACYOQ<X*E
MO!G$+OF%L8JQ>$(!7)!R?3Q=5! 5)\\3+\KBA$;)\\%7@'#  @& #B2PI8$\
MD 4$'7V-??!*WA,$.$ ,,@ ?."B8H1&)LAXA/,:"(O G1'R0/SS.7];+!X60
M_SK,RH\.(%W66R@;D0V>0)P+PD .O);(1@F'HR6 QY 1_",Z!S8NS#<'-FG_
MO^>'V.\,$S+A"D8R%)&N-N1)#"0&$$.(041;W #WP;WP<'CT@\T99^ >0_/X
M[D]X0N@D/"1<)W03;DT6S!?_E.4XT WU@Q2U2/NQ%K@5U'3%_7%OJ Z5<1W<
M #C@+C .$_>%D5TARU+D+:T*_2?MO\W@A[NA\",[D5&R+MF/;//S2%4[5==A
M%6FM?ZR//->TX7JSAGM^CL_ZH?H\> [[V1-;C!W SF(GL?/84:P1T+$6K EK
MQXY)\?#J>BQ;74/18F3Y9$,=P3_B#=U9:27SG6J=>IV^R/L*^-.D[VC RA--
M%PLR,@OH3/A%X-/90J[C2+JSD[,K -+OB_SU]29:]MU =-J_<PO^ ,"[97!P
M\,AW+K0%@'WN\/$__)VS8<!/AS( YPYS)>)".8=+#P3XEE"#3YH^, ;FP ;.
MQQFX 2_@!P)!*(@$<2 93(+99\)U+@93P4PP#Q2#4K "K 'KP2:P%>P$>\!^
MT B.@I/@#+@(+H/KX Y</3W@!>@'[\!G!$%("!6A(?J("6*)V"/." /Q00*1
M<"0&2492D0Q$B$B0F<@"I!0I0]8C6Y :9!]R&#F)G$<ZD5O( Z07>8U\0C%4
M!=5"C5 K=!3*0)EH&!J'3D0ST"EH$;H07896H-7H;K0!/8E>1*^CW>@+=  #
MF#*F@YEB#A@#8V&16 J6CHFQV5@)5HY58W58,[S/5[%NK _[B!-Q&D[''> *
M#L'C<2X^!9^-+\77XSOQ!KP-OXH_P/OQ;P0JP9!@3_ DL E)A S"5$(QH9RP
MG7"(<!H^2SV$=T0B48=H372'SV(R,8LX@[B4N(%83SQ!["0^(@Z02"1]DCW)
MFQ1)XI *2,6D=:3=I!;2%5(/Z8.2LI*)DK-2D%**DE!IOE*YTBZEXTI7E)XJ
M?2:KDRW)GN1(,H\\G;R<O(W<3+Y$[B%_IFA0K"G>E#A*%F4>I8)21SE-N4MY
MHZRL;*;LH1RM+%">JURAO%?YG/(#Y8\JFBIV*BR5"2H2E64J.U1.J-Q2>4.E
M4JVH?M04:@%U&;6&>HIZG_I!E:;JJ,I6Y:G.4:U4;5"]HOI2C:QFJ<94FZ16
MI%:N=D#MDEJ?.EG=2IVESE&?K5ZI?EB]2WU @Z8Q6B-2(U=CJ<8NC?,:SS1)
MFE::@9H\S86:6S5/:3ZB831S&HO&I2V@;:.=IO5H$;6LM=A:65JE6GNT.K3Z
MM36U7;03M*=I5VH?T^[6P72L=-@Z.3K+=?;KW-#YI&NDR]3EZR[1K=.]HOM>
M;X2>GQY?KT2O7N^ZWB=]NGZ@?K;^2OU&_7L&N(&=0;3!5(.-!J<-^D9HC? :
MP1U1,F+_B-N&J*&=88SA#,.MANV& T;&1L%&(J-U1J>,^HQUC/V,LXQ7&Q\W
M[C6AF?B8"$Q6F[28/*=KTYGT''H%O8W>;VIH&F(J,=UBVF'ZV<S:+-YLOEF]
MV3USBCG#/-U\M7FK>;^%B<4XBYD6M1:W+<F6#,M,R[669RW?6UE;)5HMLFJT
M>F:M9\VV+K*NM;YK0[7QM9EB4VUSS99HR[#-MMU@>]D.M7.UR[2KM+MDC]J[
MV0OL-]AWCB2,]!@I'%D]LLM!Q8'I4.A0Z_# 4<<QW'&^8Z/CRU$6HU)&K1QU
M=M0W)U>G'*=M3G=&:XX.'3U_=//HU\YVSESG2N=K8ZAC@L;,&=,TYI6+O0O?
M9:/+35>:ZSC71:ZMKE_=W-W$;G5NO>X6[JGN5>Y=#"U&%&,IXYP'P</?8X['
M48^/GFZ>!9[[/?_R<O#*]MKE]6RL]5C^V&UC'WF;>7.\MWAW^]!]4GTV^W3[
MFOIR?*M]'_J9^_'\MOL]9=HRLYB[F2_]G?S%_H?\W[,\6;-8)P*P@." DH".
M0,W ^,#U@?>#S((R@FJ#^H-=@V<$GP@AA(2%K SI8ANQN>P:=G^H>^BLT+8P
ME;#8L/5A#\/MPL7AS>/0<:'C5HV[&V$9(8QHC 21[,A5D?>BK*.F1!V))D9'
M15=&/XD9'3,SYFPL+79R[*[8=W'^<<OC[L3;Q$OB6Q/4$B8DU"2\3PQ(+$OL
M3AJ5-"OI8K)!LB"Y*864DI"R/65@?.#X->-[)KA.*)YP8Z+UQ&D3ST\RF)0S
MZ=ADM<F<R0=2":F)J;M2OW B.=6<@31V6E5:/Y?%7<M]P?/CK>;U\KWY9?RG
MZ=[I9>G/,KPS5F7T9OIFEF?V"5B"]8)762%9F[+>9T=F[\@>S$G,J<]5RDW-
M/2S4%&8+V_*,\Z;E=8KL1<6B[BF>4]9,Z1>'B;?G(_D3\YL*M."/?+O$1O*+
MY$&A3V%EX8>I"5,/3-.8)IS6/MUN^I+I3XN"BGZ;@<_@SFB=:3ISWLP'LYBS
MMLQ&9J?-;IUC/F?AG)ZYP7-WSJ/,RY[W^WRG^67SWRY(7-"\T&CAW(6/?@G^
MI;98M5A<W+7(:]&FQ?ABP>*.)6.6K%ORK817<J'4J;2\],M2[M(+OX[^M>+7
MP67IRSJ6NRW?N(*X0KCBQDK?E3O+-,J*RAZM&K>J835]=<GJMVLFKSE?[E*^
M:2UEK61M=T5X1=,ZBW4KUGU9G[G^>J5_97V58=62JO<;>!NN;/3;6+?):%/I
MID^;!9MO;@G>TE!M55V^E;BU<.N3;0G;SO[&^*UFN\'VTNU?=PAW=.^,V=E6
MXUY3L\MPU_):M%92V[M[PN[+>P+V--4YU&VIUZDOW0OV2O8^WY>Z[\;^L/VM
M!Q@'Z@Y:'JPZ1#M4TH T3&_H;\QL[&Y*;NH\''JXM=FK^= 1QR,[CIH>K3RF
M?6SY<<KQA<<'6XI:!DZ(3O2=S#CYJ'5RZYU32:>NM46W=9P..WWN3-"94V>9
M9UO.>9\[>M[S_.$+C N-%]TN-K2[MA_ZW?7W0QUN'0V7W"\U7?:XW-PYMO/X
M%=\K)Z\&7#USC7WMXO6(ZYTWXF_<[)K0U7V3=_/9K9Q;KVX7WOY\9^Y=PMV2
M>^KWRN\;WJ_^P_:/^FZW[F,/ AZT/XQ]>.<1]]&+Q_F/O_0L?$)]4O[4Y&G-
M,^=G1WN#>B\_'_^\YX7HQ>>^XC\U_JQZ:?/RX%]^?[7W)_7WO!*_&GR]](W^
MFQUO7=ZV#D0-W'^7^^[S^Y(/^A]V?F1\//LI\=/3SU._D+Y4?+7]VOPM[-O=
MP=S!01%'S)']"F"PH>GI +S> 0 U&0 :W)]1QLOW?S)#Y'M6&0+_"<OWB#)S
M Z ._K]']\&_FRX ]FZ#VR^HKS8!@"@J '$> !TS9K@-[=5D^TJI$>$^8'/@
MU[3<-/!O3+[G_"'OG\] JNH"?C[_"S7=?$[W0_:7    BF58269-30 J
M"  $ 1H !0    $    ^ 1L !0    $   !& 2@  P    $  @  AVD !
M  $   !.         )     !    D     $  Y*&  <    2    >* "  0
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M((   @@T(! C :D!-79!  $$$$   0000  !!!!   $$$$   0000  !!!!
M  $$$$   0000 "!($ "$E\$!!!   $$$$   0000  !!!!   $$$$   000
M0  !!!!   $$$$   000:%B !*2&Z=@1 0000  !!!!   $$$$   0000  !
M!!!   $$$$   0000  !!!!   $$2$#B.X   @@@@  """"   ((((   @@@
M@  """"   ((((   @@@@  """"   (-"Y" U# =.R*   ((((   @@@@  "
M"""   ((((   @@@@  """"   ((((   @@@@  )2'P'$$   0000  !!!!
M  $$$$   0000  !!!!   $$$$   0000  !!!! H&$!$I :IF-'!!!   $$
M$$   0000  !!!!   $$$$   0000  !!!!   $$$$   000( &)[P """"
M  ((((   @@@@  """"   ((((   @@@@  """"   ((((   @@T+$ "4L-T
M[(@  @@@@  """"   ((((   @@@@  """"   ((((   @@@@  """"   (D
M(/$=0  !!!!   $$$$   0000  !!!!   $$$$   0000  !!!!   $$$$
M@88%2$!JF(X=$4   0000  !!!!   $$$$   0000  !!!!   $$$$   000
M0  !!!! @ 0DO@,(((   @@@@  """"   ((((   @@@@  """"   ((((
M @@@@  """#0L  )2 W3L2,""""   ((((   @@@@  """"   ((((   @@@
M@  """"   ((((   @B0@,1W  $$$$   0000  !!!!   $$$$   0000  !
M!!!   $$$$   0000  !!!H6( &I83IV1  !!!!   $$$$   0000  !!!!
M  $$$$   0000  !!!!   $$$$   1*0^ X@@  """"   ((((   @@@@  "
M"""   ((((   @@@@  """"   ((((! PP(D(#5,QXX(((   @@@@  """"
M  ((((   @@@@  """"   ((((   @@@@  """!  A+? 0000  !!!!   $$
M$$   0000  !!!!   $$$$   0000  !!!!   $$$&A8@ 2DANG8$0$$$$
M 0000  !!!!   $$$$   0000  !!!!   $$$$   0000  !!$A XCN   ((
M((   @@@@  """"   ((((   @@@@  """"   ((((   @@@@  "#0N0@-0P
M'3LB@  """"   ((((   @@@@  """"   ((((   @@@@  """"   ((((
M"4A\!Q!   $$$$   0000  !!!!   $$$$   0000  !!!!   $$$$   000
M0*!A 1*0&J9C1P000  !!!!   $$$$   0000  !!!!   $$$$   0000  !
M!!!   $$$" !B>\  @@@@  """"   ((((   @@@@  """"   ((((   @@@
M@  """"   ((-"Q  E+#=.R(  ((((   @@@@  """"   ((((   @@@@  "
M"""   ((((   @@@@  ")"#Q'4   0000  !!!!   $$$$   0000  !!!!
M  $$$$   0000  !!!!  (&&!4A :IB.'1%   $$$$   0000  !!!!   $$
M$$   0000  !!!!   $$$$   0000( $)+X#"""   ((((   @@@@  """"
M  ((((   @@@@  """"   ((((   @@@T+  "4@-T[$C @@@@  """"   ((
M((   @@@@  """"   ((((   @@@@  """"   ((D(#$=P !!!!   $$$$
M 0000  !!!!   $$$$   0000  !!!!   $$$$   00:%B !J6$Z=D0  000
M0  !!!!   $$$$   0000  !!!!   $$$$   0000  !!!!   $2D/@.((
M @@@@  """"   ((((   @@@@  """"   ((((   @@@@  """" 0,,")" U
M3,>."""   ((((   @@@@  """"   ((((   @@@@  """"   ((((   @@@
M0 (2WP$$$$   0000  !!!!   $$$$   0000  !!!!   $$$$   0000  !
M!!!H6( $I(;IV!$!!!!   $$$$   0000  !!!!   $$$$   0000  !!!!
M  $$$$   01(0.([@  """"   ((((   @@@@  """"   ((((   @@@@  "
M"""   ((((   @T+D(#4,!T[(H   @@@@  """"   ((((   @@@@  """"
M  ((((   @@@@  """"   E(? <00  !!!!   $$$$   0000  !!!!   $$
M$$   0000  !!!!   $$$$"@80$2D!JF8T<$$$   0000  !!!!   $$$$
M 0000  !!!!   $$$$   0000  !!! @ 8GO  ((((   @@@@  """"   ((
M((   @@@@  """"   ((((   @@@@  ""#0L0 )2PW3LB  """"   ((((
M @@@@  """"   ((((   @@@@  """"   ((((   B0@\1U   $$$$   000
M0  !!!!   $$$$   0000  !!!!   $$$$   0000 "!A@5(0&J8CAT10  !
M!!!   $$$$   0000  !!!!   $$$$   0000  !!!!   $$$$" !"2^ P@@
M@  """"   ((((   @@@@  """"   ((((   @@@@  """"   (((-"P  E(
M#=.Q(P((((   @@@@  """"   ((((   @@@@  """"   ((((   @@@@  "
M")" Q'<  0000  !!!!   $$$$   0000  !!!!   $$$$   0000  !!!!
M  $$&A8@ :EA.G9$  $$$$   0000  !!!!   $$$$   0000  !!!!   $$
M$$   0000  !$I#X#B"   ((((   @@@@  """"   ((((   @@@@  """"
M  ((((   @@@@$## B0@-4S'C@@@@  """"   ((((   @@@@  """"   ((
M((   @@@@  """"   ((($ "$M\!!!!   $$$$   0000  !!!!   $$$$
M 0000  !!!!   $$$$   000:%B !*2&Z=@1 0000  !!!!   $$$$   000
M0  !!!!   $$$$   0000  !!!!   $$2$#B.X   @@@@  """"   ((((
M @@@@  """"   ((((   @@@@  """"   (-"Y" U# =.R*   ((((   @@@
M@  """"   ((((   @@@@  """"   ((((   @@@@  )2'P'$$   0000  !
M!!!   $$$$   0000  !!!!   $$$$   0000  !!!! H&$!$I :IF-'!!!
M  $$$$   0000  !!!!   $$$$   0000  !!!!   $$$$   000( &)[P "
M"""   ((((   @@@@  """"   ((((   @@@@  """"   ((((   @@T+$ "
M4L-T[(@  @@@@  """"   ((((   @@@@  """"   ((((   @@@@  """"
M  (D(/$=0  !!!!   $$$$   0000  !!!!   $$$$   0000  !!!!   $$
M$$  @88%2$!JF(X=$4   0000  !!!!   $$$$   0000  !!!!   $$$$
M 0000  !!!! @ 0DO@,(((   @@@@  """"   ((((   @@@@  """"   ((
M((   @@@@  """#0L  )2 W3L2,""""   ((((   @@@@  """"   ((((
M @@@@  """"   ((((   @B0@,1W  $$$$   0000  !!!!   $$$$   000
M0  !!!!   $$$$   0000  !!!H6( &I83IV1  !!!!   $$$$   0000  !
M!!!   $$$$   0000  !!!!   $$$$   1*0^ X@@  """"   ((((   @@@
M@  """"   ((((   @@@@  """"   ((((! PP(D(#5,QXX(((   @@@@  "
M"""   ((((   @@@@  """"   ((((   @@@@  """!  A+? 0000  !!!!
M  $$$$   0000  !!!!   $$$$   0000  !!!!   $$$&A8@ 2DANG8$0$$
M$$   0000  !!!!   $$$$   0000  !!!!   $$$$   0000  !!$A XCN
M  ((((   @@@@  """"   ((((   @@@@  """"   ((((   @@@@  "#0N0
M@-0P'3LB@  """"   ((((   @@@@  """"   ((((   @@@@  """"   ((
M((  "4A\!Q!   $$$$   0000  !!!!   $$$$   0000  !!!!   $$$$
M 0000*!A 1*0&J9C1P000  !!!!   $$$$   0000  !!!!   $$$$   000
M0  !!!!   $$$" !B>\  @@@@  """"   ((((   @@@@  """"   ((((
M @@@@  """"   ((-"Q  E+#=.R(  ((((   @@@@  """"   ((((   @@@
M@  """"   ((((   @@@@  ")"#Q'4   0000  !!!!   $$$$   0000  !
M!!!   $$$$   0000  !!!!  (&&!4A :IB.'1%   $$$$   0000  !!!!
M  $$$$   0000  !!!!   $$$$   0000( $)+X#"""   ((((   @@@@  "
M"""   ((((   @@@@  """"   ((((   @@@T+  "4@-T[$C @@@@  """"
M  ((((   @@@@  """"   ((((   @@@@  """"   ((D(#$=P !!!!   $$
M$$   0000  !!!!   $$$$   0000  !!!!   $$$$   00:%B !J6$Z=D0
M 0000  !!!!   $$$$   0000  !!!!   $$$$   0000  !!!!   $2D/@.
M((   @@@@  """"   ((((   @@@@  """"   ((((   @@@@  """" 0,,"
M)" U3,>."""   ((((   @@@@  """"   ((((   @@@@  """"   ((((
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M>!8(;Q'H0 $2D#JPT;EE!&8)$!.8A<%+!#I0@)A !S8ZMXS + %B K,P>(D
M N<L0 +2.5.Q(0*=*T "4N>V/7>. ,%&O@,(=+8 P<;.;G_N'@&"C7P'$$"
M!"2^ PATM@ Q@<YN?^X> 6("? <0Z&P!8@*=W?[</0*-"I" U*@<^R'000(D
M('508W.K")PE0+#Q+!#>(M!A @0;.ZS!N5T$SA(@V'@6"&\1Z$ !$I ZL-&Y
M901F"1 3F(7!2P0Z4("80 <V.K>,P"P!8@*S,'B)  +G+$ "TCE3L2$"G2M
M E+GMCUWC@#!1KX#"'2V ,'&SFY_[AX!@HU\!Q! @ 0DO@,(=+8 ,8'.;G_N
M'@%B GP'$.AL 6("G=W^W#T"C0J0@-2H'/LAT$$")"!U4&-SJPB<)4"P\2P0
MWB+080($&SNLP;E=!,X2(-AX%@AO$>A  1*0.K#1N64$9@D0$YB%P4L$.E"
MF$ '-CJWC, L 6("LS!XB0 "YRQ  M(Y4[$A ITK0 )2Y[8]=XX P4:^ R\K
M4#UK;:S^WC^H?UBIK:Q_./NY]KJ^J6]9_[BV%T^M(4"PL37:@:M H%D"!!N;
M)<]Y$6@= 1*06J<MN!($FB% 3* 9ZIP3@=81(";0.FW!E2#0# %B LU0YYP(
MM+\ "4CMWX;< 0)S+D "TIP3<P($6E: 8&/+-DUS+VQVXI!?R9GDH=D?S'Y]
M9H/:=;], M*+CE/;C*>F"Q!L;'H3< $(-%6 8&-3^3DY BTA0 )22S0#%X%
MTP2("32-GA,CT!("Q 1:HAFX" 2:)D!,H&GTG!B!MA8@ :FMFX^+1V!^!$A
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M E)=HE6>"3:V2DMP'0@T1X!@8W/<.2L"K21  E(KM0;7@L#\"Q 3F']SSHA
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M/ 'IQ>L\#:F^>/+1BS_5NW =]2UX;B<!8@+MU%I<*P(77H"8P(4WY8@(=((
M"4B=T,K<(P*O48 $I-<(R.X(M+$ P<8V;KRYO'0/4-:.'STK5*D 9SQ$*WV-
M/SQ\65_J 4[?( I&5NNC(7V3VL%"3'(F;EG?F><F"A!L;"(^IT:@!00(-K9
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M;L66""Q$ 8*-"[%5N2<$SD^ !*3S\V)K!!:: #&!UF[1BOK^_D@DHBK&]<%
MH7NLQ"'O&NNCT(<NE\MA>O1XPCOF/A#)XP:UV(&J%H>^N_>A9R]^ *VK:-^J
MQPTTO7I,CZJ.'9W+8PS>W?;S^X[>/]=GM?_YV[C>QS3(B:4]!8@)M&>[<=4(
M7"@!8@(72I+C(-!9 B0@=59[<[<(-"1  E)#;.R$P((0(-C8ALWH <,HEJC
MH%Z$Z<D\:.@)1WH*"3O1]&@^S#%646)2R%%2X#(^I4I'NVQD_%D;F=AA$ZIV
M-#%]V"8+$PHB5BV9TE1J3J+#>G#1DXX\K\>/JYAG>#XSU#($)*/MHB0A[><!
M21TG)"OY)87]O&)2])DNQ91;I%KQ54W3UFV]7<NL*WV1+>K;;(-]5Z@ZTFI5
M3AK2CKH*CU]J6KFP^'O?N7:<F*H]64BTTJ<5KWSD%QMMRL_S$R#8>'Y>;(W
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MV4VK;_3HB3KUD4]P4I\^2D)R*S=CF2\!8@+S)<UY$&A- 6("K=DN7!4"K2Y
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M;-T&5?;2[Z[_WM7WV?G<8?O*%Y^TI[Z_QTZ?F [?=9\&T9?9H2VO3I;7[\.
M$ID^\%/7VT]^Y*;:,?1[J"2>![^UP[[Y+T_;[AU'58FLJ-_9<(@7_?"K\E_\
M27V^^>H5]N&?O<5NNG6]MHEN[NDG]MK]7WG&GGG\@)TZ.:6_!U[I3(,6/<DJ
M#%WTPU7UMRANRY7 =/.;-]H=[]RDUXO\#YXNV$_JB3\Q>_1[S]M]NIYGGCAL
MD^-Y74\MWAB.X)MK.]U@L>!_X^)V^]LVV*_^YEV6SGA\SJ\G2B#:]M1^^\:7
MGK+'O[_/1L?R^INJ!$]]>O92TK7ZGX=K;EACO_D[=RNQ2O,\_HBEI&3+O_R3
M[]B_?.$I_9TJ*8'3!VGJ^G4,3_I,ZKV?Q]V+>56'\\^TQO]7*)1M:%&/_?RO
MOLG>\HXK0ASU._<_9UONW68[E43JE>NK/J)3_Q<-_-3].(^.EE6RU>H-B^VV
MMUUN;WG;%=8?KM/OU\_6&@LQ@=9H!ZX"@783( &IW5J,ZT6@"0(D(,V@MW8"
MDE]G[3]0$SV6Z%NMY -51F%!X#4(+,Q@X_EUY';M/&#_SY_^M7WN'_Y9P3$E
M^&G:KDI%H_4T>B@*$-03B/RX4<?ZG,E]%^_PATZYGC2E8E$CF/KZNNUC/W./
M_<(OOT]ES;U#K9+EFCHLG>VU7<=.V*<>V&+W/_:(2K1W*[G(.^.U43)1#U8'
M\@2D@OX&3&@48]K*>77^??1/9DK)B3U6+O19K#ABJY?LL#=?<]0V+2E8>4H=
MZ'+<*IY\E%1XQ#O&.G+H\FHZMA#OJ*WPS]INT3771Y-YQU]WI&2C:#33TIXW
MV&6K?MGZ^RX1G4:-DH!TIGD74K!Q?'S<QL;&-/IO.CPF)B9"H-V#Y_[E\*^U
M!^N[NKHT>JW7LAI5[*.'!P<'-2JM-HKOC PO$.@, 8*-G='.W"4"/TJ !*0?
MI<-G""Q\@849$YC?=JLG]?BS+Z$BDKKP7]KR.7MDZR-V6%6(3HV?4@6AG/HB
M,5LZV&^;UV]0'SQMV[<?LD7#:[67XA#JT\=5\2BEZ=G\D4XI>4?/79FTDH]4
M-4GQ@5[U81*JBNY5D<M%)2-I+-.*_B7JXB?L^,D3-J7IT!9?O%Q3L!?LY.D3
MJM;1JRG0<IIR;5J1">\T^_5%B4=>^<@3C\KJ+X4J2)Z$Y!6.]/[,0^N\8I(G
M(GE"03WY*$S+IFT]9I+/38=_T._N[K.)7$')$?H'?%U'10E(E6I!]U'5/\+'
M% N9U+83UMO797OW'E2?3<=4%>@52];:A^_^L-UU\ULMJ4%324^N"DE<<7\*
M_3AW99D;@844$Y@+(?]]WO;4 ?O-7_L'.[9O3$F$_KWTZ,*+%]\NKT0?_SLP
ML*C+[K[G]?:!#]]H:R_U)"1/3%'"W>%1^Y/?_Z9]^^O;[?3Q\7"LC"H*>>6S
MVI^/60>M6FZZ9'T#&?NIGWNC_=ROO$65B'SJP[(]^O!N^[,_^*9M^^$AFYXJ
MZ.]%4HD\JK8><GAFKLTC8AZ2G)S(VQ5O6&$_]VMWV%OOND+GJMB!?2?MOW_B
M&_;PMW?:R,G),/UC.JO?O;"[XB>U )O?5V[2XVBJ@K1FD;WGGFOL?_[8&Y5H
MU:MUGJ03MV>>W&]_^<D'[*$M.VUJ4LF(X7I426CF4G3.Z)A%)?\DE(!TY[LW
MVV__[GLMVUT?'!BSW3N/V%__^8-V_Y>WVNAI55'2<;KT^4MM?';*J/K]=3==
M8K_WR9]4Y2D?O/G*BR=)_N'OWFM?_+LG55E*UZB_K]XF(0E)MU%14E<(E":B
MO\..6:^JY E(@\-=]N]^XPY[[P=OL$<?V66?^N_?MA]^;Z_E5!W+JQQE@YU2
MCCR@6@NP>M)340F9;KGAJF5*(KO1WGO/]:'=7X3SRI<]+Y\0$Y@79DZ"P((3
M( %IP34I-X3 A1<@ 6G&]+4G(&VM'6S6?V'/'/X"O?+_.-9_IJJ21Z)[I:9E
M4^)!U,.X0,?G,)TDT"G!QGJG,NI SW2DCQ\;M<_^S9?MKS[S>8U8F52'L4==
MYY0":[Z-?Q,\@*A.Z(LJ($6C<E[M>^*_IR%8IN-$Y_??7>_^5VSCQK7V\=_Y
M=;ORFDOTWLN:JTR[DF82J8S=^\Q3]LFO?=F.G3INZ=ZA4+DH)#YYWUH=_YA'
M'A7P,%/24GQ*@<>D50J>@*2@14K1QX1*+"G!IE)0)SA^TEZW]IC==<5)Z].H
M0[^FVB >4UQ/TZY%[_4?C!;7;7INDO>5?7W;+;KF,&)405&_ =U.2$#R4M'I
M:I^M6_8SMOJB.T,"BOZ ZE-_L+1SL-%_GZ:FILP3CXX>/6J[=NVRW;MWV_'C
M*H$]*QG)1R'[[[X_/ ')DX[Z^OI4RGS 5JQ881LV;+ U:];8\/!P2$PB&8G?
MBTX2(-C82:W-O2+P\@(D(+V\"VL1Z!2!3HD)S&5[>K_$^QSU?K__0_>IT1/V
MZ<__D8U51NR%0P=M(I^W;$\V)!4-#_39E1LO5S+"24U[-&W+5UZJ) )5,-'
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M#;!Q3) 0)=J\?>_S#^27M&(3VR]G)QCZT$-(&C&2[_SFCS$'<N_ -0$)^))
M (#D2RJ!?0$)'#D2:)<V@1:L/LWDIP%YQ$^)G$=J7JI"[W!'M;T*:__Z Q_,
M?Q,E%3O0JW<:P0&]L2-[%W)R\Y&0D(2(R"B&<LJGWL&P9*$Q9$PBRQ&9@4QD
M##)0AS43<!0D8=;X;>)<Q$P#AHG I&"C6>TG]HC[70J,Y'"&DS$I@B';2#YD
M9NBULD(Z' &AYGB"E,(5ZY&MID*%0G-P+BX,*CIA/V+)[9R?"QN2YH1$/4B
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M,T%((03GN$69IQ.2,"27E)8@+(P,[^$LJ;Z&4_=:9?,PB)&#K*E.LK++=%[
M1GH"]D4_JK8ZZ*A%=B/NMY,I61;ZA7M9?<0N(J BVB $3,2_5%<<O(ZV!Y:[
MNKJ*]@<='YV@)>I,/@%(S,/%FWH 3:(.N<A.[>2<RD%PE)117*HB"<*R5EH0
M3B>"63-G8=S@HVGVJ*4N1X<JGQ/N@UNW1W)NK=DFT!KJ9=N6?+STY'=8OB03
MU15T_N._(/91 ?V)M5&BITNHP*3.T>C<)1[EI=78LFXW2ABJ;/K90Q5#CF)
M*BS'8_<0@/3E)L22 :DY "2/'/8%($TB .G* P4@S7H76]?D*);XN(Z1" HC
MT[H:WT1OK4]NT:FIWY83>%6PLYR]48=C"0P2!B0CUUW$/O/N:S]C#AE^<K-+
M$!/-<8_/%QPNT2&\\I+!CC_UM-L%A9K0LV\23CAM,/H/%)N$=MZ"CU?BS1=^
M0N9?N1S'S 1JA2$J5IPSM>.>W"1;*9>9#J9=TQ,P?<9 #!F97E_H9FP% $A
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M$U@DNG$M:9)KY$/6Y%HN\,N<QTT=10!(PCHL;$;E%:4LN[ ]R_W)?D3;A3<
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MQFTZ[]92[S>9R(8D0".3L!O1@9GS?\5T1#U(@8[XVR1,1SPFX=AD7#)RT5T
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ME+DQ#Z\]^ST6?+@:*:F)N.)6,CZ=/MCGN8=K9[NR"1PN(0;N&Y# $2B!-@-
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MZ?7![&8\5U=O/#SH54_@KX'4S.4,P39R=']<0P:D,:.&\+[T[N/-7"Q#.0%
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M2TI*\<13S^'?_WF9U/?1=<9'#<GKI*?BE.,FXME_WT?VF]0FZ\!FL^'5U]_
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M=V/(\"X8?TQO@G\T(+0\J[#BK%R^ W_]N0OEG&O((K:O-J[N3 "2V#-[]NV
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M>>__0M9)SM7WW(T;S$_T.BGGS'/'XJ'[_P_?+EZ'2V?]C_JG1B2CEH/KNJ8
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M#)&TR!K3U=<"_?PLX4N7P/^&<&/J!&JKY2L#D&3C0$@_-N[;BGG+YB$N+98
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M$%3'H<"R! 5DXKB+;DZG$(#4.#B RCF>WA;AEBP[QZ)B\=FJ-3@=1V.(>2D
MR; D4@T)VKOZP@+73 /":(0M<ADU-2_DRQ8YB;EH0-=KMW4(15! II(C3*@
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M0&70K9V<KJ7<PY/'<A RP-<5/3HW48Q.7NX5W4[4%( D(()?MAS!QC]#D$J
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M(%W?^=GCTV].P-/#&L,&-X2W1V6ES/=+3I%MRAQ]>_C!VY-& (,@RI)5OU[
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M#'<V=&/W]B=O$Y#H!0L#>>W:/L^;J4D+U*5.X.83N-D"-UN@[EN@MG4"5PM
MTESY=>P8B-]^>5&Y.C1NI:CH9+PQ>Q6^G_\GU[C*MG_C^/)=9,[J&)#B"&"Y
M[\$OL>VOTXHAT))KEC&X1,1J ?Q+$"8G"ZYMHEL4H+PP@0JX7H(P#!H'T3L(
M %\$Q+M&=,:\KQ^%/<%%QD$8=EZ8N12;?CT$.[HMJRI(/0SS$F9$_8$ XB=4
M.80%GM8.@P,!6CI2CFRNP^(U:=*$'OCX@TEE;*(2IR8 ) '62#X"*#,,(N6*
M#4(!H 1L4\W:+:P_ I1Z9]983)K8FT0@=CAX*%0Q"VW:=%2!KIB*8=*JC04
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M?ST 23U#/DEMT O*GY8R/#_M8;Q,=V&VME6?='KW@\\QY\OY2*%BS)RG^=3
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MD4IM 9"24O+P]Q&>#N5)B'N&!ZD2K=T2@?-A:;BEO2>Z=O3B)DLOB&D )&%
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M1!H&:U6_;N^U!4 *B\C [@/Q9#1R0F<"CC:3G6C_\20J'+SXXLD-;L:T4!T
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M2[$'&3>I#,,* *12!B0MGKA12R8 :<VN:P! ZAB/"?UU=..A9T JRX/C-YT
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M !G$@Q["S%S?P[\:@"3 H<;^?EC]XU=8_?,&?/KU0F01N6]&85Q ..+:9-B
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M^_;M5'(YJKG:,$-Y7I<%(/&4<'+J-0(@=:(+-HT!26A'2X.L]^E9!"!MNC(
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MGV['^A7':5\T@:>_/5IU#."ZS'%K\#B$@2B/:WPD@3:A3$_8.CIT;8 9;XU
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MML/X<=5?ZL1%(>>KJ5,?1^_>O14;C-8'!(RS>_<>?/CA1VH<"2!G)-T?1!*
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M9..D! RM/MJ[*E/- 4CZ^E-!8\I3A:1(]_:YB/YM(M#<D3ZE*?2RB#S55 I
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MBX&-12:<&2^[N=(O)-/8)H# "W,S&QI.%N.X(:PF9&(BVU 2V;N47666(76
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M.88%B_\E ,D(G3HT0/]^[;!CZQ$L_G<W%:'Q:-FT&IF1ZA'D8D]W:Q%DWPE
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MBF-7X>LB>9=/%8#$3=B,V*,$($WE ,>-3(ZI#Q0$@%2R%HQ<1G&=YYGGD5<
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MZHF1X]NB?I-R12>>YPKC$820)LF<*Y?.!6'B!ZMQAP"D4J7M,6/Q0)1TR66
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M$%@5CFO7_!6X2L!1+5LV9[YRA0*9.XX>/8JY<^<1;!2&-][HJ5S,"7N%A/P
M)''!)@QI"Q8L)!O3;E7>;MVZD=&HL[J_L#_"AG'X\!&Z8!,6*0-X>95#]^ZO
MLX[**Z"5G'L>PDNI;.18H D\4$@:S8FL3+(C\#TN_V<;9O[VE^J? D!28!VU
MQ-4^J#N?\%@+0E&+;/9= ?<\0)"M3%$ZI!#@E)E%6\54,AA6+T=&K<%HW:X)
M%7$4/'E-CTJW9&Z.+-AW!!N.':*/]W N+L1:UI1]F+*$.2T?N581)3=H%2G
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MT *0/B  B2[8M$'J3>:=T\=OX/?OO'%L[S4TI-NZ#[[HB*IT8_?P0>I.@@:
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MZ\/[-L4'0]O0,- H3UFW[KV G^=ZXRP9'S3WT^T4\[[@IR%HTZ0BW<X9/!<
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MG=SX743_NI$$-?5#Y\Z=23=H>T\7;,* ) "D^O7K0T!+ IP2-V,RSEF0Z4V
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M$#2OW5+%EY$L "26AFNR5^')U<"SU E(.WAX!B0_,B"Y8N1] $B_$H#D7P@
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M\"R5C=I7$!X>KMRP'3IT2(W?6CF;35XQ(%7VB,?;G9+H.L^ 2G)-XY2_1L*
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MC'M)!*V,^; 3 3/=:-QOC5-G;I"Y:2W6KRTB']%):-&J,B9^T0,MR%#Z($'
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MB/<\."=X$!@D'9;<HA49RB,"]LB"1 G'N&5G;-Y7>?6-5>>G_LQO\YWUYJ=
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M"99LW#@03SQY'RX>TL=8!;JP+[LQ3Q<>&B[8O!5OSOD>>XX<H++-BR BEJ6
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M_O>_<A=L O9X^U05<%3/9<N6X>VWW\7APT=PS36CR$(TO ( Z>]__P<D@ L
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M)5SG<GF F)--YG*NBV:O37V*E!"N^F-:!6(>518>3-FP*Y48]XVY6=GT^ES
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M3+R:@QVCV?U%[@0GO7^W,1RID, 9^.-W#T#20!&"/B,C@P/)!X&!U;O!.E$
M4B[=H<R9MQ@OO?86EBQ?"5<?7[(1Y"'0SY>4T&W0KT\/=#^O*R>+&$Z2C6@M
M12LE'IK((EK^Z;?OV(59<Q?CZ^]G8^NN>!XF\E"$G47+3 '!2'\E<]&]=]Z*
M1F0)J2DHG?_[V_/XXKO9/&1TLT!,4OXS%%&0%U:X950TNG1NBZY=.B VIIEQ
MRR9E7"H/S9-H6;Y[UUYLV+(-ZS9N(>4T00\<*>XLCX) 4@5'$W'%R,OQXK_^
MAI:Q,>:ZLW_J&H"TGZ[41EX_&X</9&'4M;'HWBV$![2$#U&^\_)RPX[=:7CU
M?W1SE9C+=U&"JZZ(PO!A48;A2.ZE[* !K+8^3!8CQ<\@9=YU5\?@PO,;FTG
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M]W0J&RM71V/RM==>X]RYW !,*X.0*L=W_'W" *3Y9$!*\>2! ,>48X+'^"[
ME-P)//C@@\8%V_&4M2QI"K9%65M0L/4ACO%R^;7L_O%\X3S@&A1%(/5S)#\J
M5V!43J(HXQ?D[WB:P@O7KO(=<^5HQ_ZM0XJ0CO"(^A/W1BV.&5_SU<D D,H'
M=J6L3G;]5,$HV+E'7PN/)F/8)E5!RW:.]0 DNR7.KL\2SBL9ZS=CUS.O WL/
M(9MC+8\RI#.%T/$ D$HX!^R9/1OQ4Z>B<.\>)%$^57>J;3@> %(QY<L"RI_%
M>?GPB:(\RGY_D//DSD\^1M:&#15<L'EPPZ #SV:77T&0S*.U+<X)QZM+ %(6
M9?3XZ62;^NPSI+)][:!WY\'YRY.ZCXLGO [O!M2CE,X%SAB0[.?T:3RX'&/>
MT'M4&]I!1TS*KS&!79Y=:'@P[D:$=NMFW_Y=?-JZ@+BX..BO/M2W0'T+G%LM
M<*[H!.KRK4K?4#D(;!.?? #_^=^+V+%K"^6$/()I8)@.Q)KM[>F/A(/)7'3(
MO.83C-PT@G8(]@D,\D=P*-T;^[H@@WI*\H71$(DNV"BSBC')C3H#L:25$(!4
M0I8B+6LZ#)->R?ZK7!8NE!1Y*?/2);-+82[=LOO0!;N_ 2"YT9C3 )JH1TC-
M*("WB_0F=(M62( U=5A>7CXFW7P>G*F6V61PD@LY3QXBEQ#<K5#(BLDU;1$9
MCJBP(X,;]1HYN? /"*3NHP 9F9DTQ*)Q*<%$KCJDI_["M9B@:7H>R#B4AB']
MAQKVH]91+4O!1SK,U [ .I[GUKX^U&$+G$Z=@,:.!4#::/KRW8]>@E$W539P
M46]P@5B!)CP["PMG;D+';E$&@#1@:/4 I-?)MK-S8P+:M"4PZ(.Q"(^T&)!6
MK]B%=UY9@%6+R&[?Q _G$> SYI8^:$"PB\93=3I:'4('!_O"U\^+XXD1628;
M@!2_C0"DSDWQT-/#T"2,A\^\[S@M*$UYVMBP]@#>?VT^D@]G(#4U%V/ON)"N
MQOJA<2B]<7"?DIZ:38.L(NRGN]*7GIF%;;\FH'OO&%QW<V]T)5A*8,&&])+@
M3E>/'$C8M3T!+S\S$\L7[D)00Q]TOS &U]Y\ <$-#9S6PRJ3C!'=T*"!#UU#
M">#A0GTIQRE=10FXL'G=?KS^K]E(V)."\.@0//[\E0BCUP9OLL/XDP50KAL5
M]NQ,Q&-RP;8U ;'M0_$HF:2Z=&]F[E7W3TT I,\_^@D?O+X8"0?2T*)=*(:-
M[(*++NM$O8O8UZI+D6<EK$L0WXMG->R.EBY!"?",-#D37TY=C<3#F6;>,\S;
M;$J]S>,)VA\85GKI1:B'[$ C\+BA[3E?LCUEY&[.HXXGQ=,;]TP (-U) %(H
M 4@;-^_',\].QV=3ESEU1>;84F(2$FAC^.7=\-8;MZ,!73@?.9*&)^G^K+8,
M2$IO_X$DW/+'_V'1XBUD"B)81A-!I2!2#$_>N^;JGA@SNB\ZDOTG,) Z>)[Q
M"("2G)*)-;_$XZ-)B_'MS+4\0V8WX+I;.8C)2'WRNFMZX[67;T& ?[D.:M7/
M._'D4],PZX>UU=8]GV??#>@B>O@5Y^'&L?W1IE6X*8?R4MI)9(#ZB8"J29\N
MP:S9ZSD^*!\X*8<8"7V\/3%R^/EX_YURPZ5C 9!T]MZ^;3A!4(/H$BZL%(#$
M\P3FG9Z>35=R1[!\Y7:L6AW/N8SRA,!'3MI38SJ'+N(>ITNY/]TU!&%TH5U3
M.)T ))7U(.6U*T?]AYY/#K"8DJDJ]A'U10&MQM\V$*/()M6*P#(?NF736F#W
MCU_(!/7JA)GF_;!1JK2+P%MR(7[/79?0I> U)KV:VN1,N/>[!R =3R.?*  I
MGHQ!S_WK%;S[]@=43#>!FP [%*JE;"LF."D@.)#^P:/H-BD:32)"Z3.>%K1N
M'J3GS4=R:@9V;-N)M03\I-&"SXU**U=W=\/ 4,SG(\)",>6#";C@_*Z<E*I.
M2)7KMW#),KSP\IN8-7^)0=6Y$PPE04V#6$)^47:VN=Z(+I$BZ-HMD*Z)-!@R
MZ-\T)3,#1X\DTF48-QO<0+B1A4D6%)KPQ A1Q(V!'\MWZ\VC\>=[Q].W9?6'
M%W4-0#I  -(?[ER$!?,/XJI1S<B"U(R^ZCT)]*"[)1\!D#+P[]<VT$U3MJ%C
MO>'Z%KAR2!3ON1/<85E_J.V,*,A_$H[DX#^O4CF;7H ;;XA%7.\PC7$"0"JV
ML!_3/IJ8@^DS]F+5NB1TZ=B %A@Q"*% EI5#X8'!CS[>%Q"@I,7EFA&QC%.1
M_:5BBF?'+RD<;:7CF5+BXMPD@LO2D+[Q-2K;T]B/U5>/$8R YTH7;(/@$S&
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M>SA'^0; H\7?Z:FVW%*JIC3T+LX, !+;1HH2M5E (WA$WP^WP MJ;#.[7O4
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MCTU[ML"_$=T\<?\JPQAN3>%/PZ= [P"N4=S99Y%UA-=] X)H9.2-;!H7&R0
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MK*_UG@U0C65Q[!^5Z^/X7M2O!&#JUJ49QMUP(49?>R$] %2J6^4$SK#?9PT
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MJUQHQ1+D*!37E +SX&&]_@P34J.^< OJ3&'C,(HS?B9CP'9^)Q#)+*(4,<B
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M( 50_^(7'H9F8\:B.0W09"UORWQV(I82E[D9P<*^>FY\VKJ N+@XZ*\^U+=
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M"*)[C)-EJJHN3UW?=R 32Y9QPB?+T07=&F/-^F0#0)*K-/=2:H=TND];N.@
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M6K=UKS[410N<33J!NJA_?9KG0@M(EU'O@JVZ-UW7.@$1=@BHHRF]\DRN&5\
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M];F_RZK336J;_P^<<]MUKY.,8F (S9J%Q1__. HG37(O[75O 4B]JN6HF1:
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M*,.O_._=.]#2%,5E5TS"HCEEG!VE,&%B+A:>0L-I2C$9DTY<B(U>)!_2K&P
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M88Y?>7DYN&S&#%P[8^8!5B/C%S3U"$CEI4[:",K:A!<)IJ+:,+&T#+>=N8Q
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M\J$?-ZDBG%1K<AP<?S8")31*!@I>ZF<SMECV:\ Z&P>W#QT#]_ V)ISH 0
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MM4J1 !P?P8I>K^B2Z5#T:)51%-W1771,OH2:IN?1V,950Z00"M"!&)##40[
M]+"IH2@1XUC(RY2O<&U:J'1P/'06TC4FR<S.2.:K>RZ=?^#K(65-HSKI.$ U
M;*M-L^E2GM(]Q!,,JD:9_"DO2@NFHK)\&<:7G8V\T#2.;P6ZW/@&)))654D/
M BV)#<I4HKILZK<&K+.QWZH:U((*:R9PBX!$ K$(R*/P9<H34$: G3A#-E55
M51D&)(%U%-I+WW5.3$D"&NVAH[&4P!Z!>Q2&3"',5J]>;5B ]!+@K+/.,H <
M 8D$UE&>V'_$;"3@CH!. NPHW%B<UTXDJU$591"@1TEM"@2E>L7>)(#2R2>?
M; !&<EJ)^6?Z]!F4A2NR^3SKNFG3IADF)LDI4)!D$YA*(=!<YB.!C032T?T*
MM".V(=7OAF#37N @,2V)F4ERZ)[U4D7AS\0P)*"0 $$"_ C0I/M3$L!+S$JS
M9LTR>G7;D0[%Q"3Y=>VR9<N,KASFIJ"YKJ2DV,@IT)'DT5Y (LFN>RL@!?WN
MW;M,>#?5)]:DQ8L7FW%-H>F4)R8J@974M\,Q66?C<.P5*Y/5P(G5@.L+$/A(
MFTU6 U8#HTL#UB<PB/V=!O^H!8& 9"%KXZ'9]$7 '^UEDYL#VO0)+WF$N/<0
MC.2EWY$<1+1Y4PAW=Y#MN!FMW*\AB\A?'G\",5XX6VRBG'^O97C74'X><@OR
M&2XM3!:C*,.JY1I[62_Q_007!;BI'8514Y[\GISF$EA$NYJVM5^(J ##LR6Z
MV1Z!2 0?E1>-P23.9R>,+</<J3.QF PL8TO'D9FXE/Z('-80</P2SAT8)J8D
MV99\]#_0[,](NEG>O0%!963;PR'5@/4)G&#URQ'G&1D I-]M(P,2 4CRR^7D
MA@Q0T<=[$Z-Y9O+0 :C'/D*[/DRVI#C#NA73)_!)VL[S,A;J.%<Y[$*-X0@>
MV+X##VW<8,"3*0Y4!;DYN(E,2^>.K^2XUA,VCDT>-4DD T#Z?_=@Z]K]!API
MQO6^DH9"U1N.. "DR]Z^&!_YQ$6FN+RR]&;V=6G6Y5N?0-9UF178:F!8:, "
MD(9%-U@AK :&MP:R$H!$E:9B76C?< >BC9R(:D8X8+:@=+^042G%+5@Z&SF3
M+D6@N)IAV783B/0<$FUK22C2RH*<)1]H0^9S>B+=+P 2RQI/ J>G6G'DYPOT
MG D$'LTBSJB8\=;W,>3::H*?]COW\#KN@[-O^(NF(J?R?(I,!B6;K :.H@'K
M;#R*@H;E:8T_,G<5AHTK'%-^FKU<F:AQBB!$9RQDW/=$(SJZ5Z.^[5GLJW^5
M;$AMB-+)*(IA'XULK7+44"9:='-(:YQ#%!V,&K/4A#Z8CF13FR*9!9BARDP%
MYFISO:KR"B3$39?(P6F&5'X7$$F.SS@=E$F"CWP< _-SBU!1/!/C2L]!:>%I
M=&>.XU6\3[,L,UV_)\:Z%&9.]R_VHTPY^-6F?FG .AO[I:8A+^0"?A36R\QY
M^I!(("6!9#++" @DX([ 0KTE 6L$Z!'KD!B0E 3:T77*4WV')LFC<X>VXZQT
M]IOZ)(O:U!BCI'.JUY5#QVI/=>A8>[=]R20@E%B6W.O5IF22#MSZ,F73.;<>
MMXPIV,>'RJL=U>_*K;V;Y]Z;SKNRZ)YTW]KK>K6OO<JZ<F8V)WE4G\L@E7EN
MN!Q;9^-PZ0DKA]7 T&G@RUR0I+1\^7*SF2_VPVK :F#4:,#Z! :QJVG?FD13
MU0"0N!?D1[FR7C5+-B^YE<$YI<XDF1'GR82N80XGGO#1IQCD')3&.J)D/2:_
M$('WS=BQ;1,Z&&XX1AM^TTZRA&[?COK6%M0W-:*%X9=3M+=]G#MKOJH6M=[(
M*U"3:F"=G,U2+K(6D7TX$8W1JDZA(.1'63D7#926H:2P A/'3D'5I.FH)$M)
M15DQQA06([]0C$<!;D&&0^)=L'K9];H'S97EK4@CJG0'Z2095%#_Y:_D@4W#
M0@/6)W""NT'/(^W'GA!LV<N ]+MM6W#_ADVT>?4\:Z&W[.2^]2F[6<QK/H9_
M7$@&HX\O6(#"0(Y&!JG$)!?<TT7_Y?W;MN-WZS:8P5+O5(KR<_&1!0MQ&A<M
M#20Y8Q(9D/:WX+,?<0!( DJ919@4..4VGE$I7ZP;.S\2B2.G* >77+L8'_OT
MQ2Q!:3,%SK@F6P^M3R!;>\[*;34PM!JP *2AU;]MW6H@*S0@AZ.V[$OD .FL
M0<?Z.Q'KV,=)(:U=8_$.]$Z<F;$H@KW^$ (EU0A4+$6P9(Z9_"8[-R/1_"H!
M0CL(>B(8*<D7_B;1J$Z2<2A8!/_$JQCN;";B-7_E&;U9IQ'/^LQ\E(Q$ AUY
M0Q7PY$Z -U=AT>A0Z-B#>-M6)+KK>(E  \;UX%0]T$\#<.)*I8))"(X_QP";
M!EJ%+3\Z-6"=C=G8[S*=:=1S\]!QZ%B^?(E/YQ^]E1Q[N-%IZ?4(G*-5C[5H
M;E^+1FY-K1O1UEV#A,)0JHP+1J)C4I3LAI:=5\G0/I R#@_DN0=FD'.]!/PB
MHUT>5)/O%%*6J8X',NI-$4KKO/P7Z(D;194#,X_C9%G1#(*/3B;[T4D$(DWE
M<$J@IHF:R1?\\KF:):(:7PF0X/WKOGL 2&E97/GL_J@:L,[&HZK(%K :&-$:
ML,[&$=V]]N:L!OJE =<78 %(_5*7+60U,.(T8'T"@]2E,HO3 "39P#1:9:[3
M)C9>0].HZP7T"I64AB:I3)S^0<&$S(MXU<'%.B&&7A?P2!X KX^VO!8D)2(&
M@-_1%49C1PM:.MNQKZX>>^KH ^AH14>D&VU=G>CJ[$*D*\+U2@3]RQ<@]G0*
M%<C)0TY>$4+!/.21*:FL( ]CR)Y47E:.RK$34%X\'B5%92@J8!F_%D)(3DK%
M19P)(J12"2Y\8([<F<E4C'X& >^#!H O'X"7^;I?)\E)X"0O@4\&4>!FV/V0
M:L#Z!$ZP^O5P\&$:&0"D;0: E(A%436F K-*2Q#R^0EP['G>,[6K,41#0D4H
MA'ED;)Y)AN2T.IA[8+#@XLDX'MF]!_=N(<B2"Y-<EG:QOT\O'X,;YL["?%[?
M_Z1QZQ  D@":W"1 ?P!(%U^S&+?<:@%(_=>Y+6DU8#4PTC5@ 4@CO8?M_5D-
M' <-R.'H.AV/0W4GO(IHXRIT;OD_,@G5\D6U6$!Z)JP#$L: >&0$D W$SQ7[
MN6,1) .'&)&\.6.9S3??\68DPS5D16KDUDQ 4A-M!E(-EY]#<-%4))I>3E_/
M4"6^/'@"1<[&N.DRT)/1=@*.:EE'/7%,K336Q5XB3P.M<L>2'Y#(!PH3%.7+
MJT1P[%("H28>R+8'5@-'TX!U-AY-0\/QO-R0 B"EQPZ*2/@0/^7U<RB(#3A)
M]GZ*3D+M"=J)QNO0WK43-8TODK9]+3HCNTC7WFT /<8W0&-<9;TL>V X2CL-
MTCO6Q[I,<HSTGH+*3)],#\&F#K<B5I!D_=HT1*L-E=9*2T\BP%66DPDXFD<'
MYWR4DATN)S".5/,$5-$9X/$39J2"=%+*@6G"S''EIZYWQ5&3=!WPDP5L&I &
MK+-Q0.JRA:T&1IP&+ !IQ'6IO2&K@0%KP/4%6 #2@%5G+[ :&!$:L#Z!0>I&
M8["F+=:TC2QSV+5AW5:-+:L3CH7,3]K-M*,9=,WDR,)-Q<DL1-LX3K^B+%^/
M%A/1)M:[<^<Z^BMYA9;I1!(Q=$7"Z";#:6=W%UH[.]#=S7!JG=UD*^+*'S*Y
MF]K9AC^8@]R\ H*&\E! YE&QB^03&)!#1I)0(,^TI1;<)#GD-/#0,)<KD^2A
MCHU.^UZLGX8AE"'>%"I)/@0M>.I)/7?.I47,SCS74\H>G7@-6)_ "=:Y'@X^
M?]D#0(K@JZ^NPI9]>PE&+,1U<V;CTBF3$>8 8$*P,1QD/!K&%0P%><74*A2&
M@L1,]CSOAVI73WZ(3,(AO\8MCF#4A\L^;#+X\11#F]^]:3-JR>;FXY@RK7PL
M&CF.B=E- ^.BR9-P_<QJ3&?(]/ZE7@!([(/^,""%708D"T#JGZIM*:L!JX%1
MHP$+0!HU76UOU&K@V#4@AZ/K=#SV6H;P2EJ]X=IG$-[U1[(*U1CPT.LR9&G0
MB[U(!K7'S] ?H6+X"$;RD9G#ES>6[$*E? ^>P\DQ5_KHY;@8CH)E!#_E$F#4
MPHDSK7#-LQ4*B2N 4O%.+DIJHXW?0=!2&[\3N6_H/%1(;]-?YPOS1!C>O/$(
M5BQF^+5IK-,:\4/XUYAU35MG8]9U&8<7_1/@2,D)C2379(IC3I)40@IS)C!.
M*D%CGHY,G3/##(UKI7"DF2Q(:]'0]@+:NS<AFF@F2Q)IVQG>2'';/5Q^:<K+
M*>*FC$-6Q\2ZM#=59IQ,#S]JRER>_FZ.62R5<D!"/J[># 5SD1LHHW-S.L85
MG\50:PN0$^(*)EWC.C/5!%=WID@3[T*.5+?&7[ N1PMR5FA]J.I.-\@CF_JG
M >ML[)^>;"FK@9&J 0M &JD]:^_+:J#_&G!] 1: U'^=V9)6 R-) ]8G,#Q[
MT[6RCVSAR@_@ )*L+3P\^S$;I+(^@1/<2W*0T;$UW !(:;$.*$/^-KVQZ(A&
M\!4"D#;MW8>BP@)<-SL3@+0%]QD 4A1OGS\?;YLQXP"PZ$!%1SB0=]/Q,4HE
MSFBWHKX.OR+X:%LM%YJ3\6A:13G>-V<N=G1TX)[-&]'2UFY"/2Z=,@77SYJ-
MROP\5D&_H&FGKQ'3&2N/)02; T *00Q('[_U$K:2ECDM[Q%N+VM.69] UG25
M%=1J8%AIP *0AE5W6&&L!H:G!K(>@"2UDD(X7/,4PGO^<GQ 2*:K.#E57"!#
MT>%EZ!\"C<AH)$"20JIYQ'#D$_BH&*'RQ2;L6;QMD[DFQ15%B)/>.-%-P%$W
MPPN%S2HC\U;=0U" @P9XG7\0G/"2^4BAW0SXJ'@&Z]4+>)NL!OJO@9'K;)3Y
MR6>$J<?\U%'/-W/2E#DTSSES?#XE@R.'8[JK5C?/D4>8Q8'B$-T:7!E5DZ%!
M3W81@$07 <%'B;B?]7)5(QF$!(84L,@X% 0"TECAB2(2;T!+^WK4MZY 6^<6
M=,<:N(HQ;(!([@I&M6'L:E=-:IS'!MHDRB1]=Y/)YQ?F<=&CTQXOEB-!<GF]
M 0*.2@DVFHVRPE-04C ;N2$".SUDC3/U\$-U*E%. 9880I[7D_')1[IX@:L\
M''<A<!7_9\C$4S8=@P:LL_$8E&8OL1H801JPSL81U)GV5JP&CE$#%H!TC(JS
MEUD-C! -C%R?P CIH '>AMA$W.28R*Z1[N;VL9=][1CEQG[OHY3-'H$:L#Z!
MH>G4FLY.?/>UU[!^SQZ'66AV-2Z?-OTP8783</.S31NQ8L<.Y.87X&8"?<Z;
M-/$P[Z9[893,1$^30>C'JU<A%HUBZ?1J7%]=C4ED.&L(1_";K5OQ^,9U= L&
M\$^+%^/"B1.10T:B0Y-&$HTAG60W^O(KJ[!Y_WXCY]L)0+ILRB3#@'3_UBTF
M!%N<[5P][R1<2P!208!LY@-*''G8F/R&6UMYKQO68^V^/<;G-Z:T##>=-!O+
MQE7R>PH_7[\.?]F^$YT$(^46%.#\JBJ\IWHF"H)JTY6XM\;5QB$AV-B>94!R
M=&5] KW]S=@\JP&K@:-IP *0CJ8A>]YJP&H (P* I'XD&,<!(3V*>&<=7U0'
M.'L]? )]3%UN#'B^O$\#DHQ1+L0 D0,^ I+RIK\-_H)I!$ ]QCQ1(BMIXJOD
MONS7M%W;<4B2AX ";TXY F4+&2:.!HKNUR:K@0%J(#N=C<ZS)18@%R3CXZH8
MUV!5OBC)D\S0,RL&(,4)]PC\)^#*@:1G577Q63:;>T)YF<^JT][!>6[9OO=R
M_"4)CE2X,8T#J23;9K4I#YG14F$>$B"$',2)5_0'!,[INZZ#SJ3%,>.03M!H
M=NULCT$S.>"?)"F/=<I+X!$1D=QXH<9$R4%@C\XYMQVAKAK0%:TE17L]PM%=
MZ [OY7$KNL*MB,;:2?7>20IE@BH5^HS7J48E(X.J966F+1VGO @P[*27]^;S
M%"(G6$1FHT+DYU6@('<B\K7E3"2%/!T(+&-D5V6LVZF9M9I[5$,$(+&;#,.1
MC^<-RDA]R',JHWM0F]PY'SJP:2 :L,[&@6C+EK4:&'D:L,[&D=>G]HZL!@:J
M 0M &JC&;'FK@9&E@>ST"8RL/CB>=Y,)0#K6>ETFDF.]WEZ771JP/H&AZ:]:
M I"^DP% >L>L:EPVG?[]0]+NM@X"D#;@E9T[D,.0B3<O( ")H"'C!SNDK+X>
M#D":10#2S(, 2(]M6,>%UD<&(*FN!)US:QKJ<=?:]:AM;$1)41$$0')#L/UA
MZS;<LV&# 3J=/F,ZWCES)JH*"W7I@%-M5Q=^M'X#5NW=8^HK+2[!FZMGX.JJ
M:0?J:F=HR?]:NPXODHTI'HL@CZ$C!=JZEO?G/Z)357[&8P,@1=(AV,2 =,NM
M%U,6.B&-/[*O'C@@;M8<6)] UG25%=1J8%AIP *0AE5W6&&L!H:G!D8, $GJ
MY<O^2-WSZ-[U(.)=#7QIS3?ZQPN$U$OW*92:&)'RJJZ"OW ZPKL?9RF]#3].
MP*=>VA3H2<D;*D%PS"ELEQ/Q@=*G]%:OS1N5&L@*9Z,,.S<9^TX98O-)(DYZ
MG 2I=D)<82-C4HB:E( W>O0%0B+P1J')O 8@(^8< O6,H:@*B?PQ4!H!6OC,
M'LAW&W2-R=Z^N^=43^\I'J=LB0AE$0@IAV1J#MC&ZP^SJ4Y>%&"KA2S#53=^
M,03U7D_ON1H'7+EXH;GW0TH:)B$79*6]>Y^4W8BOZ]-U\'II2]^U3Z&#X*DP
MHO%V=(8)3N*62C%\).5.D&4IQBU.EC<E'U=*">#E]80(."(S'-F,0H%B H\8
M7BTX!D%?D0%?>3TY9&/*5<>P>0DPH!LV;=F/XZ\!ZVP\_CJU-5H-9),&K+,Q
MFWK+RFHU,#@:L "DP=&KK=5J(%LTD!4^@6Q1YC"0TP*0AD$G9)D(UB=PXCI,
M@)Z&[C 7^"4@ -+_;MZ,[;5U!DAS\=0IN*AJ*OUP253DY2+7SX6#_.<R( F
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M4UL//_7TSZ<NQ/*)DQ&@7_70ZP1<TO]]>QKQKS?=C8VK:^B#%1.]V."Y':P
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MNY[![MU-IEX'@.2<[NU3U<0)JLK)"^&,<V;BZFN7]%8LZ_.L3R#KN]#>@-7
MD&C  I"&1.VV4:N![-+ 2 8@F9Y(1A%M7H?PGC^3#6DC)ZH)>/RYQZ63!A6
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MZ(M1F.[!*6'NJY\AG73Y:$O6)S#:>MS>K]7 P1JP/H&#]6&_60U8#?1/ Q:
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MKUO_:-I;G\!HZFU[KU8#AVO ^@0.UXG-L1JP&CBZ!BP Z>@ZLB6L!D:]!BP
MZ? _@62D"8G.G61%VHQ8^RX:Y^U(A%MII3),FZQ<&LK&]DW2V X6(6_JE6D
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M2=J5SD>I/ZQ/GL/><)+)V1&7G;ZFCC/MDG1\/*?2>%R^P*_?2&STZ^E1YT3
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M&Y8^9"\+"+9ELZV7;8.4,[:@<!QC"O.GL^;AM==>1?[\^9D0?0_*E"Z&$S1
M??WU"JQ=NQX5RI=#KUZ=F$Y=P>GGMNW[:-@:3_/12E2L6!:WWWX+"A?.AT.'
MCF+.G$7X<=UFM'CD+K3O]!A*%"GLJ$+KUFUB>;MWF.Z\$M=?5QEU:]=C:E,T
M=8V36/GMC]BP:0M3H&_"4!J0<F:C9H)X4RG845NG<^WO&)"LWV9 <M06GK=U
M?> >T@0"=^XU<A$P M($]#T0 1'X*P1D0/HKU'2/" 08 1F0 FS"-5P12$?
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MMFQW,B:^]B%JUBZ'AK=682)0%#[_="TN7#R#P<,>QTUU*F/P\Z_BPYE+T7]
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M6R+@/@(2&]TW9^JQ"'B;@ Q(WB:J]D3 702D";AKOM1;$? V 6D"WB:J]D3
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MQP1D0/+CR5'71,#'!"0V^ABPFA<!/R<@L='/)TC=$P$?$Y#8Z&/ :EX$7$!
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M$1 !$1 !$1 !$1 !$? * 1F0O()1C8B "(B "(B "(B "(B "(B "(B "(B
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M$1 !$1 !KQ"0 <DK&-6("(B "(B "(B "(B "(B "(B "(B "(B "(B "(B
M"(B "(B "(B "(B "(B "(B " 0F 1F0 G/>-6H1$ $1$ $1$ $1$ $1$ $1
M$ $1$ $1$ $1$ $1$ $1$ $1$ $1$ $1$ $1$ $1$ $1\ H!&9"\@E&-B( (
MB( (B( (B( (B( (B( (B( (B( (B( (B( (B( (B( (B( (B( (B( (B( (
MB$!@$I !*3#G7:,6 1$0 1$0 1$0 1$0 1$0 1$0 1$0 1$0 1$0 1$0 1$0
M 1$0 1$0 1$0 1$0 1$0 :\0D ')*QC5B B(@ B(@ B(@ B(@ B(@ B(@ B(
M@ B(@ B(@ B(@ B(@ B(@ B(@ B(@ B(@ B(@ @$)@$9D )SWC5J$1 !$1 !
M$1 !$1 !$1 !$1 !$1 !$1 !$1 !$1 !$1 !$1 !$1 !$1 !$1 !$1 !$? *
M 1F0O()1C8B "(B "(B "(B "(B "(B "(B "(B "(B "(B "(B "(B "(B
M"(B "(B "(B "(A 8!*0 2DPYUVC%@$1$ $1$ $1$ $1$ $1$ $1$ $1$ $1
M$ $1$ $1$ $1$ $1$ $1$ $1$ $1$ $1$ &O$/A3!J3"84V\\C U(@(B( (B
M( (B( (B( (B( (B( (B( (B( (B( (B( (B( (B( (B( (B( (B( (B( (B
MX-\$#B0L^)\Z* /2_X1+%XN "(B "(B "(B "(B "(B "(B "(B "(B "(B
M"(B "(B "(B "(B "(B "(B "(A QB8@ U+&GE^-3@1$0 1$0 1$0 1$0 1$
M0 1$0 1$0 1$0 1$0 1$0 1$0 1$0 1$0 1$0 1$0 1$0 1\2D &))_B5>,B
M( (B( (B( (B( (B( (B( (B( (B( (B( (B( (B( (B( (B( (B( (B( (B
M( (BD+$)R("4L>=7HQ,!$1 !$1 !$1 !$1 !$1 !$1 !$1 !$1 !$1 !$1 !
M$1 !$1 !$1 !$1 !$1 !$1 !GQ*0 <FG>-6X"(B "(B "(B "(B "(B "(B
M"(B "(B "(B "(B "(B "(B "(B "(B "(B "(B "&1L C(@9>SYU>A$0 1$
M0 1$0 1$0 1$0 1$0 1$0 1$0 1$0 1$0 1$0 1$0 1$0 1$0 1$0 1$0 1$
MP*<$9$#R*5XU+@(B( (B( (B( (B( (B( (B( (B( (B( (B( (B( (B( (B
M( (B( (B( (B( (B( (9FX ,2!E[?C4Z$1 !$1 !$1 !$1 !$1 !$1 !$1 !
M$1 !$1 !$1 !$1 !$1 !$1 !$1 !$1 !$1 !$? I 1F0?(I7C8N "(B "(B
M"(B "(B "(B "(B "(B "(B "(B "(B "(B "(B "(B "(B "(B "(A QB8@
M U+&GE^-3@1$0 1$0 1$0 1$0 1$0 1$0 1$0 1$0 1$0 1$0 1$0 1$0 1$
M0 1$0 1$0 1$0 1\2D &))_B5>,B( (B( (B( (B( (B( (B( (B( (B( (B
M( (B( (B( (B( (B( (B( (B( (B( (BD+$)R("4L>=7HQ,!$1 !$1 !$1 !
M$1 !$1 !$1 !$1 !$1 !$1 !$1 !$1 !$1 !$1 !$1 !$1 !$1 !GQ*0 <FG
M>-6X"(B "(B "(B "(B "(B "(B "(B "(B "(B "(B "(B "(B "(B "(B
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M\1 :51ZH*&OK@&1$^VPK%\>MS5TS4.IC;ENS*DP')!42&DB !$B !$B !$B
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ME$YF=$"2R?%* B1  B1  B1  B1  B1  B1  B1  B1  B1  B1  B1  B1
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MVQO./EJ%J%]'MC>C9(XV^$LZ6BUQLKC8?'BJ98<>.=/3)\]1)D][JY-/4.^
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M)$ ")$ ")$ ")$ ")$ ")$ ")$ ")$ ")$ ")$ ")$ ")$ ")$ ")$ "P4K
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M3E4P8+1ZYZCN;29A\<S-BKRV$4_;9Y0#TL*9&]&SS13;)C%, B1  B1  B1
M B1  B1  B1  B1  B1  B1  B1  B1  B1  B1  B1  B1  B3@@P1\S@%)
M,/K]U RD29]4A>NW#8?0N,I E5T8PH4/B[UG9R-1DKBJ]-5+?T?[^J-]Q@&I
M;8\:Z#&X,82SE?WK[.DK:%1Y &Y=OV^?9(W7:5X&HZ=UM,;E@-:Q:HZ.:VM8
MI3]V;#@B%U5< ],^.B I4#)" B1  B1  B1  B1  B1  B1  B1  B1  B1
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M['1T[?(=+)V[!5-'_JHJ+QN\U3ZY?OOKJIUCD:M )H7Y?T?/HUS>#@H;(R1
M B1  B1  B1  B1  B1  B1  B1  B1  B1  B1  B1  B1  B1  B1  B1
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M0 (D0 (D0 )6 G[K@"1Z,')Z!]1K5M;:&4<!.B Y(D,["9  "9  "9  "9
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M< Z0@+D)4!,P]_BS]R0@$Y!U 3GNZDH')%>$F$X")B<@+RIT0#+Y1&#W34N
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M"^AM%1V0]))B/A(P*0%Y4:$#DDDG +MM>@(4&TT_!0C Y 0H-II\ K#[IB=
ML5'?%"A=)1]F_=K?8>9=6__ IK4'<//:/<2,%0WYBGR+JG6*(T*$<-8R[C@@
M60L%,A J5"BD2I\8&;(DQ\/[_^#HP;-X^_J=9JUQXL= SOP9\>'#!YP_<PW7
M+MW%O__^JYE7-D;[)@KB)(B!F+&C(4:LKQ'UZZ_P\L5K/'GT#(\?/L/5B[?Q
M^M5;.;OJ:H0#4H1(X9$B=4*D2),(L>-^@[NW'^'*A5NX>NF.P[ZJ&F)R S4!
MDT\ =M_T!*@)F'X*$(#)"5 3,/D$8/=-3X":@.FG  &0@(6 K OHQ4$')+VD
MF(\$3$I 7E3H@&32"<!NFYX Q4;33P$",#D!BHTFGP#LOND)4&QT/04B?Q41
MN\_,1/R$L5697[U\@\[-QV'#\KVJM-AQHV/PQ%:H4+VP)<U=!Z3#E^<C>HRO
M%?5.&K$(/XY:;K75;5$& T:WM,9%X,WKMRB<J3E^Z%L'-1N4E)R"(EO3W[U[
MCT.[3Z%-O9'XY_%S" >EIATJH6ZSLDB=+HDUGPA<OG 3[1J,PJFC%Q1V$>DW
MNCDJU"B$!(G43&PS"SX;5^_%\OF_X<#.4]:D5.D28>/!*?@J2B2KS3X@RLJO
MN[<?HE"&9G+4<BU8XCOT']4"Z3(EL_1#D2A%/GWZA/4K=F-0UYFX)SDE\>68
M #4!QVR80@)F($!-P RCS#Z2@&,"U 0<LV$*"9B! #4!,XPR^T@"K@G(NH#K
MG)]ST %)+RGF(P&3$I 7%3H@F70"L-NF)T"QT?13@ !,3H!BH\DG +MO>@(4
M&UU/ >'HLF33",V,@[K]A)D3UVBFR<: )B71H5<=M*TW B<.G[.8+[]<C_#A
MO^R.)(S3QRW'L)ZSY6+0DZ=MCQKH-;2IM8P<$,Y%W\2(*D=5U^.'SZ);JXD8
M/KD=<A?,K$J7#>_??T#QK"UQ^?PMV62YKMLW =ERIU?87$4&=)F.V9/76K)]
MFS,--AZ8[*J(-?W9TY?($*N:)1XKSC<8.KDMRE<K:$UW%A [,G5L,@9;5A]P
MELW4:=0$3#W\[#P)@)H )P$)F)L -0%SCS][3P+4!#@'2( $! %9%]!+@PY(
M>DDQ'PF8E("\J- !R:03@-TV/0&*C::? @1@<@(4&TT^ =A]TQ.@V.AZ"H@=
M@@:-:ZW*>.9_EU F5WN7QY2I"DH&/<Y%>O(X<D#2NJ>GM@TK]Z)5P#!%<4\<
MD,1Q;E6+=L'1 V<1& >D9=M&(G_1K(KVN(H\?O@4!3,TQ=,G+UQE-64Z-0%3
M#CL[30)6 M0$K"@8( %3$J F8,IA9Z=)P$J FH 5!0,D8&H"LBZ@%P(=D/22
M8CX2,"D!>5&A Y)))P"[;7H"%!M-/P4(P.0$*#::? *P^Z8G0+'1]108.;T#
MZDE'E-F_IHW]%<-[_6)OUA77XURD)T]0.""]??L>*:-44/3+U@'IS9MWN/CW
M=5RY*'9)"F4Y$LW^.#>Y\*3ABS!FP *D3I\8VXY-1[AP8>4DU?7#AX]6FSB"
M+4_*AFC2OB(&CV]CM<N!LZ>O8.NZ_;ARZ0XJURR,HJ5SR4G6ZX*?-Z!7VZG6
M. -?"% 3^,*"(1(P(P%J F8<=?:9!+X0H";PA05#)&!& M0$S#CJ[#,)J G(
MNH Z1=M"!R1M+K22  G\1T!>5.B Q"E! N8D0+'1G./.7I. 3(!BHTR"5Q(P
M)P&*C:['??7N<<B9+Z,J8Z=F8[%\WG:578]!CW.1GCR.')"N7;F#^3,VX.JE
MV\B6,RW:=@_0;)8XJNVG"<OQ]YEK2)<Q*;H.:(BP8<.H\F9/6A?W;C^RVCOT
M#D#<^#&Q><U^'-AY2K4+5('B63%WS6!$C!C>6D8$?M]\! TJ]K?:,GR; MN.
M3K/&Y4#+VD.Q<<4^.6JYAH\0%F?NKT"DR!$5]D6S-Z-'JTD*V]ZSLY$\54*%
M[=:-^\B=HH'"QLAG M0$.!-(P-P$J F8>_S9>Q*@)L Y0 +F)D!-P-SCS]Z3
M@$Q U@7DN*LK'9!<$6(Z"9B<@+RHT ')Y!.!W3<M 8J-IAUZ=IP$+ 0H-G(B
MD("Y"5!L=#W^AR_/1\+$<509 TKWQ+X=)U5V/08]SD5Z\CAR0$H?LRJ>/WME
M;<HO*_NC9,5\UK@<*)RI*2Z=$SL7?7X-G]H.#5J6EZ/6:_G\'7'RR#EKW#8@
M'(-2IT^"E&D32TY)T1$K]C>(&2<ZJM0NA@@1PMEFQ:GC%U V=WNKS1T'I,S9
M4V'S(?4.1MW;3,+E\S>M=8I SR&-D2-O!H7MTZ=/2!VM,MZ\?JNP,P)0$^ L
M( %S$Z F8.[Q9^])@)H YP )F)L -0%SCS][3P(R 5D7D..NKG1 <D6(Z21@
M<@+RHD('))-/!';?M 0H-IIVZ-EQ$K 0H-C(B4 "YB9 L='U^-L>-V:;NV.3
M,5BY8(>M27=8CW.1GCR.')!21ZN$UZ^^.-J('8NZ#VJD:E^^-(UP_<I=J[U6
MXY(8]W-G:UP.5"SX XX?^EN.6JXY\J5'LPY54;Q,3M6N1(J,-I' ."#5:58:
MHZ?_8%.;^\'OL[7"WZ>ONE\PA)>@)A#"!YC=(P$7!*@)N #$9!((X02H"83P
M 6;W2, % 6H"+@ QF01,0D#6!?1VEPY(>DDQ'PF8E("\J- !R:03@-TV/0&*
MC::? @1@<@(4&TT^ =A]TQ.@V.AZ"HR=V0D!C4JI,DX;^RN&]_I%9==CT.-<
MI">/7@>D)NTK8O#X-JJFV3L@5:A9"-,7]5;ELW= :MZI"OH,;Z9Y7)NJL(TA
M, Y(@R:T0M-VE6UJ<S]8M5A7'-G[I_L%0W@):@(A?(#9/1)P08":@ M 3":!
M$$Z FD ('V!VCP1<$* FX (0DTG ) 1D74!O=^F I)<4\Y& 20G(BPH=D$PZ
M =AMTQ.@V&CZ*4  )B= L='D$X#=-ST!BHVNIX!PMADPNJ4JX_'#9U&Q0">5
M78]!CW.1GCQZ'9#JMRJ'$5.^''TFM]'> :E,U7R8N:R_G&R]VCH@.:K+FED*
MB./?HGX=V=9D"0?& 6G@N);2CDM55'6Z8Z #DC8M:@+:7&@E ;,0H"9@EI%F
M/TE FP U 6TNM)* 60A0$S#+2+.?)."<@*P+.,_U)94.2%]8,$0")*!!0%Y4
MZ("D 8<F$C ! 8J-)AAD=I$$G!"@V.@$#I-(P 0$*#:Z'N0BI;-CX?IAFAF[
MMYF$Q3,W:Z;)QJ)E<J#'X$;HUFHB3A^[:#'K<2[2DT>O U*]EF4Q<FH'N4G6
MJ[T#4NDJ^3#K5^<.2//7#4:Q,KFL=<B!-<MV8O'LS3AS\C*>/GF!&<OZH%S5
M@G*RY:K? 6D8-J[8JRCKZ BVOC_\B#]/?.:J** 1.7'X'#Y^_%<CQ=PF:@+F
M'G_VG@2H"7 .D("Y"5 3,/?XL_<D0$V <X $2$ 0D'4!O33H@*27%/.1@$D)
MR(L*'9!,.@'8;=,3H-AH^BE  "8G0+'1Y!. W3<] 8J-KJ= C%A?X]#%^8C\
M5415YI<O7J-IC4'8M_VD*DWD[SJPOF77GM"A0Z-AE?[8L>&()9\>YR(]>8+:
M 2E\A+ X<W\%(D56LMB][2CJENNK8! 8!Z0>;2=AT<]*QZ[O<J?%^GV3%/<0
MD67SMJ)+LPDJNZTA9X&,B)\P%M8MVVUK9O@_ M0$.!5(P-P$J F8>_S9>Q*@
M)L Y0 +F)D!-P-SCS]Z3@$Q U@7DN*LK'9!<$6(Z"9B<@+RHT ')]R9"J%"A
M(/YL7__^Z_X3NQ$C14"BI+&1,&E<)$@4"V'#A<7SIR]Q^<(M7#YW$R^>O[:]
MA6'A./%C2/>-@P2)8T/\<//A_4?<OOD E_Z^B9O7[N/3IT^&W8L5>4Z UBP:
MW@  0 !)1$%48J/G[%B2!$(" 8J-(6$4V0<2\)P Q49][)JTKXC!X]LXS+QM
MW0&L6[%'^HQ[#]%B1$7N_)E0MUE91/LFBK5,2'! BIL@)HY=6V3MDQSX;?U!
M-*XZ2(XB6:KX^/6WT=)WC]A6FPC8[X"4)$4\'#@W5Y%'1 [L^A]JE^YEV:TH
M7/BPB!(U,MZ\?HNSCU8A;-@PJOQSIZ_#Y!%+<?_.8VM:A$CA\5VNM.C0(P"%
M2F3'ZU=OD#I:96LZ U\(4!/XPH(A$C C 6H"9AQU]ID$OA"@)O"%!4,D8$8"
MU 3,..KL,PFH"<BZ@#I%VT(')&TNM)( "?Q'0%Y4Z(#D6U,B3)C0.'5G&:)%
MCZIH6+T*?;!KRS&%S5$D;::D:/%#552I70SAPX=SE U']I_!S,DKL77-(7CB
MX&1;<82(X5"U;C'IOM60.ET2VR1%^)GD "6.:)CSXSK<NGY?D<9(T!*@V!BT
MO'DW$O U A0;?6U$V!X2"%H"%!OU\18/!:S9,Q[9\Z375T C5TAP0!+=$DY
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M M0$=*-B1A((D02H"83(866G2$ W 6H"NE$Q(PF$: *R+J"WDW1 TDN*^4C
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M9E=$_5K;Z=&V@'"Z:B7MUG9H]VE;LS4LV(G=V_1^5A)'0?9L,QEOW[RWUL&
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M]2KZT:W51)P\\C<*E<B&0>-::VX[7R9/.\6Q<YL.3T&6;*FM]<B!W=N.8M2
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MW?U(-%6O Y(0YW;^[V=5[Y;-VXHNS92>F?Y2IZHS- 0) 7E1H0-2D.#F34C
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MM^NHZA1/2!?-W!S7K]Q5I6D9C%X#/'% ,GH-,+H^+6YFM?FKV'CX\GS-]V-
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MMQS#>LZ6HY9KCGSIT:Q#510ODU/:X3"B(LU11*\#DB?M:M*^(@:/;Z.Z=8N
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MDA^U))$Q49*XMLF*<)MZ([!NV6Z%S3[BZ$?R1P^>HH#T_GW^[)5]$<VX-]8
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MCE&SS2>'A6.A_?\^D>:I Y(HZZI=G?K609<!RJ<Q1;D*!3KBQ.%S(FA]N7)
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MJ%$;B'BL]Y\&/6M$)280TZ74W\P_[9YA>;R:MW:[^])](,:ROW[.5'O\^5F
MOV/W_CZ>M_[3?;L1%_#5@00D7Z7<U/,T"U*@9C]2EQ#5H(#Z!O87"];8GT'Y
M]^5KIM:$RC%-%\W*?R9@W%0>1P+2?]9('TY$ I(/2%&H0@)2%-#^XUV",=CH
MSV\T&9Q1G04I*G\DJ&_[#^DU0Y9_NM8XO>G=UP0D%<R;/W.5#.DYW9+8XWQ
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MZEB!^"S W[%[?Q]/M9N75<"("UBWN"\A <F]B\^EKK,@!7+V(Y\OBHH(^%'
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MFDEJWZYC[C9K5V;X_[)VEVU&J#[:M9\&(Z"[ ,%&W4< [===@&"C[B. ]B-
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ME""@DP#!1IUZF[8BX%Z F(![%TH1T$6 F( N/4T[$7 O0$S O0NE".@B0$Q
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M*RZ[:+=*3$"[+J?!")@$B F8.%A!0#L!8@+:=3D-1L DH$-,P-1@5A! P*V
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M!+P+&'$![S4?UB !R5<IZB&@J8!Q4R$!2=,!0+.U%R#8J/T0 $!S 8*-F@\
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M1T!7 6("NO8\[4;@H0 Q 48" GH+1#4FH+<:K4<@Y@D8<0%?6T8"DJ]2U$-
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M-]-(!#P*1#4FX/& ;$  @9 4,.("OEX\"4B^2E$/ 4T%C)L*"4B:#@":K;T
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MQ 3T[G]:CP Q <8  GH+$!/0N_]I/0*&@!$7,-:]O9. Y$V([0AH+F#<5$A
MTGP@T'QM!0@V:MOU-!P!NP#!1@8" GH+$&S4N_]I/0)*@)@ XP !O06(">C=
M_[0> 6("C $$]!8@)J!W_]-Z! P!(RY@K'M[)P')FQ#;$=!<P+BID("D^4"@
M^=H*$&S4MNMI. )V 8*-# 0$]!8@V*AW_]-Z!)0 ,0'& 0)Z"Q 3T+O_:3T"
MQ 08 PCH+4!,0._^I_4(& )&7,!8]_9. I(W(;8CH+F <5,A 4GS@4#SM14@
MV*AMU]-P!.P"!!L9" CH+4"P4>_^I_4(* %B HP#!/06(":@=__3>@2("3 &
M$-!;@)B WOU/ZQ$P!(RX@+'N[9T$)&]";$= <P'CID("DN8#@>9K*T"P4=NN
MI^$(V 4(-C(0$-!;@&"CWOU/ZQ%0 L0$& <(Z"U 3$#O_J?U"! 38 P@H+<
M,0&]^Y_6(V (&'$!8]W;.PE(WH38CH#F L9-A00DS0<"S==6@&"CMEU/PQ&P
M"Q!L9" @H+< P4:]^Y_6(Z $B DP#A#06X"8@-[]3^L1("; &$! ;P%B GKW
M/ZU'P! PX@+&NK=W$I"\";$= <T%C)L*"4B:#P2:KZT P49MNYZ&(V 7(-C(
M0$! ;P&"C7KW/ZU'0 D0$V <(*"W #$!O?N?UB- 3( Q@(#> L0$].Y_6H^
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MT+O_:3T"AH 1%S#6O;V3@.1-B.T(:"Y@W%1(0-)\(-!\;04(-FK;]30< ;L
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M2M:L67W>PZ<$I"%#AOA\0"HB@  """"   ((((   @@@@  """"   ((((
M @@@@  """"   ((((! Z HT;]Z<!*30[3ZN' $$$$   0000  !!!!   $$
M$$   0000  !!!!   $$$$   0000 "!QRL0D 2DZ]=N/MY6<78$$$   000
M0  !!!!   $$$$   0000  !!!!   $$$$   0000  !!!#X3P2>2)(@4N?Q
MZ1%L)"!%RI3*"""   ((((   @@@@  """"   ((((   @@@@  """"   ((
M((   @B$K  )2"';=5PX @@@@  """"   ((((   @@@@  """"   ((((
M @@@@  """"   */7X $I,??!UP! @@@@  """"   ((((   @@@@  """"
M  ((((   @@@@  """"   (A*T "4LAV'1>.  ((((   @@@@  """"   ((
M((   @@@@  """"   ((((   @@@@,#C%R !Z?'W 5>   ((((   @@@@  "
M"""   ((((   @@@@  """"   ((((   @@@@$#("I" %+)=QX4C@  """"
M  ((((   @@@@  """"   ((((   @@@@  """"   (((/#X!4A >OQ]P!4@
M@  """"   ((((   @@@@  """"   ((((   @@@@  """"   (((!"R B0@
MA6S7<>$(((   @@@@  """"   ((((   @@@@  """"   ((((   @@@@  "
M"#Q^ 1*0'G\?< 4(((   @@@@  """"   ((((   @@@@  """"   ((((
M @@@@  ""(2L  E((=MU7#@""""   ((((   @@@@  """"   ((((   @@@
M@  """"   ((((   H]?@ 2DQ]\'7 $""""   ((((   @@@@  """"   ((
M((   @@@@  """"   ((((   B$K0 )2R'8=%XX  @@@@  """"   ((((
M @@@@  """"   ((((   @@@@  """" P.,7( 'I\?<!5X   @@@@  """"
M  ((((   @@@@  """"   ((((   @@@@  """" 0,@*A&P"TKU[]^3R7Y<E
M5<I4?L._??NV7+Y\2>+$C2LIDJ>06+%B^>W8$1WHRI4K]LU)DR:-J)K/VZY?
MORYW[MR19,F2^;Q/1!7]?7T1G8MM"""   ((((   @@@@  """"   ((((
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M:?GCCS]<-TF-ZC5ET<+/+.44((   @@@@  """"   ((((   @@@@  """"
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MXS!1?G?WZ+DH'XP=$4   0000  !!!!   $$$$   0000  !!!!   $$$$
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M\^9-IK($"1+89Y-ZXHDG3.5J);K71P*2A90"!!!   $$$$   0000  !!!!
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MY21.!20@.6&PB  """"   ((((   @@@@  """"   ((((   @@@@  """"
M  ((A+! T"<@*=L;-V[(I,D39)WML6/;MF^3JU>ONB6/%R^>;8:BE5+Z^3)N
MMZO"Z]>ORQ=?+):ERY;(^O7K[,?V6-FVH42)DA+>IY^HF8.B\VK?L:W,GS\O
MRH=XI6X]F3MGOMO]ITR=+#,_G"Y'CARQ/WK-N5)86)CDS)%3NG7M(:^__H;S
M)M-R(*_/=*+_KZBDLL\7FQ^W5K-&+5GXR:?NJE.&  ((((   @@@@  """"
M  ((((   @@@@  """"   ((((   @@@$*0"(9& Y&QW__Y]V7]@OPP?/E26
MKUCFO,G^:+2#!XY(ZE2I3>6>5N[>O2O'CQ^7HT>/R,6+%^1?6Z)3@OCQ)95M
M_TR9,TOF3)GEB2>>\+1[T)7?O'E3]N_?)P</';1?6[Z\^21W[CP2W]:F8'O=
MNG5+;M^^;;HLE4 6C-=JNDA6$$   0000  !!!!   $$$$   0000  !!!!
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M"""   (((!!) 1*0(@E&=0000  !!!!   $$$$   0000  !!!!   $$$$
M 0000  !!!!   $$$'@D0 +2(PN6$$   0000  !!!!   $$$$   0000  !
M!!!   $$$$   0000  !!!! ()(")"!%$HSJ"""   ((((   @@@@  """"
M  ((((   @@@@  """"   ((((   @@@\$B !*1'%BPA@  """"   ((((
M @@@@  """"   ((((   @@@@  """"   ((((! ) 5(0(HD&-410  !!!!
M  $$$$   0000  !!!!   $$$$   0000  !!!!   $$$$#@D0 )2(\L6$(
M 0000  !!!!   $$$$   0000  !!!!   $$$$   0000  !!!!  (%("I"
M%$DPJB.   ((((   @@@@  """"   ((((   @@@@  """"   ((((   @@@
M@, C 1*0'EFPA  """"   ((((   @@@@  """"   ((((   @@@@  """"
M  ((((   I$4( $IDF!41P !!!!   $$$$   0000  !!!!   $$$$   000
M0  !!!!   $$$$  @4<")" ]LF ) 0000  !!!!   $$$$   0000  !!!!
M  $$$$   0000  !!!!   $$(BE  E(DP:B.  ((((   @@@@  """"   ((
M((   @@@@  """"   ((((   @@@@  "CP0"E(!TZ]$96$(  0000  !!!!
M  $$$$   0000  !!!!   $$$$   0000  !!!!  ($8*Y @45P)"XOM<_MB
M/;"]O-6^?HT$)&]&;$<  0000  !!!!   $$$$   0000  !!!!   $$$$
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M7 6(";B*L(Z G@(D(.G9[[0:@8 )$&P,&"T'1B D! @VAD0W<9$(!$R 8&/
M:#DP B$A0+ Q)+J)BT0@H +$! +*R\$1"'H!8@)!WT5<( (!%2 F$%!>#HY
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M:#L$2#:V79$SPT2@!@&2C35P\ <1:$L$R FT9;$STT0@0("<0  %;XA 6R)
M3J MBYV9)@(! N0$ BAX0P3:&@$J(+5U\3/S1"!_!$@VYH\I8R0"94* 9&.9
M2HNR$H'\$2#9F#^FC)$(E D!DHUE*BW*2@2*08"<0#&X,E8B4!8$R F4I:0H
M)Q$H!@%R L7@REB)0%D0("=0EI*BG$2@6 2H@%0LOHR="+0= B0;VZ[(F6$B
M4(, R<8:./B#"+0= B0;VZ[(F6$B4(, R<8:./B#"+0E N0$VK+8F6DB$"!
M3B" @C=$H"T1("?0EL7.3!.!  %R @$4O"$";8T %9#:NOB9>2*0/P(D&_/'
ME#$2@3(A0+*Q3*5%68E _@B0;,P?4\9(!,J$ ,G&,I46924"Q2! 3J 87!DK
M$2@+ N0$RE)2E),(%(, .8%B<&6L1* L") 3*$M)44XB4"P"5$ J%E_&3@3:
M#@&2C6U7Y,PP$:A!@&1C#1S\003:#@&2C6U7Y,PP$:A!@&1C#1S\003:$@%R
M FU9[,PT$0@0("<00,$;(M"6") 3:,MB9Z:)0(  .8$ "MX0@;9&@ I(;5W\
MS#P1R!\!DHWY8\H8B4"9$"#96*;2HJQ$('\$2#;FCREC) )E0H!D8YE*B[(2
M@6(0("=0#*Z,E0B4!0%R F4I*<I)!(I!@)Q ,;@R5B)0%@3("92EI"@G$2@6
M 2H@%8MOV\4^^.RSY)%''K+Y'G^"">3Z:V^4B2::J.UP:.<,DVQLY])GWHF
M",E&?@5$H+T1(-G8WN7/W!,!DHW\!H@ $2 GP&^ "+0W N0$VKO\F7LB0$Z
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MK=+1@$,'6EY\DDDFL5%@WHN-@X<..-C^QO,WWWA',&:'*[K_MHDX_XKD!:&
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MQCS[YBQMP(<??B@@..!@;2QN T)8YC1M ,+XUF7?<&$Y^;MQ!$@V-HYA66+
M^+]9%I'3C#_.O^ \.?B0 U/#A^.C7QXV(K5_>DR/ #F!]%A5P6=:!:0Q8\;(
MPHLN8+.\P_8[RCEGGU>%[#,/$0B0$X@ I0L?Z2)A%A%@H0R6RO)PAQ]QF)PU
M^$P;E7O4NN^\(BQ36MXC'(Z_BT. G$!QV#8:,RR0PA(IW"<??5YW/0]^\FP_
M8 EMP87GER^__,(>%S5RQ.LRX803(IE(EV;\'QDP]#"N#0IYX\\<$2 GD".8
M"5&MM_[:\NACC\ILL\UF-A2/V\ ?#N*.P??:<V\Y^:13PUXB?\?5'=_^NVA>
ML)%UA4@ ^+!A!*B U#"$[1G!=]]])W/,.:L])FF]==>7ZZ^[L2X0./-YS[UV
MMWY./>5TV6/W/>OZY\OR(D"RL5QEEZ;CWZG?#G+3S>/J^ ?O?Q2<$QO.Z6+F
MF#:84,51!CC2(,FY@Y]Z1SEAIQ0TKN'8?B2AVO7O239V?1FH!#"7NNSR2]N?
M P<<)@,'C+/^H^]QA96Q!1>>SUHB@_+.*\->[71<B?K_\<<?;=__\\\_R^FG
MG2F[[3JN7]?W]:YIVAHH%\UI+!=T='3(=GVWE_/.O:!3E&Y[X%ID@QEIF).&
M>^>M=RV9$0ZL;52<Q;6P?_[V0X!DHQ]N64/EU3=G:0,@XPDG'B\GG7R"M9:&
MX]?&'W_\5**G:0,0D6]=]@V72GAZRH0 R<9,<)7:<[,L(J<=?ZS0:SD9,6*X
MG8O<6V?1]&1S?/3UUU]KL7_JB6?LD32E+H@6%)Z<0 L62H$BI55 PA%0.,H%
M[OAC3Y#^_?<O4"I&W94(D!/H2O0[I_W]]]_++[_^TOG%_Y[<=-.-,O"P0^TO
M6!V?8X[N,O%$$]<]%BDVLH@76VRYF=QS[]V69_CR\W\'?(/OO"*<1!K>(QR&
MOXM%@)Q L?@V$OMJJZ\BS[_PG$PZZ:3RV2=?RE_^\I>ZT>79?H!'0+V'.__<
M"Z5OW^UBTTX[_H^-P'D1UP8Y7GB;,P+D!'(&M$YTRH7]]:]_E3'&(, T4T_3
MR3<,@\! "!PV & C0!H75W=\^^^B><%&UA72X$$_V1&@ E)VS!C"(. J%%U[
MS?6RP?H;UL4%1RS-WKV;_/[[[Y;@ ]%'5TT$2#:6JUS3=/SGG'NV#!AXB,W8
M22>>(GOO->Z\:#>GGW_^F<RWP#SRVV^_25@I$4H!PUY^R7K?=IN^LOQR*]A[
M*!G,-,OT@LG,3#/-+"^]\'(DP7'@0?L+SG"%XR*!A:&E_Y%L;%[QW'7WG=)[
M]3XRT40312:ZU=9;"/S W7+3K;+FFN,(?]>S>P[TY9==:2TEN>_=^ZNOODKV
MV&LWNT-I]*CWY1__&&==R?43=Y^FK4'8#39:3QY^^"%K*?&%%X;56%Q#FX'W
MCSSRL$PVV60RYMT/+&F"<"^]]**LO.J*N#6*5IV5K5QSLX<-/%P&''J8]<M_
M^2- LC%_3*-B;+1OUCBSM %__OFGL7XTKSVNL?^^^\OQQYV@T21>T[8!OG79
M-URBX/20&0&2C9DA*VV 9EE$3C/^P#&L.(H1;O_]#I1CCSDN%M=GGGU:^JRQ
MNGV_^VY[R&FGGA'KER_\$" GX(=;64.E44#ZX8<?!/-$* G"/?C 0P$O4-9\
M4^YX!,@)Q&/3BF^NN>9JV7W/<5:070M%*FL<IX?W;[SYAMU M,#\XZR;:1B]
MXJBG7BNM8(]'76211>7I)Y^UK[+,*_+@/50>7IN# #F!YN <3N6!!^Z7'L;"
MYQQSS!%^97]C# RKX^#6EEUF.8'"H;IZ]5S]1%V3V@\-\X6Q>K20L7X$*TBP
M0OJB60. PD2<2S/^1UC?-B@N73[/!P%R OG@F"86=U/0UEMO(Q==,&YSKAMV
MV[Y;R^UWW&8?/??,"[+@@@MYUYTL_;<K ^Z+Y@61AN^Z L+2Y8\ %9#RQ[0M
M8EQ_PW7M N#DDT]NCU^+6_QTP5"-23Q[X[6W!18(Z*J' ,G&UB]3#/9Q9 +<
ML\\^(YMNOK&]O^;JZV25E5>U][!H@-T0<.^]]YZQHK*4G23 -.JYYYQ?<S32
MV+$?RHX[[6!W4,#_K;?<+GWZC-.JQN^MM]E2[KSK#MQ*^ @UG/N,\Y_A5EEY
M%;GHPDMDAAEFM+\QH+GZFJMD[WWVM),C#(XP2*)K;01(-C:O?*:?\9]V9^(N
MN^PJ/7OVDOGFG=\JYKSUUIMR[/''R(,//F"%67+)I>21AQ[KM+/IHX_&FF,0
M%[+6#%&_<*3:>..-%YN!55=?65YXX7G99.--Y<HKKH[UIR^RMC4(APD1)D9P
M4%8\XXQ!,O]\\PMV,0PZZTPY[_QS[;OMM]O!MD7VQ__^+;G48O+6VV_9/)QW
MS@6R_OH;R"233"(O#7M1MMEV:VOF&?F#A;:99Y[%#<K['!$@V9@CF'6B:K1O
M1M19VX!''GU$UM]@'2L5K*7UZ-&CCH1BQPU9QAL:F6]=]@VGZ?*:#P(D&_/!
ML=5C::9%Y#3CCZ../E+../,T"]OSS[TD<0NA\(!%EWGFZR&??/*Q57A^=]1[
MJ:VYM7JYM(I\Y 1:I22:(X<J(.'HAW/-&!P.]>S''W^0;[_Y5D:^]JH,&7*+
M_.NK?]EW.+[UANMOJCOOL![YK[0(D!,H5]$E*1#4X_3./F>PM9ZT^NJ]!1L.
MYS>*2-V-!:6OO_E:[KSS#CG.\!)??_VU!<3E"K/,*QKE/<I5&M60EIQ UY3C
MEEMM+O?>=X\U%+#IIIO)O//,)[!T#C[M%M,/GW;Z*=;Z.:2[[MH;9/WU-@@$
MK5?/ T\1-TGMAP91*RWXC9-4L'FYGDLS_D=XWS:H7MI\US@"Y 0:QS!+#!MM
MLH$,'?J@#7+ _@?)(0<?:OEP6!)#>XQZ K?A!AL)UO_@?.M.EOX;Z?BL#2"<
M+[_7R+H"TJ7+%P$J(.6+)V,C FV/ ,G&UO\$YIU_;KOH6$]2[$9X>=B(P,N-
M-]T@_7;^?_.,V$TQ]]SSR#=??R.O#'_96CZ"YT,.'B!'''YD$ XW]28QO_SR
MBZR\2B]Y_8W7;9B))YY8%EUD,9EBRBGD3;.3:NS8L?;YM/^<5AY_[$GIUHV*
MBQ:0%OY'LK%YA0,B#I.)>F[JJ::6!\P.XWGGF;>3MWZ[["0WWGB]?7[;D#ND
M=^\^G?SH@W=&O2.++[&(_7G7G?=:A4%]%W?U:6N@K("V!D>MJ8,2$8Y]4X?V
MZ<X[[NZD1/3L<T:A<K.-!8NB<# E_;>__4U^_?57#<KC'@(DBKLAV5@<MN&8
M&^F;$5>6-@#^<1PJZN8R2R\K#S_T*![5=3YM "+TK<N^X>IF@B\S(T"R,3-D
MI0S0+(O(:<8?4'1 >_/QQQ\99>SY[([J)% //^(P.6OPF=;;D)MODS766#,I
M"-]G0("<0 :P*N!5%9#29&6555:5ZZ^]T6Z:2..??LJ) #F!<I5;D@)!/4Y/
M%S"3<MQOIYWEK$%G!]ZRS"L:Y3V"1'G3- 3("30-ZIJ$H(!T]SUWU3R+^K'3
MCOWL!F'W7;UZ[OH+WR>U'_#_[KOORA)++6HMH2VQQ)+R^*-/AJ.I^9UF_*\!
M?-L@#<]K,0B0$R@&U[A8L4%Q^9[+""R.PH$/GW;:Z:SR(>;*<-V[=Y?''GE2
MIIIJ*OO;M^YDZ;^14+-YP4;6%2PP_)<K E1 RA5.1D8$B #)QM;_!N9;8.Y
ML2=.VGF,<M&PE\:91U<_SSW_K#F*[5 9-NPE?11<>\S50TX\X>1(\MXU\QAU
MSBPTH6'99/#9@P0*2:Z#.59,C X;>(1,/?74[BO>MR@")!N;5S#8Z3_DUB'R
MVFLC.R6*NK/YYEO*2:9>1M6=T:-'RZ*++V1W)Z^P?$]YX/ZAG>)P'^A"7;=N
MW:P5PWJ6DC2<;UN#R=$11QXNEUYV<8V"%2RSK6PLI5U^Z96QQ[^]::P_[6"4
M)&"&V7508CSII%-D\\VV<!_SO@ $2#86 &J=*'W[YJQMP#???"/=YYK-*AQ?
M<-Y%LNVV?>M(->Z5;QN T+YUV3=<8F;H(34")!M30U5JC\VRB)QF_/'BBR_(
M*JNM9/$\^JACY, ##D[$%F.G99=?VOK;:JMMY&)CA94N/P3(">2'91EB6G'E
MGO+RR\,B1<48?,:99I+99IU-=MUU-^FY0J](?WQ8+03("92K/*^[[AK9=?==
MK- C1[S1Z?BF>IP>^M,S!YTA#SQX?[#PZ>9^EEFZF:-.3Q=8/E.7=5[1".^A
M:?+:7 3("307;TWM\2<>ETLOO5@>'/I )WX=?F -Z:033ZFICQJV7CU7/U'7
MI/8#8;#)$)NGX.Z]YP%9L=>*]C[N7YKQOX;U:8,T+*_%(4!.H#ALXV*&==_]
M#N@O]]UW;XT7K _LL?N>QF# 4=8JDK[TJ3M9^V^DU16\8"/K"HH/K_D@0 6D
M?'!D+$2 "/P/ 9*-U?\4,* 9/6:,?&2L$TT[[;0REU$^PI&*T*YNQ,'"R9@Q
MHV7,>V.LQ9*YYIS+QCW%%%,T$BW#-AD!DHU-!MPD]]6_OY*//_I(/OWT4_GM
M]]_LF>]S=I_36O_)0QKL'N@QSYSV"+.! PZ3@0,.SR/:Q#@P81CU[BAYPUA(
MF\4<F89CXM(<^8J(805I^(CA]NB'119>I).UI,3$Z<$; 9*-WM U%+"HOEF%
MNNCB"^6  _>SQ[.^-_K#X)A6?5_4U;<N^X8K*A_M%"_)QG8J[6+SVE7CCV)S
MU1ZQDQ-HCW)F+HE ' +D!.*0J>[SWW__W6YT_/2S3^3SSS^7Z::;WEA-GUNF
M,Q88PLYW7E$T[Q&6D[_]$2 GX(]='B$QAO[TTT]D[$=CY;///K/U<:XYYY09
M9I@QC^@+C<-W_)^E#2HT XS<(D!.H.L^A&^__5;>>OM-NT: M8%YS(D($TXX
M8:Q 6>J.;_\=FWC*%[[\7B/K"BE%H[<$!*B E  07Q,!(I - 9*-V?"B;R)0
M-01(-E:M1,T.I7OOD<VWW%1@]>C-U]\6[&*D(P)Q")!LC$.FW,^76V$9&3GR
M5>F[[79R_GD7ECLSE+Y0!$@V%@IO6T7.\4=YBYN<0'G+CI(3@3P0(">0!XK5
MC8/SBNJ6K>:,G( BP6M6!#C^SXI8:_HG)]":Y=*H5.R_&T6P_<)3 :G]RIPY
M)@*%(D"RL5!X&3D1:'D$2#:V?!%E%G#S+3:5>^^[1U8QQY_==6>M*=?,D3%
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MX)4(M"<")!O;L]R9:R*@")!L5"1X)0+MBP Y@?8M>^:<"  !<@+\#HA >R-
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MF>0=K\.XI!#CC3=>DA>^)P)$@ @0 2) !(@ $2 "1( ($ $B0 2( !$@ D2
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M4 4$2#96H129!R+@CP#)1G_L&)((5 $!DHU5*$7F@0CX(T"RT1\[AB0"54&
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M2E967/-V9F=J!_I@S6O2U0P8\Q:AY>,S9$. S\8;;]SR\C93P#3M<U'RH$_
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M;&D5D/"]H(S,6:X=6, T%@\Z#C[XX)HZ8,PRUJ!$\JD&CK;X8:R==5)FK:>
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MQ,8O_5ZU+42YHGY!UGHN2UF'ZW%:#J@HO.KE*X]W6K?RY@3RD*U>'.[&5RP
MJ0-?@SDROA4<-:+SA7#;82Q:!]^3L2:@P>TUJDZD[9NB^EC,&3 GU$W/D WM
M1-H-NQ *FW_U^T<:4<Y8VPO\N&,OWWFSUH5Z8U_40<A5Q%Q6T]=\IZV+P":J
M#/&\$0ZR$7F0=JLZ]/^*<:O*V(YRI55 \N$8@&=46Y5V/M!H>=1;LVDT;H;/
MCD"1G$!V:9)#0 E7VRPHJ/JX1G0.M"^(4T#2H[_B%)",5:1 ?I?'=.MDG *2
M.W9QCW:#PHT:T%!LHJX^"DB^Z]\ZOO19ZT\JTR0%)"A=:_[#1]FY<8/3@3]L
M\,GB?/!.4[[*_;OZ)5GD:K;?4BD@H5)A=R0*'!,%W;V@Q!-V+\0Y5Z/-/<_/
MF.:U\6& BH[MBBNNL+_5B@UVW.B':(Z*ZU#B!X03R'O7I?E L"B(^-P/9.ZY
MY[;/L$@1YQI5JE&-3:2-ALT<6=0!4@X-$A;=0+C@G:N 9(['"?(>7IA3.4$*
M*#XN\8:%8#S'! 03L*0_=R*H<4==E4SHW;MWU&O[K%&LZI$N2$ MOQ@SEP&!
MH18XH,R!B8KK&L$BJ;,R1U$%^.>](*!YT/)M1;)1.ZDP2:"RQUU//?74#FCW
MNHHKJ)OF^*9.0=0" KZK.*?E!*Q >KD[C3!@T,X=[4;X^XB+4Y^C,XRK'VG.
M9T4>L<M(%:L0+^)SE9"RG#6K R3DU6U+$2]V"6O] "9AA1)?G+#33+_#_OW[
M=[)^YK;O;CL$F=(X[.) _,#*M9;3B *2]B6(UYC;["2&JX"D>5,9H. %37@?
MJTN=$LKA@=:SO,E&$.+NP@X6[[#0CX&N.6*IPYBCK"O]*:><$GP7^,;#"A?H
MMZ!HHPI(4"I2DA&D7MCZ )1'M4V XH#KW&\7=2?/\X[==.+NXX@Q=]R!O@;M
MA8Z-$)=:6,2WA?8'WY4[=H%5).".]^XB%\*Z<:.<PH-Q*"WHMYO'N=)9RQ,R
M)K7/K7@&=1*NF%CJ=P@K:NI<0A@6.L,.Q+26A^[8#_OQ_=UJ9&-6!207.^S
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MNM*DB0JD><<NTR@7I8"$!DK#A1L>C2..>-MCCSUL6.#I+N)J.-\KCEV"3)A
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MV&D><44=5@4O13%IW*G^XJZ^XTO?[SAK_P>YZ[4U4?,17]GB,-+GC;37K:*
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M)M[..^\<BN;?U<V)IKVI#5TQA )25:'J\,,/C[8GE39MF@NA H<\RS:5GZ*
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M* Q@90E&F@5NQS_@ 0^8*H_U@7X)$?!-8]?FC]4&7#>H>R.M#R'"C&VVV:9
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M^-=U_M45D=)6S:_+^C(O6F=(W&@[APJA : % .@ Z(%9 .LMXU#<I/BSL%B
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M;,91CI$QL,P8R,S&9>[=W+:,@68,9&9C,XYRC(R!9<= 5D!:]A[.[<L8J,=
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MI(/V5Y?+H<+8XU[^\I>[+WSA"_Z<\^<__]G3Y:1]T8M>Y.YTISN%DN5W(\)
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M9.15$/?4I5*,N ";^,PE23WG/?>YSYVZ* &/4[];!:146?Q$X8$?7>7AJ?7
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M:IY5;^UJ&6BR:?YRD-37K<QNJF4F65S*=-4'-!<U?_47+\I'_ATN"V+FFV4
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M$:=LN[J:I)TIN*P3Y"CNQA+JGK.,"DBX9="YA<E-% 8YZ(LED5+AF>^X&+6
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MI<[#/OOL4X@KMDZ-Z"/_/N><<TIE(WC^Z&"@.X$<!B6AK;;:JJP;\IDF0%;
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MWW.%Z>CDP+&8C<BUSAC(&$C& 'O_RU_^<I]^1,>&Y/;DA!D#&0/=,,"Y&UH
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MO/VJ4-/&KSYC.:$*Y $O/W9NK>;!A:>/?_SCU6R6XO<L> )+@9C<B(R!%<'
M(O($N.2GLFPN'V))"-Y;'2 +9FV'?Q>3<=OT&-H@/CS&&"#?U?T"*X4*;<X#
M*,!J6F3$G_K4IX)_[#_$JS.FH>428IQ#\ZWCG^JE.>O>;6@%I*[R[[>^]:VE
MI2-<QJ&8I;0\;>(B*-:=8A8/54:/L92V=%);!:0^^B)]TMJ^'=OSTB@@??[S
MGR\G35_&Z,]^]C-_2UXG(8M!""QCX;SSS@M%\>]8L,AKN^VVB\;APQO>\(:R
M#2C[H"C3%OJDM66PL#+8F:C:_E!8)>S;+)CXRR2O!S[P@661*MC&7V0,^C!
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MSD\R_L!U5IP],?[ 2R0[P2 D$=""SQI)K@]VW5'KM0PV2:_9:-#EXJ8  $
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M4D?4$B];,0"7/L@2%TT8 #$=&;;AX<E.\J4@+H11%TSY0AWR!Q.\$^V+&]J
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M-.=AG'% DF,4UR9$/\(Q#R977GFEAS$P7AXB<LN22R[IGQ?!<R)X;(3]#N.
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M%D<7E(0$\B! 8V,>U-DF"12' (V-Q=$%)2&!O C0)I 7>;9+ L4@0)M ,?1
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MP ,_X:$C/?EEL!*G/SKJD'&*1!U@#L>NDTXZR=MUUUT]'7W(KUM')?+KKN:
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M?63:AXQPJ HF].^$$TXP3IS!?:[^1E_Q1P<D5S5(N4D@'0':!-+Q8VD2<)V
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MA/O"55==I599996*[:[^H$W 5<U1;A)H# ':!!K#D;60@*L$7+8)N,J<<I-
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M(4!C8UDTR7Z00'("M DD9\>2)% & K0)E$&+[ ,))"= FT!R=BQ) F4@0)M
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M">1*@#:!7/&S<1+(G0!M KFK@ *00*X$:!/(%3\;)X'<"= FD+L**  ).$F
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M#(7X1V-C(=1 (4@@5P*T">2*GXV30.X$:!/(7044@ 1R)4";0*[XV3@)Y$Z
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M@:QL JU)E[TF@>(3H$V@^#JBA"101 *,@*0M*4PD0 +1!/BU8S0;[B&!5B#
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M\ .G'_OO=[_[G<F#Z$6R'8Y+]:2A0X?Z[;STTDO&\0D.3^COXX\_[E<U<.!
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MD%<!DHUYC0SC0J Z B0;J^/,4Q#(LP Y@3Q'A[$A4'D!<@*5-^8)".19@)Q
MGJ/#V!"HO  Y@<H;\P0$;!2@ ,G&J#(G!#(4(-F8(29=(5"# B0;:S!H#!F!
M# 5(-F:(25<(U*  R<8:#!I#1B!C 7("&8/2'0(U)D!.H,8"QG 1R%B G$#&
MH'2'0(T)D!.HL8 Q7 1R(D !4DX"P3 0R*L R<:\1H9Q(5 = 9*-U7'F*0CD
M58!D8UXCP[@0J(X R<;J./,4!/(L0$X@S]%A; A47H"<0.6->0(">18@)Y#G
MZ# V!"HO0$Z@\L8\ 0$;!2A LC&JS F!# 5(-F:(25<(U*  R<8:#!I#1B!#
M 9*-&6+2%0(U*$"RL0:#QI 1R%B G$#&H'2'0(T)D!.HL8 Q7 0R%B GD#$H
MW2%08P+D!&HL8 P7@9P(4("4DT P# 3R*D"R,:^185P(5$> 9&-UG'D* GD5
M(-F8U\@P+@2J(T"RL3K./ 6!/ N0$\AS=!@; I47("=0>6.>@$">!<@)Y#DZ
MC V!R@N0$ZB\,4] P$8!"I!LC"IS0B!# 9*-&6+2%0(U*$"RL0:#QI 1R%"
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M.6.6,33FG&:<IBW)1B/!*P+N"IC?2\D)N/L=8.9N"Y 3<#O^S!Z!K',"B"*
M0&T)D!.HK7@Q6@3R(D !4EXBP3@0R*D R<:<!H9A(5 E 9*-58+F,0CD5*!2
MR49906;TZ-'>H$&#O//..\_KTJ5+4"PB/WNT:-'"FSAQ8J"2I+!BJZVVTGWL
MLLLN^CXI.#(_QR1YE3'(\<PSSP3W#1DR1%]+\DM<P9 4 4GAE&POUM XJE6
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M\<4737/]VI0%2#* 4L8L]S7F+&W2'B0;TXK1'@'[!,R?6?+[/P<""+@G0$[
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M5!"7KA&H 0%R C40)(:(0 4%R E4$)>N$;!8@ (DBX/+U!#(0H!D8Q:*](%
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MQB/G' @@X)Z ^;V(G(![L6?&"(@ .0&^!PBX+=#4.0&W]9D] DTO0$Z@Z6/
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MFJV]]MK>EU]^&?M/]^[=@S%\^.&'^G%IYR$WR2I7YN=>67TIZH@K0*IT7"A
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M'?51O6O2UL3YP@LOK/=Y^$)XI:HSSC@C^"CM/)YXXHG@F1*GJ".N *G2<:$
M*2H:7$, @6H)F-^/*4"JECC/02!? N0$\A4/1H- M07RDA.H]KQY'@((_$^
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M LFM:(F C0+D!&R,*G-"(+D .8'D5K1$ ($Z 0J0ZBPX0P"!" &2C1$H7$+
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M$TAN14L$$*@3H "ISH(S!!"($"#9&('")00<$B#9Z%"PF2H"$0(D&R-0N(2
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MYH- .@&2C>F\:(V ;0(D&VV+*/-!()T R<9T7K1&P$8!<@(V1I4Y(9!<@)Q
M<BM:(F"C #D!&Z/*G!!(+D!.(+D5+1% H$Z  J0Z"\X00"!"@&1C! J7$'!(
M@&2C0\%FJ@A$")!LC$#A$@(."9!L="C83!6!& %R C$P7$; $0%R HX$FFDB
M$"- 3B &ALL(.") 3L"10#--!#(6H  I8U"Z0\ V 9*-MD64^2"03H!D8SHO
M6B-@FP#)1MLBRGP02"= LC&=%ZT1L%& G("-465.""07(">0W(J6"-@H0$[
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ME3DAD%R G$!R*UHB8*, .0$;H\J<$$@N0$X@N14M$4"@3H "I#H+SA! ($*
M9&,$"I<0<$B 9*-#P6:J"$0(D&R,0.$2 @X)D&QT*-A,%8$8 7(",3!<1L 1
M 7("C@2::2(0(T!.( :&RP@X(D!.P)% ,TT$,A:@ "EC4+I#P#8!DHVV193Y
M()!.@&1C.B]:(V"; ,E&VR+*?!!()T"R,9T7K1&P48"<@(U194X()!<@)Y#<
MBI8(V"A 3L#&J#(G!)(+D!-(;D5+!!"H$Z  J<Z",P00B! @V1B!PB4$'!(@
MV>A0L)DJ A$")!LC4+B$@$,")!L="C9312!&@)Q # R7$7!$@)R (X%FF@C$
M") 3B('A,@*.") 3<"303!.!C 4H0,H8E.X0L$V 9*-M$64^"*03(-F8SHO6
M"-@F0++1MH@R'P32"9!L3.=%:P1L%" G8&-4F1,"R07("22WHB4"-@J0$[ Q
MJLP)@>0"Y 226]$2 03J!"A JK/@# $$(@1(-D:@< D!AP1(-CH4;*:*0(0
MR<8(%"XAX)  R4:'@LU4$8@1("<0 \-E!!P1("?@2*"9)@(Q N0$8F"XC( C
M N0$' DTTT0@8P$*D#(&I3L$;!,@V6A;1)D/ ND$2#:F\Z(U K8)D&RT+:+,
M!X%T B0;TWG1&@$;!<@)V!A5YH1 <@%R LFM:(F C0+D!&R,*G-"(+D .8'D
M5K1$ ($Z 0J0ZBPX0P"!" &2C1$H7$+ (0&2C0X%FZDB$"% LC$"A4L(."1
MLM&A8#-5!&($R G$P' 9 4<$R DX$FBFB4", #F!&!@N(^"( #D!1P+--!'(
M6( "I(Q!Z0X!VP1(-MH64>:#0#H!DHWIO&B-@&T")!MMBRCS02"= ,G&=%ZT
M1L!& 7("-D:5.2&07("<0'(K6B)@HP Y 1NCRIP02"Y 3B"Y%2T10*!.@ *D
M.@O.$$ @0H!D8P0*EQ!P2(!DHT/!9JH(1 B0;(Q X1("#@F0;'0HV$P5@1@!
M<@(Q,%Q&P!$!<@*.!)II(A C0$X@!H;+"#@B0$[ D4 S300R%J  *6-0ND/
M-@&2C;9%E/D@D$Z 9&,Z+UHC8)L R4;;(LI\$$@G0+(QG1>M$;!1@)R C5%E
M3@@D%R GD-R*E@C8*$!.P,:H,B<$D@N0$TAN14L$$*@3H "ISH(S!!"($"#9
M&('")00<$B#9Z%"PF2H"$0(D&R-0N(2 0P(D&QT*-E-%($: G$ ,#)<1<$2
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M,0*%2P@X)$"RT:%@,U4$8@3("<3 <!D!1P3("3@2:*:)0(P .8$8&"XCX(@
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MV6A;1)D/ ND$2#:F\Z(U K8)D&RT+:+,!X%T B0;TWG1&@$;!<@)V!A5YH1
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M)HI V0(4()5-2 <(((   @@@@  """"   ((((   @@@@  """"   ((((
M @@@@  ""+@K0 &2N[%GY@@@@  """"   ((((   @@@@  """"   ((((
M @@@@  """"   ((E"U  5+9A'2   ((((   @@@@  """"   ((((   @@@
M@  """"   ((((   @@@@("[ A0@N1M[9HX  @@@@  """"   ((((   @@@
M@  """"   ((((   @@@@  """" 0-D"52E >GWJ>VKWMCN6/5@Z0  !!!!
M  $$$$   0000  !!!!   $$$$   0000  !!!!   $$$$  @7P)5+P :<+/
MWZH'QS^ANG<\7*VS?(=\S9[1((   @@@@  """"   ((((   @@@@  """"
M  ((((   @@@@  """" 0%D"%2] >N"KQ]7$N9/4VBW75#W6^U-9@^5F!!!
M  $$$$   0000  !!!!   $$$$   0000  !!!!   $$$$   000R)= 10N0
MS.I'9LJL@F0D>$4  0000  !!!!   $$$$   0000  !!!!   $$$$   000
M0  !!!! P Z!BA8@F=6/#!6K(!D)7A%   $$$$   0000  !!!!   $$$$
M 0000  !!!!   $$$$   000L$.@8@5(Q:L?&2Y603(2O"*   ((((   @@@
M@  """"   ((((   @@@@  """"   ((((   @@@4/L"%2M *E[]R%"Q"I*1
MX!4!!!!   $$$$   0000  !!!!   $$$$   0000  !!!!   $$$$  @=H7
MJ$@!4MSJ1X:+59",!*\(((   @@@@  """"   ((((   @@@@  """"   ((
M((   @@@@  ""-2V0$4*D.)6/S)4K()D)'A%  $$$$   0000  !!!!   $$
M$$   0000  !!!!   $$$$   0000*"V!3(O0&IL]2/#Q2I(1H)7!!!   $$
M$$   0000  !!!!   $$$$   0000  !!!!   $$$$   01J5R#S J3&5C\R
M5*R"9"1X10 !!!!   $$$$   0000  !!!!   $$$$   0000  !!!!   $$
M$$"@=@4R+4!*NOJ1X6(5)"/!*P((((   @@@@  """"   ((((   @@@@  "
M"""   ((((   @@@@  "M2F0:0%2TM6/#!6K(!D)7A%   $$$$   0000  !
M!!!   $$$$   0000  !!!!   $$$$   000J$V!S J0TJY^9+A8!<E(\(H
M @@@@  """"   ((((   @@@@  """"   ((((   @@@@  """" 0.T)9%:
ME';U(T/%*DA&@E<$$$   0000  !!!!   $$$$   0000  !!!!   $$$$
M 0000  !!&I/(),"I%)7/S)<K()D)'A%  $$$$   0000  !!!!  '4G[_,
M $  241!5 $$$$   0000  !!!!   $$$$   0000*"V!#(I0"IU]2-#Q2I(
M1H)7!!!   $$$$   0000  !!!!   $$$$   0000  !!!!   $$$$   01J
M2Z#L J1R5S\R7*R"9"1X10 !!!!   $$$$   0000  !!!!   $$$$   000
M0  !!!!   $$$$"@=@3*+D J=_4C0\4J2$:"5P000  !!!!   $$$$   000
M0  !!!!   $$$$   0000  !!!!   $$:D>@K *DK%8_,ERL@F0D>$4  000
M0  !!!!   $$$$   0000  !!!!   $$$$   0000  !!!! H#8$RBI >N"K
MQ]3$N=]E-E-60<J,DHX00  !!!!   $$$$   0000  !!!!   $$$$   000
M0  !!!!   $$$*B*0,D%2%FO?F1FRRI(1H)7!!!   $$$$   0000  !!!!
M  $$$$   0000  !!!!   $$$$   03R+U!R 5+6JQ\9*E9!,A*\(H   @@@
M@  """"   ((((   @@@@  """"   ((((   @@@@  """"0?X&2"I JM?J1
MX6(5)"/!*P((((   @@@@  """"   ((((   @@@@  """"   ((((   @@@
M@  "^18HJ0"I4JL?&2I603(2O"*   ((((   @@@@  """"   ((((   @@@
M@  """"   ((((   @@@D&^!U 5(E5[]R'"Q"I*1X!4!!!!   $$$$   000
M0  !!!!   $$$$   0000  !!!!   $$$$  @?P*I"Y JO3J1X9J[9;M58_U
M_FC>\HH  @@@@  """"   ((((   @@@@  """"   ((((   @@@@  """"
M  (Y%$A=@)3#.3 D!!!   $$$$   0000  !!!!   $$$$   0000  !!!!
M  $$$$   000:"(!"I":"-Z5QW[PP0?JQ!-/U--=8845U%MOO>7*U',W3V*1
MNY P( 000  !!!!   $$$$   0000  !!!!   $$$$   0000  !!*P0H #)
MBC#F=Q(OO_RRVG????4 6[9LJ7[^^>?\#K9&1S9SYDS5IDT;Y7F>VF:;;=2P
M8<,B9T(L(EFXB  """"   ((((   @@@@  """"   ((((   @@@@  """"
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M8GG\\<>KJ5.GJO'CQ^L"LQMOO%$MM]QRYE9>$4   0000  !!!!   $$$$
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ML/E8Q_"MM][26\1)[.6@ "G@X00!!!!   $$$$   0000  !!!!   $$$$
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M%_5MM]UV>F4E&8.LP"5%568;/2GJVWOOO>6C>H=\AV65,3DH0*K'PP4$$$
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M_GG5K5LW?=ZU:U?U^NNOZ_.H7RA BE+A&@((((   @@@@  """"   ((((
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MZ-&Z6=X*D&1KP$<>>42/+;Q5H)E3^%7B+O&70U9ODKEQ((   @@@@  """"
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M/Q<00  !!!!   $$$$   0000  !!!!   $$$$   0000  !!!! H+8$K"E
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MU+: \P5(31&^J *DIA@'ST2@V@+77GNMZMV[MWZLK%KUP ,/5'L(/ \!!!!
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M0(   0($"! @0(   0($"! @0(   0($1A400!J5W\$)$"! @  ! @0($"!
M@  ! @0($"! @  ! @0($"! @  ! @0(++>  -)RCY_>$R! @  ! @0($"!
M@  ! @0($"! @  ! @0($"! @  ! @0($!A50 !I5'X')T"   $"! @0($"
M  $"! @0($"   $"! @0($"   $"! @0(+#< @)(RSU^>D^   $"! @0($"
M  $"! @0($"   $"! @0($"   $"! @0($!@5(&Y TA[_^]_-7_=]?,U[_21
M;SNS.?Y__>>:'\<!"! @0(   0($"! @0(   0($"! @0(   0($"! @0(
M 0($"!!87&#N -)??O&SYC?_[[\7/^+ ;Q[W'_^G67?*60.WMAD! @0($"!
M@  ! @0($"! @  ! @0($"! @  ! @0($"! @  ! F,(S!U 2B?7N@K2D1O?
MWAS_O_]K# _')$"   $"! @0($"   $"! @0($"   $"! @0($"   $"! @0
M($!@#H&% DAK705)]:,Y1M"F! @0($"   $"! @0($"   $"! @0($"   $"
M! @0($"   $"!$846"B E/ZN514DU8]&O!H<F@ ! @0($"! @  ! @0($"!
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M$"! @  ! @0($"! @  ! @1&%%AQ "E]7VD5)-6/1KP"')H  0($"! @0(
M 0($"! @0(   0($"! @0(   0($"! @0(# "@16)8"TTBI(JA^M8 1]E0 !
M @0($"! @  ! @0($"! @  ! @0($"! @  ! @0($"! @,"( JL20$K_%ZV"
MI/K1B*/OT 0($"! @  ! @0($"! @  ! @0($"! @  ! @0($"! @  ! @16
M*+!J :1%JR"I?K3"$?1U @0($"! @  ! @0($"! @  ! @0($"! @  ! @0(
M$"! @  ! B,*K%H *><P;Q4DU8]&''F')D"   $"! @0($"   $"! @0($"
M  $"! @0($"   $"! @0(+ * JL:0)JW"I+J1ZLP@G9!@  ! @0($"! @  !
M @0($"! @  ! @0($"! @  ! @0($"! 8$2!50T@Y3R&5D%2_6C$47=H @0(
M$"! @  ! @0($"! @  ! @0($"! @  ! @0($"! @  ! JLDL.H!I*%5D%0_
M6J41M!L"! @0($"   $"! @0($"   $"! @0($"   $"! @0($"   $"(PJL
M>@ IYS*K"I+J1R..N$,3($"   $"! @0($"   $"! @0($"   $"! @0($"
M  $"! @06$6!-0D@S:J"I/K1*HZ@71$@0(   0($"! @0(   0($"! @0(
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M"! @0(   0($"! @L$8":QY JE605#]:HQ&T6P($"! @0(   0($"! @0(
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M"(PO(( T_ACH 0$"! @0($"   $"! @0($"   $"! @0($"   $"! @0($"
M (&E%1! 6MJATW$"! @0($"   $"! @0($"   $"! @0($"   $"! @0($"
M  $"XPL(((T_!GI @  ! @0($"! @  ! @0($"! @  ! @0($"! @  ! @0(
M$"! 8&D%!)"6=NATG  ! @0($"! @  ! @0($"! @  ! @0($"! @  ! @0(
M$"! @,#X @)(XX^!'A @0(   0($"! @0(   0($"! @0(   0($"! @0(
M 0($"!!86@$!I*4=.ATG0(   0($"! @0(   0($"! @0(   0($"! @0(
M 0($"! @,+Z  -+X8Z '! @0($"   $"! @0($"   $"! @0($"   $"! @0
M($"   $"!)960 !I:8=.QPD0($"   $"! @0($"   $"! @0($"   $"! @0
M($"   $"! B,+R" -/X8Z $! @0($"! @  ! @0($"! @  ! @0($"! @  !
M @0($"! @ "!I1400%K:H=-Q @0($"! @  ! @0($"! @  ! @0($"! @  !
M @0($"! @  ! N,+"""-/P9Z0(   0($"! @0(   0($"! @0(   0($"! @
M0(   0($"! @0&!I!020EG;H=)P  0($"! @0(   0($"! @0(   0($"! @
M0(   0($"! @0(# ^ ("2../@1X0($"   $"! @0($"   $"! @0($"   $"
M! @0($"   $"! @06%H! :2E'3H=)T"   $"! @0($"   $"! @0($"   $"
M! @0($"   $"! @0(#"^@ #2^&.@!P0($"! @  ! @0($"! @  ! @0($"!
M@  ! @0($"! @  ! @265D  :6F'3L<)$"! @  ! @0($"! @  ! @0($"!
M@  ! @0($"! @  ! @0(C"\@@#3^&.@! 0($"! @0(   0($"! @0(   0($
M"! @0(   0($"! @0(  @:45$$!:VJ'3<0($"! @0(   0($"! @0(   0($
M"! @0(   0($"! @0(   0+C"P@@C3\&>D"   $"! @0($"   $"! @0($"
M  $"! @0($"   $"! @0($!@:04$D)9VZ'2<  $"! @0($"   $"! @0($"
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MZUU+T?4#=2W\^,<_;AYXX(%F\^;-,T.<*X&;-H>L9+^^2X   0($"! @0(
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MD-88^,7=3PL/_/.?_VSR+Z&.90AV'!BQQ8^R+/?>XF=XX+^YC &D*!V(:T$
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M^^;R!./R-R3S15J]'_-S[N^-&S?FQ]XVU#T&F1]S[]3Y,?-HO9?J_%B754L
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M*'_',@<E[)-6K^W\GCDKXS+DGLAWN_=OWALZ+]?Y9<A<-FT.R3$U @0($"!
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MK0DV)2B9Y4C3AMX3V7;2_9O/9HUA-9HUU[<#2'US2(ZE$2! @  ! @0($"!
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MJ6*5P%P"(JD\E>I'N:9R;:U6.Y#'6JT^V\_R"DP*("WO&>DY 0($"! @0(
M 0($"! @0(   0($"! @0(   0($#@X! :2#8QSF[L433SS1W'CCC;W?6XWJ
M1[T['OG-G3MWEF7A3CWUU&;+EBTC]^;0/?S--]]<EE_KGF$JR&S=NK54J.I^
MMNCO!_)8B_;1]PX= 0&D0V<LG0D! @0($"! @  ! @0($"! @  ! @0($"!
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M0(   0($"! @0(   0($1A000!H1WZ$)$"! @  ! @0($"! @  ! @0($"!
M@  ! @0($"! @  ! @0(++N  -*RCZ#^$R! @  ! @0($"! @  ! @0($"!
M@  ! @0($"! @  ! @0($!A10 !I1'R')D"   $"! @0($"   $"! @0($"
M  $"! @0($"   $"! @0(+#L @)(RSZ"^D^   $"! @0($"   $"! @0($"
M  $"! @0($"   $"! @0($!@1 $!I!'Q'9H  0($"! @0(   0($"! @0(
M 0($"! @0(   0($"! @0(# L@L(("W[".H_ 0($"! @0(   0($"! @0(
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!@@$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
